Document:

EXHIBIT 10.0

--------------------------------------------------------------------------------

                               TRAVELNOW.COM INC.

                       CLASS A CONVERTIBLE PREFERRED STOCK

                               PURCHASE AGREEMENT

<PAGE>

                                TABLE OF CONTENTS

                                                                            Page
                                                                            ----
SECTION 1.   AUTHORIZATION AND SALE OF SHARES.................................1
    1.1      Authorization....................................................1
    1.2      Sale of Shares...................................................1
    1.3      Terms of Preferred Stock.........................................1

SECTION 2.   CLOSING DATE; DELIVERY...........................................1
    2.1      Closing Date.....................................................1
    2.2      Delivery.........................................................1

SECTION 3.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY....................2
    3.1      Organization and Standing........................................2
    3.2      Corporate Power; Authorization...................................2
    3.3      Issuance and Delivery of the Shares and the Common Stock.........3
    3.4      SEC Documents; Financial Statements..............................3
    3.5      Intellectual Property............................................3
    3.6      Properties.......................................................4
    3.7      Capitalization...................................................4
    3.8      Litigation.......................................................4
    3.9      No Defaults......................................................4
    3.10     Governmental Consents............................................4
    3.11     Taxes............................................................5
    3.12     Insurance........................................................5
    3.13     No Material Adverse Change.......................................5
    3.14     Disclosure.......................................................5
    3.15     Nasdaq SmallCap Market Qualification.............................5
    3.16     Investment Company...............................................5

SECTION 4.   REPRESENTATIONS, WARRANTIES AND COVENANTS OF PURCHASERS..........5
    4.1      Authorization....................................................5
    4.2      Investment Experience............................................6
    4.3      Investment Intent................................................6
    4.4      Registration or Exemption Requirements...........................6
    4.5      Restriction on Short Sales.......................................7
    4.6      No Legal, Tax or Investment Advice...............................7

SECTION 5.   CONDITIONS TO CLOSING OF PURCHASERS..............................7
    5.1      Representations and Warranties...................................7
    5.2      Legal Opinion....................................................7
    5.3      Officer's Certificate............................................7
    5.4      Registration Statement...........................................7

<PAGE>

    5.5      Covenants........................................................7
    5.6      Additional Documents.............................................7

SECTION 6.   CONDITIONS TO CLOSING OF COMPANY.................................8
    6.1      Receipt of Payment...............................................8
    6.2      Representations and Warranties...................................8
    6.3      Covenants........................................................8

SECTION 7.   AFFIRMATIVE COVENANTS OF THE COMPANY.............................8
    7.1      Financial Information............................................8
    7.2      Registration Requirements........................................8
    7.3      Indemnification and Contribution................................11

SECTION 8.   RESTRICTIONS ON TRANSFERABILITY OF SHARES AND COMMON STOCK:
             COMPLIANCE WITH SECURITIES ACT..................................13
    8.1      Restrictions on Transferability.................................13
    8.2      Restrictive Legend..............................................13
    8.3      Transfer of Shares and Common Stock.............................14
    8.4      Purchaser Information...........................................14
    8.5      Special Provisions Relating to Tudor............................14

SECTION 9.   MISCELLANEOUS...................................................15
    9.1      Waivers and Amendments..........................................15
    9.2      Governing Law...................................................15
    9.3      Survival........................................................15
    9.4      Successors and Assigns..........................................15
    9.5      Entire Agreement................................................15
    9.6      Notices, etc....................................................15
    9.7      Severability Of This Agreement..................................16
    9.8      Counterparts....................................................16
    9.9      Further Assurances..............................................16
    9.10     Expenses........................................................16

<PAGE>

             CLASS A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT

          This Class A Convertible Preferred Stock Purchase Agreement (the
"Agreement") is entered into this ____ day of January, 2000 by and among
TRAVELNOW.COM INC., a Florida corporation (the "Company"), with its principal
office at 318 Park Central East, Suite 306, Springfield, Missouri 75806 and
RAPTOR GLOBAL PORTFOLIO, LTD., with its principal office at 40 Rowes Wharf,
Boston, Massachusetts, 02110, on its own behalf and on behalf of each of the
Tudor Entities (as defined below) that acquires or holds Shares or Common Stock
(as defined below) (collectively, the "Purchasers").

SECTION I. AUTHORIZATION AND SALE OF SHARES

     A. Authorization. The Company has authorized the sale and issuance of up to
Five Hundred Thousand (500,000) shares of Class A Convertible Preferred Stock,
no par value (the "Shares").

     B. Sale of Shares. Subject to the terms and conditions of this Agreement,
the Company agrees to issue and sell to each Purchaser and each Purchaser
severally agrees to purchase from the Company on the Closing Date (as defined
below), the number of shares of Class A Convertible Preferred Stock set forth
opposite each Purchaser's name on Exhibit A for a purchase price (the "Purchase
Price") of Nine Dollars ($9) per Share.

     C. Terms of Preferred Stock. The Shares shall have the preferences and
rights set forth in the Articles of Amendment to the Articles of Incorporation
of TravelNow.com, Inc. adopted by the Board of Directors and filed with the
Florida Department of State on or before the "Closing Date" (as defined below)
substantially in the form attached hereto as Exhibit B. Without limiting any of
the rights, powers, preferences and qualifications set forth in said Articles of
Amendment, the Shares shall be convertible into shares of common stock of the
Company (the "Common Stock").

SECTION II. CLOSING DATE; DELIVERY

     A. Closing Date. The closing of the purchase and sale of the Shares (the
"Closing") shall be held at the offices of Shook, Hardy & Bacon, L.L.P., 1010
Grand Boulevard, Kansas City, Missouri at 10:00 a.m. Central Standard Time, on
January 5, 2000 or at such other time and place upon which the Company and
Purchasers purchasing the majority of the Shares shall agree. The date of the
Closing is hereinafter referred to as the "Closing Date."

     B. Delivery. At the Closing, the Company shall deliver to each Purchaser a
certificate, registered in the Purchaser's name as shown on Exhibit A,
representing the number of Shares to be purchased by the Purchaser. Such
delivery shall be against payment of the Purchase Price therefor by wire
transfer of immediately available funds in the amount set forth opposite such
Purchaser's name on Exhibit A to a bank account designated in writing by the
Company to each Purchaser at least two (2) business days prior to the Closing
Date. Each Purchaser shall only be obligated to pay the Purchase Price of the
Shares purchased by it.

<PAGE>

SECTION III. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company hereby represents and warrants as of the date hereof to, and
covenants with, the Purchasers as follows:

     A. Organization and Standing. The Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the
jurisdiction of its incorporation, has full corporate power and authority to own
or lease its properties and conduct its business presently and as proposed to be
conducted and as described in the Company's annual report on Form 10-KSB for the
year ended March 31, 1999 (the "Form 10-KSB") and is duly qualified as a foreign
corporation and in good standing in all jurisdictions in which the character of
the property owned or leased or the nature of the business transacted by it
makes qualification necessary (except where the failure to be so qualified would
not have a Material Adverse Effect (as defined below) on the business,
properties, financial condition or results or operations of the Company). Except
as set forth on Schedule 3.1 hereto, the Company has no subsidiaries or equity
interest in any other entity.

     B. Corporate Power; Authorization. The Company has all requisite corporate
power, and has taken all requisite corporate action, to execute and deliver this
Agreement, to sell and issue the Shares and to carry out and perform all of its
obligations under this Agreement. This Agreement constitutes the legal, valid
and binding obligation of the Company, enforceable in accordance with its terms,
except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws relating to or affecting the enforcement of
creditors' rights generally, (ii) as limited by equitable principles generally
and (iii) as to those provisions of Section 7.3 hereof relating to indemnity or
contribution as limited by public policy. The execution and delivery of this
Agreement does not, and the performance of this Agreement and the compliance
with the provisions hereof and the issuance, sale and delivery of the Shares by
the Company will not conflict with, or result in a breach or violation of the
terms, conditions or provisions of, or constitute a default (or an event that
with notice or lapse of time or both would constitute a default) under, or
result in the creation or imposition of any lien pursuant to the terms of, the
Company's articles of incorporation, as amended, (the "Articles of
Incorporation") or its bylaws (the "Bylaws") or, to the Company's knowledge, any
statute, law, rule or regulation, or any state or federal order, judgment or
decree applicable to the Company or any indenture, mortgage, lease or other
agreement or instrument to which the Company or any of its properties is
subject, except as would not individually or in the aggregate have a material
adverse effect on, or result in a material adverse change in, the business,
properties, operation, condition (financial or other), prospects or results of
operations of the Company, taken as a whole, or render this Agreement, or any
portion hereof, invalid or unenforceable or impair in any material respect the
ability of the Company to perform fully its obligations hereunder (any of the
foregoing shall be referred to herein as a "Material Adverse Effect").

     C. Issuance and Delivery of the Shares and the Common Stock. The Shares
have been duly authorized and, when issued and paid for in compliance with the
provisions of this Agreement, will be validly issued, fully paid and
nonassessable. When issued upon the conversion of the Shares, the Common Stock
so issued will be duly authorized, validly issued, fully paid and nonassessable
and will conform to the description thereof contained in the Registration
Statement (as defined below). Neither the issuance and delivery of the Shares

<PAGE>

nor the Common Stock issuable upon conversion of Shares is subject to
preemptive, co-sale, right of first refusal or any other similar rights of any
third person or any liens or encumbrances. The Company has not granted any
presently effective registration rights with respect to its securities other
than the registration rights set forth herein. No further approval or authority
of the stockholders or Board of Directors of the Company will be required for
the issuance and sale of the Shares or the Common Stock issuable upon conversion
of the Shares.

     D. SEC Documents; Financial Statements. Except as set forth in Schedule 3.4
hereof, the Company has filed in a timely manner all documents that the Company
was required to file with the Securities and Exchange Commission (the SEC")
under Sections 13, 14(a) and 15(d) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), during the twelve (12) months preceding the date
of this Agreement. As of their respective filing dates, all documents filed by
the Company with the SEC (the "SEC Documents") complied in all material respects
with the requirements of the Exchange Act. The SEC Documents as of their
respective dates contained no untrue statement of material fact or omitted to
state a material fact required to be stated therein or necessary to make the
statements made therein, in light of the circumstances under which they were
made, not misleading. The financial statements of the Company included in the
SEC Documents (the "Financial Statements") comply as to form in all material
respects with applicable accounting requirements and with the published rules
and regulations of the SEC with respect thereto. The Financial Statements have
been prepared in accordance with generally accepted accounting principles
consistently applied and fairly present the financial position of the Company at
the dates thereof and the results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal,
recurring adjustments). There is no material commitment of the Company which is
not reflected in the Financial Statements except commitments made in the
ordinary course of business. There have not been any changes in the assets,
liabilities, financial condition or operations of the Company from that
reflected in the Financial Statements, except changes in the ordinary course of
business that have not had a Material Adverse Effect.

     E. Intellectual Property. The Company owns or possesses adequate rights to
use all patents, patent rights, inventions, trade secrets and know-how used by
it or that are necessary for the conduct of its business as presently conducted
and proposed to be conducted as described in the SEC Documents. The Company has
not received any notice of, nor has any knowledge of, any infringement of or
conflict with asserted rights of others with respect to any patent, patent
right, invention, trade secret or know-how that, individually or in the
aggregate, if the subject of an unfavorable decision, ruling or finding, would
have a Material Adverse Effect.

     F. Properties. The Company has good and valid title to all of the
properties and assets reflected as owned in the Financial Statements, free and
clear of all liens, mortgages, (statutory or otherwise), security interests,
pledges, claims or encumbrances except those, if any, disclosed in the Financial
Statements. The Company holds its leased properties under valid and binding
leases, with such exceptions as are not materially significant in relation to
the business of the Company. The Company owns or leases all of such properties
which, to its knowledge, are necessary to its operations as now conducted.

<PAGE>

     G. Capitalization. All of the Company's outstanding shares of capital stock
have been duly authorized and validly issued and are fully paid and
nonassessable, have been issued in compliance with all federal and state
securities laws, and were not issued in violation of or subject to any
preemptive right or other rights to subscribe for or purchase securities. The
actual authorized and outstanding capital stock of the Company as of the date
hereof and as of the Closing Date is set forth in Schedule 3.7 hereto, assuming
that all Shares are issued pursuant to the terms of this Agreement. Except as
disclosed in Schedule 3.7 hereto, there are no outstanding options to purchase,
or any preemptive rights or other rights to subscribe for or to purchase, any
securities or obligations convertible into, or any contracts or commitments to
issue or sell shares of the Company's capital stock or any such options, rights,
convertible securities or obligations.

     H. Litigation. There is no pending or, to the Company's knowledge,
threatened action, suit or other proceeding before any court, governmental body
or authority, or arbitrator to which the Company is a party or to which its
property or assets are subject.

     I. No Defaults. The Company is not in violation or default of any provision
of the Articles of Incorporation or Bylaws, or any organizational documents, or,
to the Company's knowledge, in breach with respect to any agreement, judgment,
decree, order, mortgage, deed of trust, lease, franchise, license, indenture,
permit or other instrument to which it is a party or by which it or any of its
properties are bound which violation, default or breach would have a Material
Adverse Effect; and the Company is not aware of any fact which constitutes an
event of default on the part of the Company as defined in such documents or
which, with notice or lapse of time or both, would constitute such an event of
default.

     J. Governmental Consents. No consent, approval, order or authorization of,
or registration, qualification, designation, declaration or filing with any
federal, state, or local governmental authority on the part of the Company is
required in connection with the consummation of the transactions contemplated by
this Agreement except for (a) compliance with the securities and blue sky laws
in the states and other jurisdictions in which Shares are offered and/or sold,
which compliance will be effected in accordance with such laws, and (b) the
filing of the Registration Statement and all amendments thereto with the SEC as
contemplated by Section 7.2 hereof. The Company has not been advised, and has no
reason to believe, that it is not conducting business in compliance in all
material respects with all applicable laws, rules and regulations of the
jurisdictions in which it is conducting business including but not limited to,
all applicable local, state and federal environmental laws and regulations.

     K. Taxes. The Company has accurately prepared and timely filed all federal,
state and other tax returns which are required to be filed by it and has timely
paid all taxes covered by such returns which have become due and payable except
for such taxes as are being contested in good faith. The Company has no
knowledge of any tax deficiency which has been or might be asserted or
threatened against the company which would have a Material Adverse Effect.

     L. Insurance. The Company maintains insurance of the types and in the
amounts it deems adequate for its business covering all risks customarily
insured against, all of which insurance is in full force and effect.

<PAGE>

     M. No Material Adverse Change. There have not been any changes in the
assets, liabilities, financial condition or operations of the Company from that
reflected in the Financial Statements except changes in the ordinary course of
business that have not had a Material Adverse Effect.

     N. Disclosure. This Agreement does not contain any untrue statement of fact
or omit to state a fact necessary in order to make the statements contained
herein not materially misleading.

     O. Nasdaq SmallCap Market Qualification. The Company has submitted a
listing application and listing agreement with Nasdaq to list the Common Stock
for quotation on the Nasdaq SmallCap Market. If such listing is approved, for so
long as the Company is obligated to keep in effect the Registration Statement
provided under Section 7.2 hereof, the Company shall use its reasonable best
efforts to maintain such listing on the Nasdaq SmallCap Market, the Nasdaq
National Market System or a national securities exchange, as defined in the
Exchange Act. The Company shall also file a share listing application with
Nasdaq, as and when appropriate, covering the Shares and the Common Stock
issuable upon the conversion of the Shares.

     P. Investment Company. The Company is not a registered investment company
within the meaning of the Investment Company Act of 1940, as amended.

SECTION IV. REPRESENTATIONS, WARRANTIES AND COVENANTS OF PURCHASERS

     Each Purchaser hereby severally and not jointly, represents and warrants to
the Company, effective as of the Closing Date, as follows:

     A. Authorization. Purchaser represents and warrants to the Company that:
(i) Purchaser has all requisite legal and corporate or other power and capacity
and has taken all requisite corporate or other action to execute and deliver
this Agreement, to purchase the Shares to be purchased by it and to carry out
and perform all of its obligations under this Agreement; and (ii) this Agreement
constitutes the legal, valid and binding obligation of Purchaser, enforceable in
accordance with its terms, except (a) as limited by applicable bankruptcy,
insolvency, reorganization, or similar laws relating to or affecting the
enforcement of creditors' rights generally and (b) as limited by equitable
principles generally.

     B. Investment Experience. Purchaser is an "accredited investor" as defined
in Rule 501(a) under the Securities Act of 1933, as amended (the "Securities
Act"). Purchaser is aware of the Company's business affairs and financial
condition and has had access to and has acquired sufficient information about
the Company to reach an informed and knowledgeable decision to acquire the
Shares. Purchaser has such business and financial experience as is required to
give it the capacity to protect its own interests in connection with the
purchase of the Shares. Purchaser is able to bear the economic risk of holding
the Shares for an indefinite period, including the loss of Purchaser's entire
investment. The Shares were not offered or sold to Purchaser by any form of
general solicitation or advertising.

<PAGE>

     C. Investment Intent. Purchaser is purchasing the Shares for its own
account as principal, for investment purposes only, and not with a view to, or
for, resale, distribution or fractionalization thereof, in whole or in part,
within the meaning of the Securities Act. Purchaser understands that its
acquisition of the Shares has not been registered under the Securities Act or
registered or qualified under any state securities law in reliance on specific
exemptions therefrom, which exemptions may depend upon, among other things, the
bona fide nature of Purchaser's investment intent as expressed herein. Purchaser
has, in connection with its decision to purchase the number of shares set forth
in Exhibit A hereto, relied solely upon the representations and warranties of
the Company contained herein.

     D. Registration or Exemption Requirements.

          1. Purchaser further acknowledges and understands that the Shares may
be required to be held indefinitely, and they may not be resold or otherwise
transferred except in a transaction registered under the Securities Act or where
an exemption from such registration is available. Purchaser understands that the
certificate(s) evidencing the Shares will be imprinted with a legend that
prohibits the transfer of the Shares unless (i) they are registered or such
registration is not required, and (ii) if the transfer is pursuant to an
exemption from registration other than Rule 144 promulgated under the Securities
Act ("Rule 144") and, if the Company shall so request in writing, an opinion of
counsel satisfactory to the Company is obtained to the effect that the
transaction is so exempt and in compliance with applicable state law.

          2. Purchaser further acknowledges that because the Shares are not
listed on the Nasdaq National Market System or a national securities exchange,
resale of the Shares may be limited by applicable state law, even where a
registration statement covering resale of the Shares has been declared effective
under the Securities Act. For example, certain states may limit resale of the
Shares to qualified institutions or in unsolicited qualified broker transactions
in the absence of qualification or another exemption in such state.

     E. Restriction on Short Sales. Purchaser represents and warrants to and
covenants with the Company that neither Purchaser nor its affiliates has engaged
or will engage in any short sales of Common Stock prior to the effectiveness of
the Registration Statement (as defined below), except to the extent that any
such short sale is fully covered by shares of Common Stock other than the shares
of Common Stock issuable upon conversion of the Shares

     F. No Legal, Tax or Investment Advice. Purchaser understands that nothing
in this Agreement or any other materials presented to Purchaser in connection
with the purchase and sale of the Shares constitutes legal, tax or investment
advice. Purchaser has consulted such legal, tax and investment advisors as it,
in its sole discretion, has deemed necessary or appropriate in connection with
its purchase of the Shares.

SECTION V. CONDITIONS TO CLOSING OF PURCHASERS

     Each Purchaser's obligation to purchase the Shares at the Closing is, at
the option of such Purchaser, subject to the fulfillment or waiver as of the
Closing Date of the following conditions:

<PAGE>

     A. Representations and Warranties. The representations and warranties made
by the Company in Section 3 hereof shall be true and correct in all material
respects when made, and shall be true and correct in all material respects on
the Closing Date with the same force and effect as if they had been made on and
as of said date.

     B. Legal Opinion. The Company shall have delivered a legal opinion from
Shook, Hardy & Bacon, L.L.P. counsel to the Company, addressed to the Purchasers
in the form attached hereto as Exhibit C with respect to the sale of the Shares
hereunder.

     C. Officer's Certificate. The Company shall deliver to the Purchasers a
certificate, dated as of the Closing Date, signed by a Co-Chief Executive
Officer of the Company, stating that the signer of said certificate has
carefully examined the SEC Documents and that the representations and warranties
set forth in Section 3 hereof are true as of and all of the closing conditions
set forth in Section 5 hereof have been satisfied on the Closing Date.

     D. Registration Statement. The Company shall have delivered a preliminary
draft of the Registration Statement (as defined below) that is to be filed with
the Securities and Exchange Commission as required herein.

     E. Covenants. All covenants, agreements and conditions contained in this
Agreement to be performed by the Company on or prior to the Closing Date shall
have been performed or complied with in all material respects.

     F. Additional Documents. The Purchasers shall have received such other
documents as they and their counsel may reasonably request for the purpose of
facilitating the consummation or performance of the sale of the Shares and they
and their counsel shall be satisfied with all matters and proceedings related to
this Agreement.

SECTION VI. CONDITIONS TO CLOSING OF COMPANY

     The Company's obligation to sell and issue the Shares at the Closing is, at
the option of the Company, subject to the fulfillment or waiver of the following
conditions:

     A. Receipt of Payment. The Company shall have received payment, by check or
wire transfer of immediately available funds, in the full amount of the Purchase
Price for the Shares sold.

     B. Representations and Warranties. The representations made by the
Purchasers in Section 4 hereof shall be true and correct in all material
respects when made, and shall be true and correct in all material respects on
the Closing Date with the same force and effect as if they had been made on and
as of such date.

     C. Covenants. All covenants, agreements and conditions contained in this
Agreement to be performed by the Purchasers on or prior to the Closing Date
shall have been performed or complied with in all material respects.

<PAGE>

SECTION VII. AFFIRMATIVE COVENANTS OF THE COMPANY

     The Company hereby covenants and agrees as follows:

     A. Financial Information. The Company will mail the following reports to
the Purchasers until the Purchasers transfer, assign or sell more than
seventy-five percent (75 %) of the Shares purchased by the Purchasers pursuant
to this Agreement:

          1. A copy of its Annual Report on Form 10-KSB, within ninety (90) days
after the end of each fiscal year or by such later date as such Form 10-KSB may
be filed with the Securities and Exchange Commission in compliance with federal
securities laws.

          2. A copy of its Quarterly Report on Form 10-QSB within forty-five
(45) days after the end of the first, second and third quarterly accounting
periods of each fiscal year of the Company or by such later date as such Form
10-KSB may be filed with the Securities and Exchange Commission in compliance
with federal securities laws.

     B. Registration Requirements.

          1. No later than fifteen (15) business days following the Closing
Date, the Company shall file with the SEC one or more registration statements on
Form SB-2 (together with any prospectus included therein, a "Registration
Statement") pursuant to Rule 415 of the Securities Act in order to register with
the SEC the continuous resale by the Purchasers, from time to time, of all
shares of Common Stock of the Company that may be acquired by the Purchasers
through any exchange or conversion of the Shares as provided for in Exhibit B
attached hereto, through the Nasdaq SmallCap Market or the facilities of any
national securities exchange on which the Common Stock is then traded, or in
privately-negotiated transactions. The Company shall use its best efforts to (i)
cause such Registration Statement to be declared effective on or before March
15, 2000 and (ii) cause a Nasdaq application covering shares of Common Stock of
the Company to have become effective (which application shall also cover the
Shares and the Common Stock issuable upon the conversion of the Shares). Each
Purchaser agrees to furnish promptly to the Company in writing all information
required from time to time to be disclosed in order to make the information
previously furnished to the Company by such holder not misleading.

          2. If at any time following the filing of a Registration Statement by
the Company, the Company shall qualify to file a registration statement on Form
S-3 under the Securities Act, the Company shall thereafter be entitled to
replace any Form SB-2 registration statement referred to in Section 7.1(a) above
with a registration statement on Form S-3 that has been declared effective by
the SEC. Any such Form S-3 used to replace a Form SB-2 pursuant to this Section
7.2(b), together with any prospectus included in such Form S-3, shall thereafter
be referred to as a "Registration Statement" and any Form SB-2 that is so
replaced shall cease to be referred to by that term for purposes of this
Agreement.

<PAGE>

          3. The Company shall pay all Registration Expenses (as defined below)
in connection with any registration, qualification or compliance hereunder, and
each Purchaser shall pay all Selling Expenses (as defined below) and other
expenses that are not Registration Expenses relating to the Common Stock resold
by such Purchaser. "Registration Expenses" shall mean all expenses, except for
Selling Expenses, incurred by the Company in complying with the registration
provisions herein described, including without limitation, all registration,
qualification and filing fees (including all SEC and Nasdaq fees), printing
expenses, escrow fees, fees and disbursements of counsel for the Company and for
any underwriter (unless paid by such underwriter), blue sky fees and expenses
and the expense of any special audits incident to or required by any such
registration. "Selling Expenses" shall mean only selling commissions,
underwriting fees and stock transfer taxes applicable to the Common Stock sold
by each Purchaser and all fees and disbursements of counsel for any Purchaser.

          4. In the case of the registration effected by the Company pursuant to
these registration provisions, the Company will use its best efforts to:

               a. keep such registration statement on From SB-2 or Form S-3
effective until the earlier of (A) the second anniversary of the date on which
the Registration Statement first becomes effective, (B) such date as all of the
Common Stock has been resold or (C) such time as all of the Common Stock held by
the Purchasers can be sold within a given three-month period without compliance
with the registration requirements of the Securities Act pursuant to Rule 144;

               b. prepare and file with the SEC such amendments and supplements
to the Registration Statement and the prospectus used in connection therewith as
may be necessary to comply with the provisions of the Securities Act with
respect to the disposition of all securities covered by the Registration
Statement;

               c. furnish such number of prospectuses and other documents
incident thereto, including any amendment of or supplement to the prospectus, as
a Purchaser from time to time may reasonably request;

               d. cause all Common Stock registered as described herein to be
listed on each securities exchange and quoted on each quotation service on which
the common equity securities of the Company are then listed or quoted;

               e. provide a transfer agent and registrar for all Common Stock
registered pursuant to the Registration Statement and a CUSIP number for all
such Common Stock;

               f. otherwise use its best efforts promptly to comply with all
applicable rules and regulations of the SEC;

<PAGE>

               g. file the documents required of the Company and otherwise use
its best efforts promptly to obtain, if applicable, and maintain requisite blue
sky clearance in (A) all jurisdictions in which any of the Shares are originally
sold and (B) all other states specified in writing by a Purchaser, provided as
to clause (B) however, that the Company shall not be required to qualify to do
business or consent to service of process in any state in which it is not now so
qualified or has not so consented; and

               h. with respect to the initial filing of the Registration
Statement, as of the date of declaration of effectiveness, obtain an opinion of
counsel to the Company in customary form and reasonably acceptable to each
Purchaser addressed to each Purchaser selling registrable securities pursuant to
the Registration Statement. The Company shall use its best efforts to qualify
for use of Form SB-2 or Form S-3 under the Securities Act to register the resale
of the Common Stock issuable upon the conversion of the Shares and to maintain
such qualification during the periods described in subsection (c)(i) hereof and
to be listed on the Nasdaq Small Cap market and maintain such listing unless
listed on NMS or another national exchange.

          5. The Company shall furnish to each Purchaser upon request a
reasonable number of copies of a supplement to or an amendment of such
prospectus as may be necessary in order to facilitate the public sale or other
disposition of all or any of the Common Stock held by the Purchaser.

          6. With a view to making available to the Purchasers the benefits of
Rule 144 and any other rule or regulation of the SEC that may at any time permit
a Purchaser to sell Common Stock to the public without registration or pursuant
to registration, the Company covenants and agrees to: (i) make and keep public
information available, as those terms are understood and defined in Rule 144,
until the earlier of (A) the second anniversary of the Closing Date or (B) such
date as all of the Common Stock shall have been resold: (ii) file with the SEC
in a timely manner all reports and other documents required of the Company under
the Exchange Act; and (iii) furnish to any Purchaser upon request, as long as
the Purchaser owns any Common Stock, (A) a written statement by the Company that
it has complied with the reporting requirements of the Exchange Act, (B) a copy
of the most recent annual or quarterly report of the Company, and (C) such other
information as may be reasonably requested in order to avail any Purchaser of
any rule or regulation of the SEC that permits the selling of any such Common
Stock without registration.

          7. The Company may, at any time, refuse to permit a Purchaser to
resell any Common Stock pursuant to the Registration Statement; provided,
however, that in order to exercise this right at any time the Company does not
qualify for either Form SB-2 or Form S-3, the Company must deliver a certificate
in writing to the Purchasers to the effect that suspension of the sale of shares
under the Registration Statement, until such time as the Company can make an
appropriate filing with the SEC, is necessary because a sale pursuant to the
Registration Statement, in its then-current form, could constitute a violation
of the federal securities laws. In such an event, the Company shall use its best
efforts to amend the Registration Statement if necessary and take all other
actions necessary to allow such sale under the federal securities laws, and
shall notify the Purchasers and the Placement Agent promptly after it has
determined that such sale has become permissible under the federal securities
laws. Notwithstanding the foregoing, the Company shall not under any

<PAGE>

circumstances be entitled to exercise its right to suspend sales under the
Registration Statement more than two (2) times in any twelve (12) month period,
and the period during which such Registration Statement may be withdrawn shall
not exceed thirty (30) days.

     C. Indemnification and Contribution.

          1. The Company agrees to indemnify and hold harmless each Purchaser
and its officers, directors, controlling persons and affiliates from and against
any losses, claims, damages or liabilities (or actions or proceedings in respect
thereof) to which such Purchaser may become subject (under the Securities Act,
state law, common law or otherwise) insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of, or are
based upon, any untrue statement of a material fact contained in, or omission of
a material fact from, the Registration Statement, or arise out of any failure by
the Company to fulfill any undertaking included in the Registration Statement or
this Agreement, and the Company will, as incurred, reimburse such Purchaser for
any legal or other expenses reasonably incurred in investigating, defending or
preparing to defend any such action, proceeding or claim; provided however, that
the Company shall not be liable in any such case to the extent that such loss,
claim, damage or liability arises out of, or is based upon an untrue statement
made in such Registration Statement in reliance upon and in conformity with
information furnished to the Company in writing by or on behalf of such
Purchaser specifically for use in preparation of the Registration Statement. The
Company will reimburse the Purchasers for any legal or other expenses reasonably
incurred and documented in investigating, defending or preparing to defend any
such action, proceeding or claim notwithstanding the absence of a judicial
determination as to the propriety and enforceability of the obligations under
this section and the possibility that such payments might later be held to be
improper, provided, that to the extent any such payment is ultimately held to be
improper, the persons receiving such payments shall promptly refund them.

          2. Each Purchaser, severally and not jointly, agrees to indemnify and
hold harmless the Company from and against any losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) to which the Company
may become subject (under the Securities Act, state law, common law or
otherwise) insofar as such losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) arise out of, or are based upon an untrue
statement made in such Registration Statement in reliance upon and in conformity
with information furnished to the Company in writing by or on behalf of such
Purchaser specifically for use in preparation of the Registration Statement;
provided, however, that no Purchaser shall be liable in any such case for any
untrue statement included in any Prospectus which statement has been corrected,
in writing, by such Purchaser and delivered to the Company before the sale from
which such loss occurred and in no event shall any Purchaser be liable for any
amount in excess of the net proceeds received for the sale of its Common Stock
pursuant to such Registration Statement.

          3. Promptly after receipt by any indemnified person of a notice of a
claim or the beginning of any action in respect of which indemnity is to be
sought against an indemnifying person pursuant to this Section 7.3, such
indemnified person shall notify the indemnifying person in writing of such claim
or of the commencement of such action, and, subject to the provisions
hereinafter stated, in case any such action shall be brought against an
indemnified person and the indemnifying person shall have been noticed thereof,

<PAGE>

the indemnifying person shall be entitled to participate therein, and, to the
extent that it shall wish, to assume the defense thereof, with counsel
reasonably satisfactory to the indemnified person. After notice from the
indemnifying person to such indemnified person of the indemnifying person's
election to assume the defense thereof, the indemnifying person shall not be
liable to such indemnified person for any legal expenses subsequently incurred
by such indemnified person in connection with the defense thereof; provided,
however, that if there exists or shall exist a conflict of interest that would
make it inappropriate in the reasonable judgment of the indemnified person for
the same counsel to represent both the indemnified person and such indemnifying
person or any affiliate or associate thereof, the indemnified person shall be
entitled to retain its own counsel at the expense of such indemnifying person.

          4. If the indemnification provided for in this Section 7.3 is
unavailable to or insufficient to hold harmless an indemnified party under
subsection (a) or (b) hereof in respect of any losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) referred to therein,
then each indemnifying party shall contribute to the amount paid or payable by
such indemnified party as result of such losses, claims, damages or liabilities
(or actions in respect thereof) in such proportion as is appropriate to reflect
the relative fault of the Company on the one hand and the Purchasers on the
other in connection with the statements or omissions which resulted in such
losses, claims, damages or liabilities (or actions in respect thereof), as well
as any other relevant equitable considerations. The relative fault shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company on the one hand
or a Purchaser on the other and the parties' relative intent, knowledge, access
to information and opportunity to correct or prevent such statement or omission.
The Company and the Purchasers agree that it would not be just and equitable if
contribution pursuant to this subsection (d) were determined by pro rata
allocation (even if the Purchasers were treated as one entity for such purpose)
or by any other method of allocation which does not take account of the
equitable considerations referred to above in this subsection (d). The amount
paid or payable by an indemnified party as a result of the losses, claims,
damages, or liabilities (or actions in respect thereof) referred to above in
this subsection (d) shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim. Notwithstanding the provisions of this
subsection (d), no Purchaser shall be required to contribute any amount in
excess of the amount, if any, by which the amount received by the Purchaser from
the sale of the Common Stock to which such loss relates exceeds the amount of
any damages which such Purchaser has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No
person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. The Purchasers'
obligations in this subsection (d) to contribute are several in proportion to
their respective sales of Common Stock.

          5. The obligations of the Company and the Purchasers under this
Section 7.3 shall be in addition to any liability which the Company and the
respective Purchasers may otherwise have.

<PAGE>

SECTION VIII. RESTRICTIONS ON TRANSFERABILITY OF SHARES AND COMMON STOCK:
              COMPLIANCE WITH SECURITIES ACT

     A. Restrictions on Transferability. Neither the Shares nor the Common Stock
shall be transferable in the absence of a registration under the Securities Act
or an exemption therefrom or in the absence of compliance with any term of this
Agreement. The Company shall be entitled to give stop transfer instructions to
its transfer agent with respect to the Shares and the Common Stock in order to
enforce the foregoing restrictions.

     B. Restrictive Legend. Each certificate representing the Shares or the
Common Stock shall bear substantially the following legends (in addition to any
legends required under applicable securities laws):

          THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
          ACQUIRED FOR INVESTMENT PURPOSES ONLY AND HAVE NOT BEEN
          REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
          ANY STATE SECURITIES LAWS. THE SHARES MAY NOT BE SOLD OR
          TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN
          EXEMPTION THEREFROM. THE COMPANY WILL PROVIDE A SUMMARY
          STATEMENT DESCRIBING THE AUTHORITY OF THE COMPANY TO ISSUE
          DIFFERENT CLASSES OF SHARES OR DIFFERENT SERIES WITHIN A
          CLASS, THE DESIGNATIONS, RELATIVE RIGHTS, PREFERENCES, AND
          LIMITATIONS APPLICABLE TO EACH CLASS AND THE VARIATIONS IN
          RIGHTS, PREFERENCES, AND LIMITATIONS FOR EACH SERIES (AND
          THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE
          VARIATIONS FOR FUTURE SERIES) TO THE RECORD HOLDER OF THIS
          CERTIFICATE WITHOUT CHARGE ON REQUEST TO THE COMPANY AT ITS
          PRINCIPAL PLACE OF BUSINESS OR REGISTERED OFFICE.

     C. Transfer of Shares and Common Stock. The Purchasers hereby covenant with
the Company not to make any sale of the Shares or the Common Stock except either
(i) in accordance with Rule 144, in which case Purchasers covenant to comply
with Rule 144 or (ii) pursuant to another exemption under the Securities Act; or
in case of sales of Common Stock in accordance with the Registration Statement,
in which case Purchasers covenant to comply with the requirement of delivering a
current prospectus. Permissible sales of the Shares shall include sales between
and among the Purchasers, provided such sales comply with the first sentence of
this Section 8.3.

     D. Purchaser Information. The Company may require each Purchaser to furnish
the Company with such information and undertakings as it may reasonably request
in writing from time to time regarding such Purchaser and the distribution of
any of that Purchaser's Common Stock and each Purchaser hereby covenants that it

<PAGE>

will notify the Company in writing of any changes regarding such Purchaser or
its distribution of Common Stock that may affect the accuracy of the
Registration Statement.

     E. Special Provisions Relating to Tudor. For purposes of determining
whether, for any provision hereof, the number of shares of capital stock held by
a Tudor Entity (as defined below) is sufficient to meet a required threshold,
such Tudor Entity shall be deemed to hold the number of shares of capital stock
issued or issuable upon conversion, exercise or exchange, directly or
indirectly, of any derivative securities held by such Tudor Entity and any of
its Affiliates and other Tudor Entities.

     "Tudor Entity" or "Tudor Entities" means each of the following: Tudor
Private Equity Fund, L.P., Tudor Arbitrage Partners, L.P., Tudor BVI Futures,
Ltd., Raptor Global Fund, L.P., Raptor Global Fund Ltd., Raptor Global
Portfolio, Ltd., ALTAR Rock Fund, L.P. or any funds or other investment vehicles
or entities of which any of the forgoing entities are Affiliates, or any
Affiliate or Affiliated Group of Tudor Investment Corporation and/or Tudor
Global Trading, Inc.

     "Affiliate" means any other person directly or indirectly controlling,
controlled by, or under direct or indirect common control with the referenced
person or entity and includes without limitation, (a) any person who is an
officer, director, general partner or direct or indirect beneficial holder of at
least 5% of the then outstanding capital stock of the referenced person or
entity, (b) any person of which the referenced person or entity and/or its
Affiliates (as defined in clause (a) above), directly or indirectly, either
beneficially own(s) at least 5% of the then outstanding equity securities or
constitute(s) at least a 5% equity participant, and (c) any entities for which a
Tudor Entity or any of its Affiliates (as defined in clauses (a) or (b) above)
serve as general partner and/or investment advisor or in a similar capacity, and
all mutual funds or other pooled investment vehicles or entities under the
control or management of such Tudor Entity or the general partner or investment
adviser thereof or any person in a similar capacity, or any Affiliate (as
defined in clause (a) or (b) above) of any of them, or any Affiliates of any of
the foregoing.

     "Affiliated Group" has the meaning given to it in Section 1504 of the
Internal Revenue Code of 1986, as amended, and in addition includes any
analogous combined, consolidated, or unitary group, as defined under any
applicable state, local, or foregoing income tax law.

SECTION IX. MISCELLANEOUS

     A. Waivers and Amendments. With the exception of Section 7 hereof, the
terms of this Agreement may be waived or amended with the written consent of the
Company and each Purchaser to be affected thereby. Any such amendment or waiver
shall be binding upon the Company and each such Purchaser. Section 7 hereof may
be waived or amended with the written consent of the Company and the record
holders of more than Fifty percent (50%) of the Shares and the Common Stock then
outstanding and held by Purchasers, and any such amendment or waiver shall be
binding upon the Company and all holders of Shares and Common Stock then
outstanding.

<PAGE>

     B. Governing Law. This Agreement shall be governed in all respects by and
construed in accordance with the laws of the State of Missouri without any
regard to conflicts of laws principles.

     C. Survival. The representations, warranties, covenants and agreements made
in this Agreement shall survive any investigation made by the Company or the
Purchasers and the Closing.

     D. Successors and Assigns. The provisions hereof shall inure to the benefit
of, and be binding upon, the successors, assigns, heirs, executors and
administrators of the parties to this Agreement.

     E. Entire Agreement. This Agreement constitutes the full and entire
understanding and agreement between the parties with regard to the subjects
hereof.

     F. Notices, etc. All notices and other communications required or permitted
under this Agreement shall be effective upon receipt and shall be in writing and
may be delivered in person, by telecopy, overnight delivery service or
registered or certified United States mail, addressed to the Company or the
Purchasers, as the case may be, at their respective addresses set forth at the
beginning of this Agreement, or on Exhibit A, or at such other address as the
Company or the Purchasers shall have furnished to the other party in writing
with a copy to:

        Shook, Hardy & Bacon L.L.P.
        1010 Grand Boulevard
        Kansas City, MO 64106
        Attention: Kevin R. Sweeney, Esq.
        Telecopier No.: (816)842-3190

   and

        Bingham Dana LLP
        150 Federal Street
        Boston, Massachusetts 02110
        Attention: Victor J. Paci, Esq.
        Telecopier No.: (617) 951-8736

All notices and other communications shall be effective upon the earlier of
actual receipt thereof by the person to whom notice is directed or (i) in the
case of notices and communications sent by personal delivery or telecopy, one
business day after such notice or communication arrives at the applicable
address or was successfully sent to the applicable telecopy number, (ii) in the
case of notices and communications sent by overnight delivery service, at noon
(local time) on the second business day following the day such notice or
communication was sent, and (iii) in the case of notices and communications sent
by United States mail, seven (7) days after such notice or communication shall
have been deposited in the United States mail.

<PAGE>

     G. Severability Of This Agreement. If any provision of this Agreement shall
be judicially determined to be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby.

     H. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.

     I. Further Assurances. Each party to this Agreement shall do and perform or
cause to be done and performed all such further acts and things and shall
execute and deliver all such other agreements, certificates, instruments and
documents as the other party hereto may reasonably request in order to carry out
the intent and accomplish the purposes of this Agreement and the consummation of
the transactions contemplated hereby.

     J. Expenses. At the Closing, the Company shall pay by wire transfer or
check (delivered at Closing) the reasonable fees and expenses of legal counsel
of the Purchasers incurred in connection with the execution and delivery of this
Agreement by the Purchasers and the consummation of the transactions
contemplated hereby, not to exceed $13,000.

     IN WITNESS WHEREOF, this Agreement is hereby executed as of the date first
above written.

                                           the "Company"
                                           TRAVELNOW.COM INC.

                                           /s/ Jeffrey A. Wasson
                                           -----------------------------------
                                           By:    Jeffrey A. Wasson
                                           Title: Co-Chief Executive Officer

                                           the "Purchasers"
                                           RAPTOR GLOBAL PORTFOLIO, LTD.

                                           Name:
                                           -----------------------------------
                                           By:
                                           -----------------------------------
                                           Title:
                                           -----------------------------------
                                                  [Print Name and Title]

<PAGE>

Exhibit A........Schedule of Purchasers
Exhibit B .......Articles of Amendment to Articles of Incorporation
Exhibit C........Form of SHB Closing Date Legal Opinion
Exhibit D........Form of Purchaser's Officers Certificate For Transfer of
                 Securities
Exhibit E........Form of SHB Effective Date Legal Opinion
Schedule 3.1.....Subsidiaries/Equity Interests
Schedule 3.4.....SEC Documents
Schedule 3.7.....Capitalization, Etc.

<PAGE>

                                   EXHIBIT - A
                                   -----------

                             SCHEDULE OF PURCHASERS

Purchaser Name and Address                            Number of Shares Purchased
--------------------------                            --------------------------
Raptor Global Portfolio, Ltd.                                   497,820
Tudor Private Equity Fund, L.P.                                       0
Tudor Arbitrage Partners, L.P.                                        0
Tudor BVI Futures, Ltd.                                               0
Raptor Global Fund, L.P.                                              0
Raptor Global Fund Ltd.                                               0
ALTAR Rock Fund, L.P.                                             2,180
All other Tudor Entities as defined in
Section 8.5 of this Agreement                                         0
                                                                -------

TOTAL SHARES SOLD:                                              500,000
                                                                =======

<PAGE>

                                   EXHIBIT - B
                                   -----------

               ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION

                                 (See attached)

<PAGE>

                                   EXHIBIT - C
                                   -----------

                     FORM OF SHB CLOSING DATE LEGAL OPINION

                                 (See attached)

<PAGE>

                                  Law Offices
                          ---------------------------
                          SHOOK, HARDY & BACON L.L.P.

 Overland Park          1010 Grand Bouldevar, 5th Floor                London
    Houston                  Post office Box 15607                     Zurich
Washington, D.C.        Kansas City, Missouri 64106-0607               Geneva
 San Francisco              Telephone (816) 474-6550                  Melbourne
     Miami                  Facsimile (816) 842-3190                Buenos Aires

                                 January 5, 2000

Raptor Global Portfolio, Ltd.
40 Rowes Wharf
2nd Floor
Boston, Maine 02110

          Re: TravelNow.com Inc.

Ladies and Gentlemen:

     We have acted as special outside counsel to TravelNow.com Inc. (the
"Company") in connection with the transactions described in the Class A
Convertible Preferred Stock Purchase Agreement dated January 4, 2000 (the
"Agreement") by and between the Company and Raptor Global Portfolio, Ltd. and
each of the Tudor Entities (collectively, the "Purchasers"), pursuant to which
the Company has agreed to issue and sell to you an aggregate of Five Hundred
Thousand (500,000) shares of Class A Convertible Preferred Stock, no par value
(the "Shares"). This opinion is furnished to you pursuant to Section 5.3 of the
Agreement. Capitalized terms used herein and not otherwise defined herein have
the respective meanings provided in the Agreement.

     In rendering the opinions expressed below, we have examined and are
familiar with originals or copies of the documents set forth below and such
other agreements, instruments and documents as we have deemed necessary as a
basis for such opinions. In rendering the opinions herein we have relied solely
upon our examination of the following documents and have made no independent
verification or investigation of the matters set forth in such documents:

     1. Certified copies of the Articles of Incorporation of the Company and
amendments thereto that have been provided to us by the Florida Department of
State and their bylaws (collectively, "Corporate Records");

     2. The Articles of Amendment to the Articles of Incorporation dated January
4, 2000; and

     3. the Agreement (and all exhibits attached thereto).

     In rendering the opinions set forth herein, we have assumed (i) the
genuineness of all signatures on all documents submitted to us, (ii) the
capacity and competence of each natural person who executed any of these
documents, (iii) the authenticity of all documents submitted to us as originals

<PAGE>

Raptor Global Portfolio, Ltd.
January 5, 2000
Page 2

and of the originals of all documents submitted to us as copies, (iv) the
conformity with the original documents of all documents submitted to us as
copies, and (v) the due authorization, execution and delivery of the Agreement
by all parties thereto other than the Company. We have also assumed that any
certificate, telegram or other document relating to corporate existence and good
standing on which we have relied, which was given or dated earlier than the date
of this letter, has remained accurate as far as relevant to the opinions
contained herein from such earlier date through and including the date of this
letter. We have further assumed that each entity that is a party to the
Agreement other than the Company has been duly organized or formed and is in
good standing as a corporate or partnership organization under the laws of its
jurisdiction. As to any facts material to this opinion, we have, to the extent
that such facts were not independently established by us, relied upon
representations and warranties contained in the Agreement.

     We are opining solely with respect to, and we express no opinion herein
concerning any laws other than, the internal laws of Missouri (exclusive of
conflict of laws principles), the 1989 Business Corporation Act of Florida, and
any applicable federal laws of the United States of America to the extent
specifically referred to herein.

     It is our opinion that:

     1. The Company is a corporation duly organized, validly existing, and in
good standing under the laws of the State of Florida, with all requisite
corporate power and authority to execute, deliver, and perform its obligations
under the Agreement, to issue, sell, and deliver the Shares, and to carry on its
business as presently conducted and to own the property and assets currently
owned by it.

     2. The Company's execution and delivery of the Agreement and its
consummation of the transactions contemplated thereby have been duly authorized
by all necessary corporate and stockholder action on the part of the Company.
The Agreement has been duly executed and delivered by the Company and is a valid
and binding agreement and obligation of the Company, enforceable against the
Company in accordance with its terms.

     3. Neither the Company's execution and delivery of the Agreement, nor its
issuance and sale to you of the Shares, including the Common Stock issuable upon
the conversion of the Purchased Shares, nor its compliance with the terms of the
Agreement will conflict with, result in any breach of any of the provisions of,
constitute a default under, or result in the creation or imposition of any lien
upon any of the property of the Company pursuant to the Company's Articles of
Incorporation (as amended) or by-laws, or any Missouri or Federal statute, rule,
or regulation, or Florida corporation law, or to the best of our knowledge, any
contract, agreement or instrument to which the Company is a party or any
judgment, order, or decree of any court or arbitrator specifically naming the
Company.

<PAGE>

Raptor Global Portfolio, Ltd.
January 5, 2000
Page 3

     4. The authorized capital stock of the Company consists of (i) 50,000,000
shares of common stock, no par value, of which to the best of our knowledge,
10,349,304 shares were issued and outstanding of record immediately prior to the
Closing, and (ii) 25,000,000 shares of Preferred Stock, no par value per share,
none of which were issued and outstanding of record immediately prior to the
Closing. To the best of our knowledge, except as set forth in Schedule 3.7 to
the Agreement, there are no options, warrants, pre-emptive rights, conversion
privileges or other securities of the Company presently outstanding which
contain or create the right to acquire any shares of the capital stock or other
securities of the Company.

     5. The Shares to be purchased by you pursuant to the Agreement have been
duly authorized by all necessary corporate and stockholder action on the part of
the Company and such Shares, and the Common Stock issuable upon the conversion
of such Shares, when issued and sold to you against full payment therefore in
accordance with the terms of the Agreement or conversion thereof pursuant to the
Company's Articles of Incorporation (as amended) will be duly authorized,
validly issued, fully paid, and non-assessable. The issuance of the Shares, and
the Common Stock issuable upon the conversion of the Shares, is not subject to
any preemptive right, first refusal right or other right to subscribe for or
purchase such shares pursuant to the Company's Articles of Incorporation (as
amended), by-laws or applicable Missouri, and Florida corporation laws.

     6. Based in part on the Purchaser's representations and warranties set
forth in Section 4 of the Stock Purchase Agreement, the issuance by the Company
to you of the Shares, and the issuance of the Common Stock upon the conversion
of the Shares, will not require registration under Section 5 of the Securities
Act of 1933, as amended, or under applicable Florida and Missouri blue sky laws.

     7. To the best of our knowledge, there is no action, suit, proceeding, or
governmental investigation pending or threatened against the Company.

     8. Except pursuant to federal and state securities laws and except for the
filing of the Articles of Amendment to the Articles of Incorporation of the
Company referred to in the Agreement with the Florida Department of State, no
consent, approval, or authorization of or by, or any designation, declaration,
filing, registration, or qualification with any governmental authority is
required on the part of the Company in connection with the Company's execution,
delivery, and performance of its obligations under the Agreement and its offer,
issuance, sale, and delivery to you of the Shares, and the Common Stock issuable
upon the conversion of the Shares, pursuant to the Agreement.

     The foregoing opinions are subject to the following qualifications and
limitations:

          A. The enforceability of the Agreement may be limited or affected by
(a) bankruptcy, insolvency, reorganization, moratorium, liquidation,
rearrangement, probate, conservatorship, fraudulent transfer, fraudulent
conveyance and other similar laws (including court decisions) now or hereafter

<PAGE>

Raptor Global Portfolio, Ltd.
January 5, 2000
Page 4

in effect and affecting the rights and remedies of creditors generally or
providing for the relief of debtors, (b) the availability of remedies which are
equitable in nature including but not limited to the remedies of specific
performance and injunctive relief which are subject to the discretion of the
court before which any proceeding therefor may be brought and may not be
available with respect to the enforcement of the terms or provision of the
Agreement and (c) concepts of materiality, reasonableness, good faith and fair
dealing.

          B. In rendering the foregoing opinions, we express no opinion as to
(a) the availability of certain equitable remedies, including specific
performance, and further, (b) the legality, validity, enforceability or binding
effect of provisions of the Agreement relating to indemnities and rights of
contribution to the extent prohibited by public policy.

          C. Whenever any opinion or statement herein with respect to the
existence or absence of facts, conditions or circumstances is qualified by the
phrase "to our knowledge", "known to us" or words or phrases of similar import
it is intended to indicate that, during the course of our representation of the
Company in connection with the negotiation, execution and delivery of the
Agreement, no information has come to our attention that would give us actual
knowledge of the existence or absence of such facts, conditions or
circumstances. We have not undertaken any independent investigation to determine
the existence or absence of such facts, conditions or circumstances and no
inferences as to our actual knowledge of the existence or absence of such facts,
conditions or circumstances should be drawn from the fact of our representation
of the Company in connection with the negotiation, execution or delivery of the
Agreement. In that regard, we have not made an independent review of any of the
business, properties, operations, transactions, contractual arrangements, orders
or actions or other matters and affairs of or pertaining to the Company, nor
have we undertaken to review our internal files or the files of the Company with
respect to any of the matters contained herein. Furthermore, the phrase "to our
knowledge" refers to the actual present knowledge of the attorneys in our Firm
who have devoted substantive attention to the negotiation, execution and
delivery of the Agreement by the Company, and not to the knowledge of the Firm
of its partners, or employees generally.

     The opinions expressed herein are solely for benefit of, and may be relied
upon by, the addressee hereof in connection with the transaction described
herein. The opinions may not be relied upon for any other purpose or relied upon
by any other person, Firm or entity for any purpose. This letter may not be
paraphrased, quoted or summarized, nor may it be duplicated or reproduced in
whole or in part, without our prior written consent. The opinions expressed
herein are as of the date hereof or, to the extent a reference to a certificate
or other document is made herein, to such date and we make no undertaking to
amend or supplement such opinions as facts and circumstances come to our
attention or changes in the law occur which could affect such opinions.

<PAGE>

Raptor Global Portfolio, Ltd.
January 5, 2000
Page 5

                                         Very truly yours,

                                         /s/ SHOOK, HARDY & BACON L.L.P.
                                         -------------------------------
                                         SHOOK, HARDY & BACON L.L.P.

<PAGE>

                                 SCHEDULE - 3.1
                                 --------------

                          SUBSIDIARIES/EQUITY INTERESTS

     Forty-nine percent (49%) equity position (percentage calculated as of
September 30, 1999 and reported on Form 10-QSB) in Nippon TravelNow, K.K. a
Japanese company.

<PAGE>

                                 SCHEDULE - 3.4
                                 --------------

                                  SEC DOCUMENTS

     Securities and Exchange Commission filings made prior to July 27, 1999 by
the Company may not have been made in a timely manner.

<PAGE>

                                 SCHEDULE - 3.7
                                 --------------

                              CAPITALIZATION, ETC.

     Authorized and outstanding Common Stock = 10,349,304 shares

     Authorized and outstanding Class A Convertible Preferred Stock = 500,000
          shares immediately convertible into 500,000 shares of Common Stock

     Stock options on 530,000 shares of Common Stock were granted during the
          quarter ended September 30, 1999. The options have exercise prices
          ranging from $1.50 per share to $65.00 per share and exercise dates
          from July 2000 to August 2004 for 500,000 of the shares and September
          2000 to September 2006 for 30,000 shares.<PAGE>

                                                                    EXHIBIT 10.1

                        SERIES B CONVERTIBLE PREFERRED
                           STOCK PURCHASE AGREEMENT

     THIS AGREEMENT made as of the 22nd day of December, 1995, by and among
Sequenom, Inc., a Delaware corporation (the "Corporation"); the several
investors named on the Schedule of Investors attached hereto (individually, an
"Initial Investor", and collectively, the "Initial Investors"); such additional
investors as may be identified on such addenda to the Schedule of Investors as
may be agreed upon by the Corporation and such additional investors in
accordance with the terms of this Agreement (individually, an "Additional
Investor", and collectively, the "Additional Investors") (the Initial Investors
and the Additional Investors being hereinafter sometimes referred to
individually as an "Investor" and collectively as the "Investors"); and, solely
for purposes of Section 8.1 hereof, Hubert Koster, Nola E. Masterson, and Robert
E. Patterson (individually a "Founder" and collectively the "Founders).

     WHEREAS, the Investors wish to purchase from the Corporation, and the
Corporation wishes to sell to the Investors, up to an aggregate of 3,333,333
shares of the Corporation's Series B Convertible Preferred Stock, par value
$.001 per share (the "Series B Preferred");

     WHEREAS, pursuant to that certain Stock Purchase Agreement dated May 26,
1994 (the "Original Purchase Agreement") the Corporation granted certain rights
of first refusal to certain of the Initial Investors and the Founders, and the
Corporation, such Initial Investors and the Founders now desire to replace such
rights of first refusal in the Original Purchase Agreement with the rights of
first refusal set forth in Section 8.1 hereof;

     NOW, THEREFORE, in consideration of the premises and the mutual covenants
and agreements herein contained, the parties hereby agree as follows:

     SECTION 1.  Amendment of Certificate of Incorporation.  Immediately prior
     ---------   -----------------------------------------
to the execution and delivery of this Agreement, the Corporation filed with the
Secretary of State of Delaware a Certificate of Amendment (the "Certificate of
Amendment"), a copy of which is attached hereto as Exhibit 1, to its Certificate
of Incorporation (the Certificate of Incorporation of the Corporation, as
amended by the Certificate of Amendment and in effect on the date hereof being
hereinafter referred to as the "Certificate of Incorporation"), for the purpose
of increasing and amending the authorized capital stock of the Corporation and
setting forth the designations and the powers, preferences and rights, and the
qualifications, limitations and restrictions thereof, granted to or imposed upon
the capital stock of the Corporation or the holders thereof.

     SECTION 2.  Purchase and Sale of the Series B Preferred.
     ---------   -------------------------------------------

          2.1  Initial Shares.  Subject to the terms and conditions of this
               --------------
Agreement, at the Initial Closing (as defined in Section 3.1), the Corporation
agrees to issue and sell an aggregate of 2,333,333 shares of Series B Preferred
(the "Initial Shares") to the Initial Investors, and each Initial Investor,
acting severally and not jointly, hereby agrees to purchase from the Corporation
the number of Initial Shares set forth opposite the name of such Initial
Investor on
<PAGE>

the Schedule of Investors, at the purchase price of $1.50 per share and at the
aggregate purchase price set forth opposite the name of such Initial Investor on
the Schedule of Investors.

          2.2  Additional Shares.  Subject to the terms and conditions of this
               -----------------
Agreement, from time to time after the Initial Closing, but on or before January
31, 1996, the Corporation hereby agrees to issue and sell up to an aggregate of
1,000,000 shares of Series B Preferred (the "Additional Shares") to one or more
Additional Investors who enter into this Agreement by executing one or more
counterparts hereof.  By executing such a counterpart, each such Additional
Investor shall agree to purchase that number of Additional Shares as may be set
forth opposite its name on such addenda to the Schedule of Investors which may
be agreed upon between the Corporation and each such Additional Investor, at the
purchase price of $1.50 per share and at the aggregate purchase price set forth
opposite such Additional Investor's name on such addenda.  Each such addendum
shall be executed by the Corporation and each such Additional Investor, a copy
of each such addendum shall be delivered to each Investor, and each such
addendum shall be deemed a part of this Agreement ab initio.  Initial Investors
                                                  -- ------
may become Additional Investors.

     The Initial Shares and the Additional Shares are referred to collectively
hereinafter as the "Shares".

     SECTION 3.  Closings.
     ---------   --------

          3.1  Initial Closing.  The closing of the sale and purchase of the
               ---------------
Initial Shares (the "Initial Closing") shall take place simultaneously with the
execution of this Agreement at the offices of Foley, Hoag & Eliot, One Post
Office Square, Boston, Massachusetts 02109, on December 22, 1995 (the "Initial
Closing Date"), or at such other location, date and time as may be agreed upon
between the Initial Investors and the Corporation.  At the Initial Closing, the
Corporation shall issue and deliver to each Initial Investor a certificate or
certificates registered in the name of such Initial Investor, representing the
Initial Shares being purchased by it at the Initial Closing, against payment by
such Initial Investor to the Corporation of the purchase price therefor in the
form of (a) a check payable to the order of the Corporation, (b) a wire transfer
to the account of the Corporation, (c) cancellation of indebtedness of the
Corporation to such Investor or an affiliate of such Investor, (d) conversion of
convertible promissory notes issued by the Corporation to such Investor or an
affiliate of such Investor, or (e) any Combination of (a), (b), (c) and (d)
above.

          3.2  Additional Closings.  The closings of the sale and purchase of
               -------------------
the Additional Shares under this Agreement (the "Additional Closings") shall
take place at such time, date and place as are mutually agreeable to the
Corporation and any Additional Investor, but such Additional Closings, if any,
shall take place on or before January 31, 1996.  At the Additional Closings, the
Corporation shall issue and deliver to each Additional Investor a certificate or
certificates registered in the name of such Additional Investor, representing
the Additional Shares being purchased by it at the Additional Closing, against
payment by such Additional Investor to the Corporation of the purchase price
therefor in the form of (a) a check payable to the order of the Corporation, (b)
a wire transfer to the account of the Corporation, (c) cancellation of
indebtedness of the Corporation to such Additional Investor, (d) conversion of

                                      -2-
<PAGE>

convertible promissory notes issued by the Corporation to such Additional
Investor, or (e) any combination of (a), (b), (c) and (d) above.

     SECTION 4.  Representations and Warranties of the Corporation.  The
     ---------   -------------------------------------------------
Corporation hereby represents and warrants to the Investors as follows:

          4.1  Organization.  The Corporation is a corporation duly organized,
               ------------
validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power and authority to own and lease its
properties, to carry on its business as presently conducted and as proposed to
be conducted and to carry out the transactions contemplated hereby. Except as
set forth in Exhibit 4.1, the Corporation is duly qualified as a foreign
             -----------
corporation and is in good standing in all such other jurisdictions (which
jurisdictions are listed in Exhibit 4.1) in which the conduct of its business or
                            -----------
its ownership or leasing of property requires such qualification and in which
the failure so to qualify or so to be in good standing would have a materially
adverse effect on the Corporation's operations or financial condition.  Exhibit
                                                                        -------
4.1 contains true, complete and accurate copies of the Certificate of
---
Incorporation and the By-Laws, as amended to date, of the Corporation (the
"ByLaws").

          4.2  Capitalization.  The entire authorized capital stock of the
               --------------
Corporation consists of:

          (a)  5,726,700 shares of Common Stock, par value $.001 per share (the
"Common Stock");

          (b)  1,650,000 shares of Series A Convertible Preferred Stock, par
value $.001 per share (the "Series A Preferred"); and

          (C)  3,376,666 shares of Series B Preferred.

     The number of shares of Common Stock and Series A Preferred that are issued
and outstanding or held as treasury shares as of the date hereof is as set forth
in Exhibit 4.2.  All issued and outstanding shares of Common Stock and Series A
   -----------
Preferred are validly issued, fully paid and nonassessable.  The number of
shares of Common Stock reserved for issuance upon the exercise of options
granted and to be granted, and upon conversion of the Series A Preferred and the
Series B Preferred, is as set forth in Exhibit 4.2.  Prior to the Initial
                                       -----------
Closing, no shares of Series B Preferred were issued or outstanding.
Immediately following the Initial Closing, 2,333,333 shares of Series B
Preferred (the "Initial Shares") will be issued and outstanding and held by the
Initial Investors, and 1,000,000 shares of Series B Preferred (the "Additional
Shares") will be reserved for issuance at the Additional Closings.

     Exhibit 4.2 contains a list of all holders of capital stock of the
     -----------
Corporation and options, warrants or rights to purchase such capital stock, in
each case including the number of shares of capital stock held by, or subject to
purchase pursuant to the exercise of any option, warrant or right held by, each
such holder.  Except as set forth in Exhibit 4.2, there are no outstanding
                                     -----------
shares of capital stock of the Corporation or warrants, options, agreements,
convertible securities or other commitments pursuant to which the Corporation is
or may become obligated to issue

                                      -3-
<PAGE>

any shares of its capital stock or other securities of the Corporation. Except
as set forth in Exhibit 4.2, the number of shares of capital stock, if any,
                -----------
reserved for issuance in connection with the securities described in the
immediately preceding sentence is not subject to adjustment by reason of the
issuance of the Shares or the Reserved Shares (as defined in Section 4.16).
Except as set forth in Exhibit 4.2, there are no preemptive or similar rights to
                       -----------
purchase or otherwise acquire shares of capital stock of the Corporation
pursuant to any provision of law, the Certificate of Incorporation or the By-
Laws or any agreement to which the Corporation is a party, or otherwise, and
except as set forth in the Voting Agreement described in Section 6.6 of this
Agreement, there is no agreement, restriction or encumbrance with respect to the
sale or voting of any shares of the Corporation's capital stock (whether
outstanding or issuable upon conversion or exercise of outstanding securities).

          4.3  Equity Investments.  Except as set forth on Exhibit 4.3, the
               ------------------                          -----------
Corporation does not currently have any subsidiaries nor currently own any
capital stock or other proprietary interest, directly or indirectly, in any
corporation, association, trust, partnership, joint venture or other entity.

          4.4  Financial Statements.  Attached as Exhibit 4.4A are the unaudited
               --------------------               ------------
balance sheet for the Corporation as of December 31, 1994, and the related
unaudited statement of income for the year ending December 31, 1994.  Attached
as Exhibit 4.4B are the unaudited balance sheet of the Corporation as of October
   ------------
31, 1995 (the "Balance Sheet"), and the related unaudited statement of income
for the ten-month period ended October 31, 1995. (October 31, 1995 is
hereinafter sometimes referred to as the "Balance Sheet Date.") The December 31,
1994 and October 31, 1995 financial statements are in accordance with the books
and records of the Corporation and present fairly the financial position and
results of operations of the Corporation as of the dates and for the periods
indicated.

          4.5  Absence of Undisclosed Liabilities.  Except as set forth in
               ----------------------------------
Exhibit 4.5 or as reflected in the Balance Sheet, at the Balance Sheet Date (a)
-----------
the Corporation had no material liabilities of any nature (matured or unmatured,
fixed or contingent) of a type required by generally accepted accounting
principles to be disclosed on a balance sheet of the Corporation which were not
so disclosed; (b) all reserves established by the Corporation and set forth in
the Balance Sheet were adequate; and (c) there were no loss contingencies (as
such term is used in Statement of Financial Accounting Standards No. 5 issued by
the Financial Accounting Standards Board in March 1975) which were not
adequately disclosed in the Balance Sheet as required by such Statement No. 5.

          4.6  Absence of Changes.  Except as set forth in Exhibit 4.6, since
               ------------------                          -----------
the Balance Sheet Date there has not been (a) any material adverse change in the
financial condition, results of operations, assets, liabilities, business or
prospects of the Corporation, (b) any material asset or property of the
Corporation made subject to a lien of any kind, (c) any waiver of any valuable
right of the Corporation, or the cancellation of any debt or claim held by the
Corporation, (d) any payment of dividends on, or other distribution with respect
to, or any direct or indirect redemption or acquisition of, any shares of the
capital stock of the Corporation, or any agreement or commitment therefor, (e)
any mortgage, pledge, sale, assignment or transfer of any tangible or intangible
assets of the Corporation, except in the ordinary course of business, (f) any
loan by the

                                      -4-
<PAGE>

Corporation to, or any loan to the Corporation from, any officer, director,
employee or stockholder of the Corporation, or any agreement or commitment
therefor, (g) any damage, destruction or loss (whether or not covered by
insurance) materially and adversely affecting the assets, property or business
of the Corporation, or (h) any change in the accounting methods or practices
followed by the Corporation.

          4.7  Encumbrances.  Except as set forth in Exhibit 4.7, the
               ------------                          -----------
Corporation has good title to all of its property and assets, real, personal or
mixed, tangible or intangible, free and clear of all liens, security interests,
charges and other encumbrances of any kind.

          4.8  Intellectual Property Rights.  Except in each case as set forth
               ----------------------------
in Exhibit 4.8:
   -----------

          (a)  the Corporation owns or has the right to use all Intellectual
Property Rights (as hereinafter defined) necessary or required for the conduct
of its business as presently conducted or as proposed to be conducted, which
Intellectual Property Rights are identified in said Exhibit 4.8;
                                                    -----------

          (b)  to the Corporation's knowledge, no royalties or other amounts are
payable by the Corporation to other persons by reason of the ownership or use of
said Intellectual Property Rights; and

          (c)  to the Corporation's knowledge, no product marketed or sold or
proposed to be marketed or sold by the Corporation violates or will violate any
license or infringes any Intellectual Property Rights of another, nor has the
Corporation received any notice that any of such Intellectual Property Rights or
the operation or proposed operation of the Corporation's business conflicts or
will conflict with the rights of others.

As used herein, the term "Intellectual Property Rights" means all patents,
trademarks, service marks, trade names, copyrights, inventions, trade secrets,
proprietary processes and formulae, applications for patents, trademarks,
service marks and copyrights, and other industrial and intellectual property
rights.

          Dr. Hubert Koster has entered into an agreement with the Company
relating to protection of proprietary information and invention assignment in
the form included in Exhibit 4.8.
                     -----------

          4.9  Litigation.  There is no action, suit, claim, proceeding or
               ----------
investigation, at law, in equity or otherwise, or by or before any governmental
instrumentality or other agency, now pending, or, to the Corporation's
knowledge, threatened against the Corporation.

          4.10 No Defaults.  The Corporation is not in violation or breach of,
               -----------
or in default under, any provision of (a) the Certificate of Incorporation or
the By-Laws or (b) except where any such violation, breach or default would not
have a material adverse effect on the Corporation, any note, indenture,
mortgage, lease, contract, purchase order or other instrument, document or
agreement to which the Corporation is a party or by which it or any of its
property

                                      -5-
<PAGE>

is bound or affected or any ruling, writ, injunction, order, judgment or decree
of any court, administrative agency or other governmental body. To the
Corporation's knowledge, there exists no condition, event or act which after
notice, lapse of time, or both, would constitute a violation or breach of, or a
default under, any of the foregoing.

          4.11  Employment of Officers, Employees and Consultants.  No third
                -------------------------------------------------
party may assert any valid claim against the Corporation, any Investor, or any
Designated Person (as hereinafter defined) with respect to (a) the continued
employment by or association with the Corporation of any of the present officers
or employees of, or consultants to, the Corporation (collectively, the
"Designated Persons"), or (b) the use or disclosure by the Corporation or any
Designated Person of any information which the Corporation or any Designated
Person would be prohibited from using or disclosing under any prior agreements
or arrangements or under any laws, including, without limitation, laws
applicable to unfair competition, trade secrets or proprietary information.

          4.12  Taxes.  The Corporation has filed all Federal, state, local and
                -----
foreign tax returns which are required to be filed by it and all such returns
are true and correct.  The Corporation has paid all taxes pursuant to such
returns or pursuant to any assessments received by it or which it is obligated
to withhold from amounts owing to any employee, creditor or third party, except,
in each case, for those which are not yet due and payable pursuant to such
returns.

          4.13  Agreements.  Except as set forth in Exhibit 4.13, the
                ----------                          ------------
Corporation is not a party to any written or oral (a) contract with any labor
union; (b) contract for the future purchase of fixed assets or for the future
purchase of materials, supplies or equipment in excess of normal operating
requirements; (c) contract for the employment of any officer, individual
employee or other person or any contract with any person on a consulting basis;
(d) bonus, pension, profit-sharing, retirement, stock purchase, stock option,
hospitalization, medical insurance or similar plan, contract or understanding in
effect with respect to employees or any of them or the employees of others; (e)
agreement or indenture relating to the borrowing of money or to the mortgaging,
pledging or otherwise placing a lien on any assets of the Corporation; (f)
guaranty of any obligation for borrowed money or otherwise; (g) lease or
agreement under which the Corporation is lessee of or holds or operates any
property, real or personal, owned by any other party; (h) lease or agreement
under which the Corporation is lessor of or permits any third party to hold or
operate any property, real or personal, owned or controlled by the Corporation;
(i) license or lease agreement with respect to any Intellectual Property Rights;
(j) agreement or other commitment for capital expenditures in excess of $25,000;
or (k) contract, agreement or commitment under which the Corporation is
obligated to pay any broker's fees, finder's fees or any such similar fees, to
any third party.  Except as set forth in Exhibit 4.13, the Corporation is not
                                         ------------
engaged in any negotiations which could lead to any such contract, agreement,
arrangement, understanding or commitment.  The Corporation has furnished to the
Investors true and correct copies of all such agreements, and other documents
requested by the Investors or its authorized representatives.

          4.14  Compliance.  The Corporation has complied in all material
                ----------
respects with all Federal, state, local or foreign laws applicable to its
business.  The Corporation has all Federal, state, local and foreign
governmental licenses, registrations and permits material to or

                                      -6-
<PAGE>

necessary for the conduct of its business, and such licenses, registrations and
permits are in full force and effect and there have been no violations in any
material respect of any such licenses, registrations or permits. No proceeding
is pending or, to the Corporation's knowledge, threatened, to revoke or limit
any thereof.

          4.15  Insurance.  Exhibit 4.15 sets forth each insurance policy
                ---------   ------------
(specifying the insurer, the amount of coverage, the type of insurance, the
policy number, the expiration date, the annual premium and any pending claims
thereunder) maintained by the Corporation on its properties, assets, business or
personnel.  The insurance maintained by the Corporation on its properties,
assets, business and personnel is in amounts deemed adequate by the Corporation,
is in accordance with the standards of the industry in which the Corporation
operates, and is under policies currently in effect and issued by insurers of
recognized responsibility.

          4.16  Authorization of this Agreement.  The execution, delivery and
                -------------------------------
performance by the Corporation of this Agreement, the Registration Rights
Agreement of even date herewith by and among the Corporation and the Investors
in the form of Exhibit 4.16A (the "Registration Rights Agreement") and the
               -------------
Voting Agreement of even date herewith by and among the parties hereto in the
form of Exhibit 4.16B (the "Voting Agreement"; this Agreement, the Registration
        -------------
Rights Agreement and Voting Agreement are herewith referred to collectively as
the "Transaction Documents") have been duly authorized by all requisite
corporate action.  The Transaction Documents have been duly executed and
delivered on behalf of the Corporation and constitute the valid and binding
obligations of the Corporation, enforceable in accordance with their respective
terms.  The execution, delivery and performance of the Transaction Documents,
the issuance, sale and delivery of the Shares and the shares of Common Stock
issuable upon conversion of the Shares (the "Reserved Shares"), and compliance
with the provisions hereof and thereof by the Corporation, do not and will not,
with or without the passage of time or the giving of notice or both, (a) violate
any provision of law, statute, rule or regulation or any ruling, writ,
injunction, order, judgment or decree of any court, administrative agency or
other governmental body or (b) conflict with or result in any breach of any of
the terms, conditions or provisions of, or constitute a default (or give rise to
any right of termination, cancellation or acceleration) under, or result in the
creation of any lien, security interest, charge or encumbrance upon any of the
properties or assets of the Corporation under, the Certificate of Incorporation
or By-Laws or any note, indenture, mortgage, lease, contract, purchase order or
other instrument, document or agreement to which the Corporation is a party or
by which it or any of its property is bound or affected.

          4.17  Authorization of Shares.  The issuance, sale and delivery
                -----------------------
hereunder by the Corporation of the Shares have been duly authorized by all
requisite corporate action, and when so issued, sold and delivered, the Shares
will be validly issued and outstanding, fully paid and nonassessable, and not
subject to preemptive or any other similar rights of the stockholders of the
Corporation or others.

          4.18  Authorization of Reserved Shares.  The issuance, sale and
                --------------------------------
delivery by the Corporation of the Reserved Shares have been duly authorized by
all requisite corporate action of the Corporation, and the Reserved Shares have
been duly reserved for issuance upon conversion of all or any of the Shares, and
when so issued and delivered upon conversion of any

                                      -7-
<PAGE>

of the Shares, the Reserved Shares will be validly issued and outstanding, fully
paid and nonassessable, and not subject to preemptive or any other similar
rights of the stockholders of the Corporation or others.

          4.19  Related Transactions.  Except as set forth in Exhibit 4.19, no
                --------------------                          ------------
director, officer or employee of the Corporation nor any "associate" (as defined
in the rules and regulations promulgated under the Securities Exchange Act of
1934 (the "Exchange Act")) of any such person is indebted to the Corporation,
nor is the Corporation indebted (or committed to make loans or extend or
guarantee credit) to any such person, nor is any such person a party to any
transaction (other than as an employee or consultant) with the Corporation
providing for the furnishing of services by, or rental of real or personal
property from, or otherwise requiring cash payments to, any such person.

          4.20  No Governmental Consent or Approval Required.  Except as set
                --------------------------------------------
forth in Exhibit 4.20, no authorization, consent, approval or other order of,
         ------------
declaration to, or filing with, any governmental agency or body is required to
be made or obtained by the Corporation for or in connection with the valid and
lawful authorization, execution and delivery by the Corporation of the
Transaction Documents, for or in connection with the valid and lawful
authorization, issuance, sale and delivery of the Shares or for or in connection
with the valid and lawful authorization, reservation, issuance, sale and
delivery of the Reserved Shares, except such exemptive filings as are required
to be made under applicable securities laws and have been and shall be made on a
timely basis.

          4.21  Registration Rights.  Except as contemplated by the Registration
                -------------------
Rights Agreement, no person has any right to cause the Corporation to effect the
registration under the Securities Act of 1933, as amended (the "Securities
Act"), of any shares of Common Stock, Series A Preferred or any other securities
of the Corporation.

          4.22  Exemptions from Securities Laws.  Subject to the accuracy of the
                -------------------------------
representations and warranties of the Investors set forth in Section 5 hereof,
the provisions of Section 5 of the Securities Act are inapplicable to the
offering, issuance, sale and delivery of the Shares and the Reserved Shares, and
no consent, approval, qualification or registration or filing under any state
securities laws is required in connection therewith, except such exemptive
filings as are required to be made under applicable securities laws and have
been and shall be made on a timely basis.

          4.23  Commitments from German Government.  Exhibit 4.23 accurately
                ----------------------------------   ------------
describes certain commitments from certain German governmental authorities made
with respect to the Corporation and its subsidiary Sequenom Instruments GmbH.

     SECTION 5.  Representations and Warranties of the Investors.  Each
     ---------   -----------------------------------------------
Investor, severally and not jointly, represents and warrants to the Corporation
as follows:

          5.1   Organization. Such Investor is an entity duly organized, validly
                ------------
existing and in good standing under the laws of the jurisdiction of its
organization, with all requisite

                                      -8-
<PAGE>

power and authority to own and lease its properties, to carry on its business,
and to carry out the transactions contemplated hereby.

          5.2  Purchase for Investment.  Such Investor is acquiring the Shares,
               -----------------------
and, in the event such Investor should acquire Reserved Shares upon conversion
of the Shares, such Investor will be acquiring the Reserved Shares, for its own
account, for investment and not for, with a view to, or in connection with, any
distribution or public offering thereof within the meaning of the Securities
Act.

          5.3  Unregistered Securities; Legend.  Such Investor understands that
               -------------------------------
the Shares have not been, and the Reserved Shares will not be, registered under
the Securities Act or any state securities law, by reason of their issuance in a
transaction exempt from the registration requirements of the Securities Act and
such laws, and that they must be held indefinitely unless they are subsequently
registered under the Securities Act and such laws or a subsequent disposition
thereof is exempt from registration.  Such Investor further understands that
such exemption depends upon, among other things, the bona fide nature of such
                                                     ---- ----
Investor's investment intent expressed herein.  Such Investor acknowledges that
the certificates for the Shares and the Reserved Shares shall bear a legend to
such effect, and appropriate stock transfer instructions may be issued.

          5.4  Status of the Investors.  Such Investor has not been formed for
               -----------------------
the specific purpose of acquiring Shares or Reserved Shares pursuant to this
Agreement.  Such Investor understands the term "accredited investor," as used in
Regulation D promulgated under the Securities Act and represents and warrants to
the Corporation that such Investor is an "accredited investor" for purposes of
acquiring Shares and Reserved Shares.

          5.5  Knowledge and Experience; Economic Risk.  Such Investor has
               ---------------------------------------
sufficient knowledge and experience it business and financial matters and with
respect to investment in securities of privately held companies so as to enable
it to analyze and evaluate the merits and risks of the investment contemplated
hereby and is capable of protecting its interest in connection with this
transaction.  Such Investor is able to bear the economic risk of such
investment, including a complete loss of the investment.

          5.6  Access to Information.  Such Investor acknowledges that such
               ---------------------
Investor and its representatives have had the opportunity to ask questions and
receive answers from officers and representatives of the Corporation concerning
the transactions contemplated by this Agreement, and to obtain any additional
information which the Corporation possesses or can acquire that is necessary to
verify the accuracy of the information regarding the Corporation herein set
forth or otherwise desired in connection with its purchase of the Shares and the
Reserved Shares.

          5.7  Authorization.  The execution, delivery and performance by such
               -------------
Investor of this Agreement have been duly authorized by all requisite action of
such Investor and its partners or equity holders.  This Agreement has been duly
executed and delivered on behalf of such Investor and constitutes the valid and
binding obligation of such Investor, enforceable in accordance with its terms.
The execution, delivery and performance of the Transaction

                                      -9-
<PAGE>

Documents, the purchase of the Shares and the Reserved Shares, and compliance
with the provisions hereof and thereof by such Investor, do not and will not,
with or without the passage of time or the giving of notice or both, (a) violate
any provision of law, statute, rule or regulation or any ruling, writ,
injunction, order, judgment or decree of any court, administrative agency or
other governmental body or (b) conflict with or result in any breach of any of
the terms, conditions or provisions of, or constitute a default (or give rise to
any right of termination, cancellation or acceleration) under, such Investor's
charter, by-laws, partnership agreement or other organizational document, or any
material note, indenture, mortgage, lease, agreement, contract, purchase order
or other instrument, document or agreement to which such Investor is a party or
by which it or any of its property is bound or affected.

          5.8  No Governmental Consent or Approval Required.  No authorization,
               --------------------------------------------
consent, approval or other order of, or declaration to, or filing with, any
governmental agency or body is required to be made or obtained by such Investor
for or in connection with the valid authorization, execution and delivery by
such Investor of the Transaction Documents or for the valid purchase by such
Investor of the Shares to be sold to it hereunder or for or in connection with
the valid issuance to such Investor of any Reserved Shares.

          5.9  Rule 144.  Such Investor understands that the exemption from
               --------
registration afforded by Rule 144 (the provisions of which are known to such
Investor) promulgated by the Securities and Exchange Commission (the
"Commission") under the Securities Act depends upon the satisfaction of various
conditions, that such exemption is not currently available and that, if
applicable, Rule 144 affords the basis for sales only in limited amounts.

     SECTION 6.  Conditions Precedent to Closing by the Investor.  The
     ---------   -----------------------------------------------
obligation of each Investor to purchase and pay for the Shares being purchased
by such Investor at the initial Closing or any Additional Closing (each a
"Closing") is subject to satisfaction (or waiver by the Investor) of the
following conditions precedent at or before such Closing:

          6.1  Corporate Proceedings.  All corporate and other proceedings to be
               ---------------------
taken and all waivers and consents to be obtained in connection with the
transactions contemplated by this Agreement shall have been taken or obtained
and all documents incident to such transactions shall be satisfactory in form
and substance to the Investors and their counsel, who shall have received all
such originals or certified or other copies of such documents as they may
reasonably request.

          6.2  Representations and Warranties Correct.  The representations and
               --------------------------------------
warranties made by the Corporation in Section 4 hereof shall be true and correct
when made, and shall be true and correct in all material respects at the time of
such Closing with the same force and effect as if they had been made at and as
of the time of such Closing.

          6.3  Compliance with Covenants.  The corporation shall have duly
               -------------------------
complied with and performed all covenants and agreements of the Corporation
herein which are required to be complied with and performed at or before such
Closing.

                                      -10-
<PAGE>

          6.4  Certificate of Compliance.  The Corporation shall have provided
               -------------------------
to each of the Investors purchasing Shares at such Closing a certificate, dated
the date of such Closing, in form and substance reasonably satisfactory to such
Investor, confirming compliance with the conditions set forth it Sections 6.2
and 6.3.

          6.5  Opinion of Counsel.  At such Closing, each of the Investors
               ------------------
purchasing Shares at such Closing shall have received from Foley, Hoag & Eliot,
counsel for the Corporation, an opinion addressed to such Investors, dated the
date of the Closing, to the effect set forth in Exhibit 6.5.
                                                -----------

          6.6  Related Agreements and Documents.  At or before such Closing, the
               --------------------------------
parties thereto shall have executed and delivered the  Registration Rights
Agreement and the Voting Agreement, the Corporation and each of the Founders
shall have executed and delivered a Stock Restriction Agreement in the form of
Exhibit 6.6 hereto (each a "Stock Restriction Agreement"), and the Corporation
-----------
shall have delivered to the Investors such other documents as they shall
reasonably request.

          6.7  Blue Sky Matters.  All consents, approvals, qualifications,
               ----------------
registrations and filings required to be obtained or effected under any
applicable state securities or "blue sky" laws in connection with the issuance,
sale and delivery of the Shares prior to the sale of the Shares shall have been
obtained or effected and copies of the same delivered to each of the Investors.

          6.8  Purchase by Other Investors.  All of the Initial Shares shall
               ---------------------------
have been purchased and paid for at the Initial Closing.

    SECTION 7. Financial Reports.  Subject to the limitations set forth in
    ---------  -----------------
Section 7.6, the Corporation agrees to furnish each of the Investors and any
transferee to which any Investor transfers at least 100,000 Shares (a "Series B
Transferee") with the following:

          7.1  Quarterly and Monthly Reports.  Within 45 days after the end of
               -----------------------------
each month and each fiscal quarter, an unaudited financial report of the
Corporation, which report shall be prepared in accordance with generally
accepted accounting principles consistently applied (except that the financial
report may (i) be subject to normal year-end audit adjustments neither
individually nor in the aggregate material and (ii) not contain all notes
thereto which may be required in accordance with generally accepted accounting
principles) and shall be certified by either the Chief Executive Officer or the
Chief Financial officer of the Corporation to have been so prepared, and which
shall include the following:

          (a)  an income statement for such month or quarter, together with a
cumulative income statement from the first day of the then-current fiscal year
to the last day of such month or quarter;

          (b)  a balance sheet as of the last day of such month or quarter;

          (c)  a statement of cash flows for such month or quarter;

                                      -11-
<PAGE>

          (d)  a comparison between the actual figures for such month or
quarter, the comparable figures (with respect to the foregoing clauses (a) and
(b) only) for the prior year (if any) and the comparable figures included in the
Budget (as hereinafter defined) for such month or quarter, with an explanation
of any material differences between them.

     The financial report for each fiscal quarter shall be accompanied by a
report by the Chief Executive Officer of the Corporation explaining business
developments and problems occurring during the quarter.

          7.2  Annual Reports.  Within 120 days after the end of each fiscal
               --------------
year of the Corporation, audited financial statements of the Corporation, which
shall include an income statement for such fiscal year and a balance sheet as of
the last day thereof, and statements of stockholders' equity and cash flows for
such fiscal year, each prepared in accordance with generally accepted accounting
principles consistently applied, certified by independent certified public
accountants of recognized national standing satisfactory to the Investors,
together with such accountants' annual management letter.

          7.3  Consolidated Financial Statements.  If for any period the
               ---------------------------------
Corporation shall have any subsidiary whose accounts are consolidated with those
of the Corporation, then in respect of such period the financial statements
delivered pursuant to the foregoing Sections 7.1 and 7.2 shall be the
consolidated and consolidating financial statements of the Corporation and all
such consolidated subsidiaries.

          7.4  Other Reports and Information.  Promptly upon becoming available:
               -----------------------------

               (a)  copies of all financial statements, reports, notices, press
     releases, proxy statements and other documents sent by the Corporation to
     its stockholders or released to the public and copies of all regular and
     periodic reports, if any, filed by the Corporation with the Commission or
     any securities exchange; and

               (b)  any other financial or other information available to
     management of the Corporation as any of the Investors shall have reasonably
     requested on a timely basis.

          7.5  Budgets and Operating Plans.  At least 30 days prior to the
               ---------------------------
beginning of each fiscal year of the Corporation, a monthly operating plan of
the Corporation, with monthly breakdowns, for such fiscal year (the "Budget").
The Budget shall be accepted as the Budget for such fiscal year when it has been
approved by the Board of Directors of the Corporation.  The Budget shall be
reviewed by the Corporation periodically and all changes therein and all
material deviations therefrom which are proposed to be made by the Corporation
shall be resubmitted to its Board of Directors and to each of the Investors in
advance and shall be accepted when approved by, and the Corporation shall not
make any such changes or material deviations to or from the Budget without such
prior approval of, its Board of Directors.  The Budget shall include an income
statement, balance sheet and cash flow information.

                                      -12-
<PAGE>

          7.6  Limitations on Rights of Investors under Section 7.  The
               --------------------------------------------------
Corporation shall provide the information required by Sections 7.1 through 7.5
to each Investor and any Series B Transferee so long as such Investor or Series
B Transferee shall own at least 200,000 shares of the Common Stock (including in
such number shares of Common Stock issuable upon Conversion of Series B
Preferred) appropriately adjusted to take account of any stock split, stock
dividend, combination of shares or the like.  The foregoing provisions of this
Section 7 to the contrary notwithstanding, the Investors shall not have any
rights and the Corporation shall not have any obligations under the foregoing
provisions of this Section 7 at such time that the Common Stock is registered
under Section 12 of the Exchange Act.

    SECTION 8. Additional Agreements of the Corporation.
    ---------  ----------------------------------------

    8.1   Right of First Refusal.
          ----------------------

          (a)  Subject to the limitations set forth in paragraph (i) of this
Section 8.1 and in Section 8.9, the Corporation hereby grants to each Investor,
each Founder, and any of their respective permitted assignees described in
paragraph (j) of this Section 8.1 (each a "Right Holder") the right of first
refusal to purchase, pro rata, all (or any part) of any New Securities (as
defined in this Section 8.1(b)) that the Corporation may, from time to time,
propose to sell or issue.  Each such Right Holder's pro rata share, for purposes
of this right of first refusal, is the ratio of (i) the number of shares of
Common Stock then held of record by, or issuable on conversion of Series B
Preferred or Series A Preferred (together, "Preferred Stock") then held of
record by, such Right Holder to (ii) the sum of the total number of shares of
the Common Stock issued and outstanding plus the total number of shares of
Common Stock issuable upon conversion of the Preferred Stock, in each case at
such time (the "Basic Amount").

          (b)  "New Securities" shall mean any equity securities of the
Corporation, whether now authorized or not, and rights, options, or warrants to
purchase said equity securities, and securities of any type whatsoever that are,
or may become, convertible into said equity securities; provided, however, that
                                                        --------  -------
"New Securities" does not include (i) securities offered to the public pursuant
to a registration statement filed under the Securities Act, the gross proceeds
to the Corporation from the sale of which would equal or exceed $10,000,000;
(ii) securities issued pursuant to the acquisition of another corporation by the
Corporation by merger, purchase of substantially all of the assets, or other
reorganization whereby the Corporation acquires not less than 51% of the voting
power of such corporation; (iii) up to 700,000 shares (appropriately adjusted to
take account of any stock split, stock dividend, combination of shares or the
like) of Common Stock (or related options) issued to employees, officers or
other persons performing services for the Corporation pursuant to any stock
offering, plan or arrangement approved by the Board of Directors of the
Corporation, which number may be adjusted upward by the affirmative vote of two-
thirds of the whole Board of Directors; (iv) securities issued in connection
with any stock split, stock dividend or recapitalization by the Corporation; (v)
shares of Common Stock issued upon conversion of the Shares; (vi) securities
issuable upon exercise or conversion of any rights, options, warrants or
convertible securities outstanding on the date of this Agreement; (vii)
securities issued to any financial institution in connection with a loan
transaction approved by the Board of Directors of the Corporation; (viii)
securities issued to vendors or customers or to other persons in similar
commercial situations with the Corporation, provided such issuance is

                                      -13-
<PAGE>

approved by the Board of Directors of the Corporation; (ix) securities issued in
connection with obtaining lease financing, whether issued to a lessor, guarantor
or other person involved in the financing, provided such issuance is approved by
the Board of Directors of the Corporation; or (x) any right, option or warrant
to acquire any security convertible into securities excluded from the definition
of New Securities pursuant to clauses (i) through (ix) above.

          (c)  The Corporation shall not issue, sell or exchange, agree to
issue, sell or exchange, or reserve or set aside for issuance, sale or exchange
any New Securities unless the Corporation shall deliver to each Right Holder a
written notice of any proposed or intended issuance, sale or exchange of New
Securities (the "Offer"), which Offer shall (i) identify and describe the New
Securities, (ii) describe the price and other terms upon which they are to be
issued, sold or exchanged, and the number or amount of the New Securities to be
issued, sold or exchanged, (iii) identify the persons or entities to which or
with which the New Securities are to be offered, issued, sold or exchanged and
(iv) offer to issue and sell to or exchange with such Right Holder (a) such
Right Holder's Basic Amount, and (b) any additional portion of the New
Securities as such Right Holder shall indicate it will purchase or acquire
should the other Right Holders subscribe for less than their Basic Amounts (the
"Undersubscription Amount"). Each Right Holder shall have the right, for a
period of 30 days following delivery of the Offer, to purchase or acquire, at a
price and upon the other terms specified in the Offer, the number or amount of
New Securities described above. The Offer by its terms shall remain open and
irrevocable for such 30-day period.

          (d)  To accept an Offer, in whole or in part, a Right Holder must
deliver a written notice to the Corporation prior to the end of the 30-day
period of the Offer, setting forth the portion of the Right Holder's Basic
Amount that such Right Holder elects to purchase and, if such Right Holder shall
elect to purchase all of its Basic Amount, the Undersubscription Amount (if any)
that such Right Holder elects to purchase (the "Notice of Acceptance").  If the
Basic Amounts subscribed for by all Right Holders are less than the total New
Securities, then each Right Holder who has set forth an Undersubscription Amount
in its Notice of Acceptance shall be entitled to purchase, in addition to the
Basic Amount subscribed for, the Undersubscription Amount it has subscribed for;
provided, however, that should the Undersubscription Amounts subscribed for
--------  -------
exceed the difference between the New Securities and the Basic Amounts
subscribed for (the "Available Undersubscription Amount"), each Right Holder who
has subscribed for any Undersubscription Amount shall be entitled to purchase
only that portion of the Available Undersubscription Amount as the
Undersubscription Amount subscribed for by such Right Holder bears to the total
Undersubscription Amounts subscribed for by all Right Holders, subject to
rounding by the Board of Directors to the extent it reasonably deems necessary.

          (e)  In the event that Notices of Acceptance are not given by the
Right Holders in respect of all the New Securities, the Corporation shall have
90 days from the expiration of the period set forth in paragraph (c) above to
issue, sell or exchange all or any part of such New Securities as to which a
Notice of Acceptance has not been given by the Right Holders (the "Refused
Securities"), but only to the offerees or purchasers and only upon terms and
conditions (including, without limitation, unit prices and interest rates) which
are described in the Offer.

                                      -14-
<PAGE>

          (f)  In the event the Corporation shall propose to sell less than all
the Refused Securities (any such sale to be in the manner and on  the terms
specified in paragraph (e) above), then each Right Holder may, at its sole
option and in its sole discretion, reduce the number or amount of the New
Securities specified in its Notice of Acceptance to an amount that shall be not
less than the number or amount of the New Securities that the Right Holder
elected to purchase pursuant to paragraph (d) above multiplied by a fraction,
(i) the numerator of which shall be the number or amount of New Securities the
Corporation actually proposes to issue, sell or exchange (including New
Securities to be issued or sold to Right Holders pursuant to paragraph (d) above
prior to such reduction) and (ii) the denominator of which shall be the amount
of all New Securities.  In the event that any Right Holder so elects to reduce
the number or amount of New Securities specified in its Notice of Acceptance,
the Corporation may not issue, sell or exchange more than the reduced number or
amount of the New Securities unless and until such securities have again been
offered to the Right Holders in accordance with paragraph (c) above.

          (g)  Upon the closing of the issuance, sale or exchange of all or less
than all the Refused Securities, the Right Holders shall acquire from the
Corporation, and the Corporation shall issue to the Right Holders, the number or
amount of New Securities specified in the Notices of Acceptance, as reduced
pursuant to paragraph (f) above if the Right Holders have so elected, upon the
terms and conditions specified in the Offer.  The purchase by the Right Holders
of any New Securities is subject in all cases to the preparation, execution and
delivery by the Corporation and the Right Holders of a purchase agreement
relating to such New Securities reasonably satisfactory in form and substance to
the Right Holders and their respective counsel.

          (h)  Any New Securities not acquired by the Right Holders or other
persons in accordance with paragraph (e) above may not be issued, sold or
exchanged until they are again offered to the Right Holders under the procedures
specified in this Agreement.

          (i)  This right of first refusal shall run to each Investor, each
Founder and any of their respective permitted assignees under paragraph (j) of
this Section 8.1 only for so long as they hold the following number of shares of
Common Stock (including in such number shares of Common Stock issuable upon
conversion of Preferred Stock):

               (i)  in the case of the Founders, the Investors who were parties
to the Original Purchase Agreement and their permitted assignees, 50,000 shares;
and

               (ii) in the case of all other Investors and their permitted
assignees, 200,000 shares.

          (j)  This right of first refusal may be assigned, in whole or in part,
(i) to any Affiliate (as hereinafter defined) of any Right Holder or (ii) to any
assignee who acquires not less than 50,000 shares of Common Stock in the case of
an assignment from assignor described in clause (i) of paragraph (i) of this
Section 8.1, or 200,000 shares of Common Stock in the case of an assignment from
an assignor described in clause (ii) of paragraph (i) of this Section 8.1 (in
each case, including in such number shares of Common Stock issuable upon
conversion of Preferred Stock and appropriately adjusted to take account of any
stock split, stock dividend,

                                      -15-
<PAGE>

combination of shares, or the like). As used in this Section, an Affiliate of a
Right Holder shall mean any partner of the Right Holder that is a partnership or
any person or entity that, directly or indirectly, through one or more
intermediaries, controls, or is controlled by, or is under common control with,
the Right Holder.

          (k)  This Section 8.1 shall supersede and replace Section 8 of the
Original Purchase Agreement, which Section 8 shall no longer have any force or
effect.

     8.2  Keeping of Records and Books of Account.  The Corporation shall keep,
          ---------------------------------------
and cause each subsidiary to keep, adequate records and books of account, in
which complete entries will be made in accordance with generally accepted
accounting principles consistently applied, reflecting all financial
transactions of the Corporation and such subsidiary, and in which, for each
fiscal year, all proper reserves for depreciation, depletion, obsolescence,
amortization, taxes, bad debts and other purposes in connection with its
business shall be made.

     8.3  Insurance.  The Corporation will do or cause to be done all things
          ---------
necessary to preserve and maintain in full force and effect fire and casualty
insurance policies, with extended coverage, on its properties, assets, business
and personnel, in amounts deemed adequate by the Corporation, and in accordance
with the standards of the industry in which the Corporation operates, sufficient
in amount to allow it to replace any of its properties which might be damaged or
destroyed.

     8.4  Key Man Life Insurance.  The Corporation shall use its best efforts to
          ----------------------
obtain and thereafter maintain in force a policy of life insurance, naming the
Corporation as beneficiary, on the life of Dr. Hubert Koster, in the amount of
US$1,000,000, once Dr. Koster becomes an employee of the Corporation.

     8.5  Maintenance of Corporate Existence, etc.  The Corporation will do or
          ---------------------------------------
cause to be done all reasonable things necessary to preserve and keep in full
force and effect its existence and all of its rights (charter and statutory),
subject in all cases to the exercise by the Board of Directors of the
Corporation of their fiduciary obligations.  The Corporation shall comply in all
respects with the provisions of its Certificate of Incorporation and By-laws.

     8.6  Maintenance of Facilities.  The Corporation will cause all facilities
          -------------------------
owned or leased in the conduct of its business to be maintained and kept in good
condition and repair and will cause to be made all necessary repairs, renewals,
replacements, betterments and improvements thereof, all as in the judgment of
the Corporation may be necessary so that the business carried on in connection
therewith may be properly and advantageously conducted at all times;
provided, however, that nothing in this Section shall prevent the Corporation
--------  -------
from discontinuing the lease or maintenance of any such facilities if such
discontinuance is, in the good faith judgment of the Board of Directors of the
Corporation, desirable in the conduct of its business and would not have a
material adverse effect on the Corporation.

     8.7  Payment of Taxes.  The Corporation will pay or discharge or cause to
          ----------------
be paid or discharged, before the same shall become delinquent, (1) all material
taxes, assessments and governmental charges levied or imposed upon the
Corporation or upon the income, profits or

                                      -16-
<PAGE>

property of the Corporation; and (2) all material liabilities of the
Corporation; provided, however, that the Corporation shall not be required to
             --------  -------
pay or discharge or cause to be paid or discharged any such tax assessment,
liability, or charge, whose amount, applicability or validity is being contested
in good faith by appropriate proceedings if adequate reserves therefor have been
established in accordance with generally accepted accounting principles.

     8.8  Compliance with Applicable Laws.  The Corporation shall conduct its
          -------------------------------
business in compliance in all material respects with all laws and valid
requirements of governmental authorities relating to the conduct of its business
or to its properties or assets.

     8.9  Limitation On Rights of Investors.  The rights of Right Holders under
          ---------------------------------
Section 8.1 and the Investors under Section 8.2 through 8.8, inclusive, and the
obligations of the Corporation under Sections 8.1 through 8.8, inclusive, shall
terminate and be of no effect upon and following the closing of a firm
commitment underwritten public offering of the Corporation's Common Stock
pursuant to an effective registration statement under the Securities Act in
which (i) the offering price per share is not less than $4.50 (prior to
underwriter's discounts and commissions), appropriately adjusted to take account
of any stock split, stock dividend, combination of shares, or the like, and (ii)
the aggregate net proceeds to the Corporation from such offering are not less
than $10 million.

     8.10  Proprietary Information and Invention Assignment Agreements.  As soon
           -----------------------------------------------------------
as practicable after the Initial Closing, the Corporation will use reasonable
efforts to cause each senior technical employee who has not already signed an
agreement with the Corporation relating to the protection of proprietary
information and the assignment of inventions to sign such an agreement in a form
acceptable to the Board of Directors of the Corporation.

     SECTION 9.   Expenses.
     ---------    --------

     9.1  Expenses.  The Corporation shall pay the reasonable fees and
          --------
disbursements of Bingham, Dana & Gould, special counsel to Boston University
Nominee Partnership, in connection with the transactions contemplated by this
Agreement, up to a maximum amount of $10,000.  Otherwise, the Corporation and
the Investors shall each bear their own expenses, including the fees and
disbursements of their respective counsel, incurred in connection with the
purchase and sale of the Shares.

     9.2  Brokers.  No party to this Agreement has employed any broker or finder
          -------
in connection with the transactions contemplated hereby.  No person or entity
will have, as a result of the transactions contemplated by this Agreement, any
right, interest or valid claim against or upon any such party of any commission,
fee or other compensation as a finder or broker because of any act or omission
by such party or any agent of such party.  Each party to this Agreement agrees
to indemnify and hold the others harmless from payment of any brokerage fee,
finders fee, or commission claimed by any third party who claims to have been
involved because of association with such party.

     SECTION 10.  Exchanges; Lost, Stolen or Mutilated Certificates.  Upon
     ----------   -------------------------------------------------
surrender by any Investor to the Corporation of a certificate or certificates
representing shares of Series B

                                      -17-
<PAGE>

Preferred purchased or acquired by such Investor hereunder or Reserved Shares
received upon conversion of any such shares of Series B Preferred, the
Corporation at its expense shall issue in exchange therefor, and deliver to such
Investor, a new certificate or certificates representing such shares, in such
denomination or denominations as may be requested by such Investor. Upon receipt
of evidence satisfactory to the Corporation of the loss, theft, destruction or
mutilation of any certificate representing any shares of Series B Preferred
purchased or acquired by the Investor hereunder or Reserved Shares received upon
conversion of any such shares of Series B Preferred and in case of any such
loss, theft or destruction, upon delivery of any indemnity agreement
satisfactory to the Corporation, or in case of any such mutilation, upon
surrender and cancellation of such certificate, the Corporation at its expense
shall issue and deliver to such Investor a new certificate for such shares of
Series B Preferred or Reserved Shares, of like tenor, in lieu of such lost,
stolen or mutilated certificate.

     SECTION 11.  Survival of Representations, Warranties and Agreements.  The
     ----------   ------------------------------------------------------
covenants, representations and warranties of the parties contained herein shall
survive any Closing hereunder.  Each of the parties may rely on such covenants,
representations and warranties irrespective of any investigation made, or notice
or knowledge held by, it or any other person.  All statements contained in any
certificate or other instrument delivered by any party pursuant to this
Agreement or in connection with the transactions contemplated by this Agreement
shall constitute representations and warranties by such party under this
Agreement.

     SECTION 12.  Remedies.  In case any one or more of the covenants or
     ----------   --------
agreements set forth in this Agreement shall have been breached by the
Corporation, the Investors may proceed to protect and enforce their rights
either by suit in equity or by action at law, including, but not limited to, an
action for damages as a result of any such breach or an action for specific
performance of any such covenant or agreement contained in this Agreement.

     SECTION 13.  Successors and Assigns.  This Agreement shall be binding upon,
     ----------   ----------------------
and inure to the benefit of, each of the parties hereto and, except as otherwise
expressly provided herein, each other person who shall become a registered
holder named in any certificate evidencing shares of Common Stock or Series B
Preferred transferred to such holder by any of the Investors or their permitted
transferees, and (except as aforesaid) their respective legal representatives,
successors and assigns.

     SECTION 14.  Entire Agreement; Effect on Prior Documents.  This Agreement
     ----------   -------------------------------------------
and the other documents referred to herein or delivered pursuant hereto contain
the entire agreement among the parties with respect to the financing
transactions contemplated hereby and supersede all prior negotiations,
commitments, agreements-and understandings among them with respect thereto.

     SECTION 15.  Notices.  All notices, requests, consents and other
     ----------   -------
communications hereunder to any party shall be deemed to be sufficient if
contained in a written instrument delivered in person or duly sent by first-
class mail, postage prepaid, or by any internationally recognized express
courier service, addressed to such party at the address set forth below or such
other address as may hereafter be designated in writing by the addressee to the
addressor listing all parties:

                                      -18-
<PAGE>

          (i)  if to the Corporation, to:

               Sequenom, Inc.
               c/o TVM Techno Venture Management
               101 Arch Street
               Suite 1950
               Boston, MA 02110
               Attention:  President

               with a copy to:

               David R. Pierson, Esq.
               Foley, Hoag & Eliot
               One Post Office Square
               Boston, Massachusetts 02109

          (ii) if to the Investors, to their respective addresses set forth on
               the Schedule of Investors.

     SECTION 16.  Amendments; waivers.  This Agreement may be amended, and
     ----------   -------------------
compliance with the provisions of this Agreement may be omitted or waived, by
the written agreement of the Corporation and Investors or assignees of their
rights hereunder holding 85% in voting power of the Series B Preferred (and
Common Stock issued upon conversion thereof) held by the Investors and such
assignees.

     SECTION 17.  Counterparts.  This Agreement may be executed in any number of
     ----------   ------------
counterparts, each such counterpart shall be deemed to be an original
instrument, and all such counterparts together shall constitute but one
agreement.  Any such counterpart may contain one or more signature pages.

     SECTION 18.  Headings.  The headings of the various sections of this
     ----------   --------
Agreement have been inserted for convenience of reference only and shall not be
deemed to be a part of this Agreement.

     SECTION 19.  Nouns and Pronouns.  Whenever the context may require, any
     ----------   ------------------
pronouns used herein shall include the corresponding masculine, feminine or
neuter forms, and the singular form of names and pronouns shall include the
plural and vice-versa.

     SECTION 20.  Governing Law.  This Agreement shall be governed by, and
     ----------   -------------
construed and enforced in accordance with, the substantive laws of The
Commonwealth of Massachusetts, without regard to its principles of conflicts of
laws.

     SECTION 21.  Severability.  Any provision of this Agreement that is
     ----------   ------------
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining provisions hereof, and any

                                      -19-
<PAGE>

such prohibition or unenforceability in any jurisdiction shall not invalidate or
render unenforceable such provision in any other jurisdiction.

     SECTION 22.  Information Confidential.  Each Investor acknowledges that the
     ----------   ------------------------
information received by it pursuant hereto (including without limitation under
Section 7 hereof) is confidential and for its use only and such Investor will
not reproduce, disclose or disseminate such information to any other person
(other than its employees or agents having a need to know the contents of such
information), except in connection with the exercise of rights under this
Agreement, unless the Corporation has made such information available to the
public generally or such Investor is required to disclose such information by
law or by any court or other governmental body.  The obligation of
confidentiality set forth in this Section shall not apply to information (i)
generally known on a non-confidential basis (without fault of an Investor) to
companies in the Corporation's line of business; (ii) lawfully obtained by an
Investor without restriction on disclosure; (iii) known to an Investor prior to
receipt from the Corporation without restriction on disclosure; or (iv)
independently developed by an Investor without use of information provided by
the Corporation.

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the
day and year first written above.

                              SEQUENOM, INC.

                              By: /s/ illegible
                                 ----------------------------------------
                                     Its Treasurer

                                      -20-
<PAGE>

     For purposes of Section 8.1 only:

                                          FOUNDERS:

                                              /s/ Hubert Koster
                                            -------------------------
                                            Hubert Koster

                                              /s/ Nola E. Masterson
                                            -------------------------
                                            Nola E. Masterson

                                              /s/ Robert E. Patterson
                                            -------------------------
                                            Robert E. Patterson

                                      -21-
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              TVM Techno Venture Enterprises No. II
                              Limited Partnership
                              -------------------------------------------
                              (Print name)

  212,267                     By:  /s/ illegible
---------------------            ----------------------------------------
Shares Purchased
                              Title:  Treasurer
                                    -------------------------------------
  $318,400.50
---------------------
Total Purchase Price          Address:  101 Arch St.
                                      -------------------------------------

                                        Suite 1950
                                      -------------------------------------

                                        Boston, Massachusetts  02110
                                      -------------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              TVM Intertech Limited Partnership
                              ------------------------------------------
                              (Print name)

  141,513                     By:  /s/ illegible
-----------------------          ---------------------------------------
Shares Purchased
                              Title:  Treasurer
                                    ------------------------------------
  $212,269.50
-----------------------
Total Purchase Price          Address:  101 Arch St.
                                      ----------------------------------

                                      Suite 1950
                              ------------------------------------------

                                      Boston, Massachusetts  02110
                              ------------------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              TVM Zweite Beteiligung - U.S.
                              Limited Partnership
                              ----------------------------------------
                              (Print name)

  432,953                     By:  /s/ illegible
-----------------------          -------------------------------------
Shares Purchased
                              Title:  Treasurer
                                    ----------------------------------
  $649,429.50
-----------------------
Total Purchase Price          Address:  101 Arch St.
                                      --------------------------------

                                      Suite 1950
                              ----------------------------------------

                                      Boston, Massachusetts  02110
                              ----------------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              TVM Eurotech Limited Partnership
                              --------------------------------
                              (Print name)

  288,633                     By:  /s/ illegible
---------------------            ------------------------------------
Shares Purchased
                              Title:  Treasurer
                                    ---------------------------------
  $432,949.50
---------------------
Total Purchase Price          Address:  101 Arch St.
                                      -------------------------------

                                      Suite 1950
                              ---------------------------------------

                                      Boston, Massachusetts  02110
                              ---------------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              TVM Techno Venture Investors No. 1
                              Limited Partnership
                              -------------------
                              (Print name)

  12,634                      By:  /s/ illegible
---------------------            --------------------------------------
Shares Purchased
                              Title:  General Partner
                                    -----------------------------------
  $18,951.00
---------------------
Total Purchase Price          Address:  101 Arch St.
                                      ---------------------------------

                                      Suite 1950
                              -----------------------------------------

                                      Boston, Massachusetts  02110
                              -----------------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              KBL Founder Ventures SCA
                              ------------------------------------------
                              (Print name)

  245,333                     By:  /s/ illegible
------------------------      ------------------------------------------
Shares Purchased                 illegible         illegible

                              Title: Director      Director
                                    ------------------------------------
                                                     Managing Director
                                    ------------------------------------

  $367,999.50
------------------------
Total Purchase Price          Address: 43 Boulevard Royal
                                      ---------------------------------

                                       L-2955 Luxembourg
                              -----------------------------------------

<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              Alpinvest International B.V.
                              -----------------------------------
                              (Print name)

  666,667                     By:  /s/ illegible
----------------------           --------------------------------
Shares Purchased
                              Title:_____________________________
  $1,000,000.50
----------------------
Total Purchase Price          Address:  Gooimeer 3
                                      ---------------------------

                                      NL - 1410 AB Naarden
                              -----------------------------------

                                      The Netherlands
                              -----------------------------------
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                        Initial Investor Signature Page
                        -------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     EXECUTED this 22nd day of December, 1995.

                              Boston University Nominee Partnership
                              --------------------------------------
                              (Print name)

  333,333                     By:  /s/ John E. Bagalay
---------------------            -----------------------------------
Shares Purchased                  John E. Bagalay

                              Title:  Partner
                                    --------------------------------
  $499,999.50
---------------------
Total Purchase Price          Address: 881 Commonwealth Avenue
                                      ------------------------------

                                       Boston, MA   02215
                              --------------------------------------

<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                       Additional Investor Signature Page
                       ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 21 day of February, 1996.

                                    /s/ Gerald E. Coughlan
                                    --------------------------------------
                                    Gerald E. Coughlan

                                    Address:  Lehman Brothers
                                            ------------------------------
                                              One Broadgate
                                              London EC2M 7HA
                                              England

<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 23 day of February, 1996.

                                        /s/ Charles P. Floe
                                        ------------------------------------
                                        Charles P. Floe

                                        Address: Lehman Brothers
                                                -----------------------------
                                                 One Broadgate
                                                 London EC2M 7HA
                                                 England
<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 6 day of February, 1996.

                                             /s/ Dr. Hellmut Kirchner
                                             ------------------------------
                                             Dr. Hellmut Kirchner

                                             Address: Martelsgraben 2
                                                     ------------------------
                                                      82327 Tutzing
                                                      Germany
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 5 day of February, 1996.

                                             /s/ Dr. Herwig Brunner
                                             -------------------------------
                                             Dr. Herwig Brunner

                                             Address:  An der Betteleiche 6
                                                     -----------------------
                                                       70569 Stuttgart
                                                       Germany

<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29th day of February, 1996.

                                   TVM TECHNO VENTURE INVESTORS
                                   NO. 1 LIMITED PARTNERSHIP

                                   By: /s/  Illegible
                                       --------------------

                                   Title: General Partner
                                          -----------------

                                   Address: c/o TVM Venture
                                            Management
                                            101 Arch Street
                                            Suite 1950
                                            Boston, MA 02210
<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29 day of February, 1996.

                                             /s/ Dr. Franz A. Wirtz
                                             -------------------------------
                                             Dr. Franz A. Wirtz

                                             Address:  Geschaftsfurhender
                                                     ------------------------
                                                       Gesellschafter Grunenthal
                                                       GmbH 52220 Stolberg
                                                       Germany

<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 14 day of February, 1996.

                                             /s/ Frau Hannemarie Wirtz
                                             -----------------------------
                                             Frau Hannemarie Wirtz

                                             Address: Atzenach 37
                                                     ---------------------
                                                      D-52223 Stolberg

<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29th day of February, 1996.

                                        /s/  Hubert Koster
                                        ------------------
                                        Hubert Koster

                                        Address:  Stapolstrasse 56
                                                  D 22529
                                                  Hamburg, Germany

                                                  Prof. Dr. Hubert Koster
                                                  Hallerstradle 74
                                                  20146 Hamburg
<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29 day of March, 1996.

                          illegible
                          --------------------------
                          SVE Star Ventures Enterprises No. III L.P.

                          By: SVM Star Ventures Managementgesellschaft MbH NR.3
                              -------------------------------------------------
                                 Managing Partner
                          Title: ----------------------------------------------

                                By:  Dr. Meir Barel, Managing Partner
                                   ---------------------------------------------

                          Address:   Star Ventures Management
                                     Possartstrasse 9
                                     D-81679 Munich Germany

<PAGE>

                                SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29 day of March, 1996.

                          illegible
                          -----------------------------------------------------
                          SVE Star Ventures Enterprises No. IIIa L.P.

                          By: SVM Star Ventures Managementgesellschaft mbH NR.3
                              -------------------------------------------------
                                 Managing Partner
                          Title: ----------------------------------------------

                                By:  Dr. Meir Barel, Managing Partner
                                   ---------------------------------------------

                          Address:   Star Ventures Management
                                     Possartstrasse 9
                                     D-81679 Munich Germany

<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                      Additional Investor Signature Page
                      ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 29 day of March, 1996.

                       illegible
                       ------------------------------
                       SVM Star Ventures Managementgesellschaft
                       NR. 3 & Co. Beteiligungs KG mbH

                           By: SVM Star Ventures Managementgesellschaft mbH NR.3
                               -------------------------------------------------

                           Title: Managing Partner
                                  ----------------------------------------------
                                  By: Dr. Meir Barel - Managing Partner

                           Address: Star Ventures Management
                                    -------------------------------------------
                                    Possartstrasse 9 D-81679 Munich Germany
                                    -------------------------------------------

<PAGE>

                                 SEQUENOM, INC.

            Series B Convertible Preferred Stock Purchase Agreement

                       Additional Investor Signature Page
                       ----------------------------------

     By executing this page in the space provided, the undersigned investor
hereby agrees (i) that it is an "Additional Investor" as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of December 22, 1995,
among Sequenom, Inc. (the "Corporation") and certain investors named on the
Schedule of Investors thereto (the "Purchase Agreement"), (ii) that it is a
party to the Purchase Agreement for all purposes and (iii) that it is bound by
all terms and conditions of the Purchase Agreement.

     Attached hereto is an addendum to the Schedule of Investors to the Purchase
Agreement, setting forth the name of the undersigned and the number of shares of
the Corporation's Series B Convertible Preferred Stock purchased by it pursuant
to the Purchase Agreement.

     EXECUTED this 28 day of March, 1996.

                              /s/  Dr. Ernst-Gunter Afting
                              -------------------------------------
                              Professor Dr. Ernst-Gunter Afting

                              Address:  Maisenweg 21
                                        82152 Krailing
                                        Germany
<PAGE>

                             SCHEDULE OF INVESTORS

<TABLE>
<CAPTION>
                                                             Number of Shares of                        Aggregate
Investor                                                     Series B Preferred Stock                   Purchase Price
--------                                                     ------------------------                   --------------
<S>                                                          <C>                                        <C>
TVM Techno Venture                                                   212,267                             $  318,400.50
  Enterprises No. II Limited Partnership
c/o TVM Techno Venture
  Management ("TVM"),
101 Arch Street, Suite 1950
Boston, MA  02210

TVM Intertech Limited Partnership                                    141,513                             $  212,269.50
c/o TVM

TVM Zweite Beteiligung-U.S.                                          432,953                             $  649,429.50
  Limited Partnership
c/o TVM

TVM Eurotech Limited Partnership                                     288,633                             $  432,949.50
c/o TVM

TVM Techno Venture                                                    12,634                             $   18,951.00
  Investors No. 1 Limited Partnership
c/o TVM

KBL Founder Ventures SCA                                             245,333                             $  367,999.50
43, Boulevard Royal
L-2955 Luxembourg

Alpinvest International B.V.                                         666,667                             $1,000,000.50
Gooimeer 3
NL-1410 AB Naarden
The Netherlands
Attn:  John van Grootel

Boston University Nominee                                            333,333                             $  499,999.50
 Partnership
881 Comonwealth Avenue
Boston, MA   02215
AttN:  William Golden

</TABLE>

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
Gerald E. Coughlan                                            13,333                                  $20,000
</TABLE>

/s/ Gerald E. Coughlan
-----------------------------------------
Gerald E. Coughlan

Date:  2/21/96
     ------------------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:   /s/ illegible
   ----------------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                                 Number of Shares of                         Aggregate
Investor                                                       Series B Preferred Stock                    Purchase Price
--------                                                       ------------------------                    --------------
<S>                                                            <C>                                         <C>
Charles P. Floe                                                          6,666                                 $10,000
</TABLE>

/s/ Charles P. Floe
-------------------------------------
Charles P. Floe

Date:  23 February 1996
     --------------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   -----------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
Dr. Hellmut Kirchner                                  66,666                                $100,000
</TABLE>

/s/ Dr. Hellmut Kirchner
---------------------------------
Dr. Hellmut Kirchner

Date:  February 6, 1996
     ----------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   ------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                    <C>                                        <C>
Dr. Herwig Brunner                                              20,000                                $30,000
</TABLE>

/s/ Dr. Herwig Brunner
--------------------------------
Dr. Herwig Brunner

Date:  05/Feb/1996
     ---------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   -------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
TVM Techno Venture                                             6,666                                 $10,000
Investors No. 1
Limited Partnership
</TABLE>

TVM TECHNO VENTURE INVESTORS
NO. 1 LIMITED PARTNERSHIP

By:  /s/ illegible
   ----------------------------------

Title:  General Partner
      -------------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   ----------------------------------
     Its: Treasurer
<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
Dr. Franz A. Wirtz                                              33,333                                $50,000
</TABLE>

/s/ Dr. Franz A. Wirtz
-----------------------------------
Dr. Franz A. Wirtz

Date:  2/29/96
     ------------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   --------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
Frau Hannemarie Wirtz                                      33,333                                   $50,000
</TABLE>

/s/ Frau Hannemarie Wirtz
----------------------------------
Frau Hannemarie Wirtz

Date:  Feb 14 1996
     -----------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   -------------------------------
     Its: Treasurer

<PAGE>

                                ADDENDUM TO THE
                             SCHEDULE OF INVESTORS
                                     TO THE
                         SERIES B CONVERTIBLE PREFERRED
                            STOCK PURCHASE AGREEMENT
                         DATED AS OF DECEMBER 22, 1995

<TABLE>
<CAPTION>
                                                        Number of Shares of                         Aggregate
Investor                                              Series B Preferred Stock                    Purchase Price
--------                                              ------------------------                    --------------
<S>                                                   <C>                                         <C>
Hubert Koster                                                  100,000                               $150,000
</TABLE>

/s/ Hubert Koster
------------------------------------
Hubert Koster

Date:  2/29/96
     -------------------------------

Accepted and agreed to this
29th day of February, 1996

SEQUENOM, INC.

By:  /s/ illegible
   ----------------------------------
     Its: Treasurer
<PAGE>

                                   EXHIBIT 1
                                   ---------

                            Certificate of Amendment
                            ------------------------

<PAGE>

                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                               OF SEQUENOM, INC.

     Sequenom, Inc., a corporation organized and existing under and by virtue of
the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:

     FIRST:  That at a meeting of the Board of Directors of said corporation
             resolutions were duly adopted proposing and declaring advisable
             that the Certificate of Incorporation of said corporation be
             amended and that such amendment be submitted to the stockholders of
             the Corporation for their consideration, as follows:

                    RESOLVED:  That the Board of Directors of this Corporation
                               recommends and deems it advisable that the
                               Certificate of Incorporation of this Corporation,
                               as heretofore amended, be further amended by
                               deleting Article FOURTH thereof and substituting
                               for said Article FOURTH the new Article FOURTH
                               set forth on Exhibit A attached hereto; and
                                            ---------

                    RESOLVED:  That the aforesaid proposed amendment be
                               submitted to the stockholders of the Corporation
                               for their consideration; and

                    RESOLVED:  That following the approval by the stockholders
                               of the aforesaid amendment as required by law,
                               the officers of this Corporation be, and they
                               hereby are, and each of them hereby is,
                               authorized and directed (i) to prepare, execute
                               and file with the Secretary of State of the State
                               of Delaware a Certificate of Amendment setting
                               forth the aforesaid amendment in the form
                               approved by the stockholders and (ii) to take any
                               and all other actions necessary, desirable or
                               convenient to give effect to the aforesaid
                               amendment or otherwise to carry out the purposes
                               of the foregoing Resolutions.

                    SECOND:    That in lieu of a meeting and vote of
                               stockholders, the stockholders have given written
                               consent to said amendments in accordance with the
                               provisions of section 228 of the General
                               Corporation Law of the State of Delaware, and
                               written notice of the adoption of the amendments
                               has been given as
<PAGE>

                               provided in section 228 of the General
                               Corporation Law of the State of Delaware to every
                               stockholder entitled to such notice.

                    THIRD:     That the aforesaid amendments were duly adopted
                               in accordance with the applicable provisions of
                               sections 228 and 242 of the General Corporation
                               Law of the State of Delaware.

     IN WITNESS WHEREOF, said Sequenom, Inc. has caused this certificate to be
signed by Randall R. Lunn, its President, and attested by David R. Pierson, its
Secretary, this 22nd day of December, 1995.

ATTEST:                                      SEQUENOM, INC.

By:  /s/ David R. Pierson                    By:  /s/ Randall R. Lunn
   ------------------------------               -------------------------------
     Secretary                                   President

                                      -2-
<PAGE>

                                   EXHIBIT A
                                   ---------

FOURTH:  The total number of shares of all classes of stock which the
------
Corporation has authority to issue is 10,753,366 shares, consisting of 5,726,700
shares of Common Stock, par value $.001 per share (the "Common Stock"),
1,650,000 shares of Series A Convertible Preferred Stock, par value $0.001 per
share (the "Series A Preferred Stock"), and 3,376,666 shares of Series B
Convertible Preferred Stock, par value $.001 per share (the "Series B Preferred
Stock", and, together with the Series A Preferred Stock, the "Preferred Stock"),
amounting to an aggregate par value of $10,753.37.

     The powers, preferences and rights, and the qualifications, limitations or
restrictions thereof, in respect of each class or series of stock of the
corporation shall be as follows:

     Section 1.  Liquidation Rights.
     ---------   ------------------

          (a)  In the event of any liquidation, dissolution or winding up of the
affairs of the Corporation, whether voluntary or involuntary, the holders of
each share of the Series B Preferred Stock shall be entitled to be paid first
out of the assets of the Corporation available for distribution to holders of
the Corporation's capital stock of all classes an amount equal to the greater
of:

               (i)  $1.50 per share of Series B Preferred Stock (which amount
     shall be subject to equitable adjustment whenever there shall occur a stock
     dividend, stock split, combination of shares, reclassification or other
     similar event with respect to the Series B Preferred Stock) plus all
     dividends declared but unpaid thereon, to and including the date full
     payment shall be tendered to the holders of the Series B Preferred Stock
     with respect to such liquidation, dissolution or winding up, or

               (ii) such amount per share of Series B Preferred Stock as would
     have been payable had all shares of Series B Preferred Stock been converted
     to Common Stock immediately prior to such event of liquidation, dissolution
     or winding up pursuant to the provisions of Section 2 hereof, plus all
     dividends declared but unpaid on each share of Series B Preferred Stock to
     and including the date full payment shall be tendered to the holders of the
     Series B Preferred Stock with respect to such liquidation, dissolution or
     winding up.

     If the assets of the Corporation shall be insufficient to permit the
payment in full to the holders of the Series B Preferred Stock of all amounts so
distributable to them, then the entire assets of the Corporation available for
such distribution shall be distributed ratably among the holders of the Series B
Preferred Stock in proportion to the full preferential amount each such holder
is otherwise entitled to receive.

     After such payments shall have been made in full to the holders of the
Series B Preferred Stock or funds necessary for such payments shall have been
not aside by the Corporation in trust
<PAGE>

for the account of holders of Series B Preferred Stock so as to be available for
such payments, the holders of each share of the Series A Preferred Stock shall
be entitled to be paid out of the assets of the Corporation available for
distribution to holders of the Corporation's capital stock of all classes an
amount equal to the greater of:

               (i)  $0.50 per share of Series A Preferred Stock (which amount
     shall be subject to equitable adjustment whenever there shall occur a stock
     dividend, stock split, combination of shares, reclassification or other
     similar event with respect to the Series A Preferred Stock) plus all
     dividends declared but unpaid thereon, to and including the date full
     payment shall be tendered to the holders of the Series A Preferred Stock
     with respect to such liquidation, dissolution or winding up, or

               (ii) such amount per share of Series A Preferred Stock as would
     have been payable had all shares of Series A Preferred Stock been converted
     to Common Stock immediately prior to such event of liquidation, dissolution
     or winding up pursuant to the provisions of Section 2 hereof, plus all
     dividends declared but unpaid on each share of Series A Preferred Stock to
     and including the date full payment shall be tendered to the holders of the
     Series A Preferred Stock with respect to such liquidation, dissolution or
     winding up.

     If the assets of the Corporation shall be insufficient to permit the
payment in full to the holders of the Series A Preferred Stock of all amounts so
distributable to them, then the entire remaining assets of the Corporation
available for such distribution shall be distributed ratably among the holders
of the Series A Preferred Stock in proportion to the full preferential amount
each such holder is otherwise entitled to receive.

     After such payments shall have been made in full to the holders of the
Series B Preferred Stock and to the holders of the Series A Preferred Stock, or
funds necessary for such payments shall have been set aside by the Corporation
in trust for the account of holders of Preferred Stock so as to be available for
such payments, the remaining assets available for distribution shall be
distributed among the holders of the Common Stock ratably in proportion to the
number of shares of Common Stock held by them.

     Upon conversion of shares of Series B Preferred Stock or Series A Preferred
Stock into shares of Common Stock Pursuant to Section 2 below, the holder of
such Common Stock shall not be entitled to any preferential payment or
distribution in case of any liquidation dissolution or winding up, but shall
share ratably in any distribution of the assets of the Corporation to all the
holders of Common Stock.

     The amounts payable with respect to shares of Series B Preferred Stock and
Series A Preferred Stock under this Section 1(a) are sometimes hereinafter
referred to as "Series B Liquidation Payments" and "Series A Liquidation
Payments," respectively, and together are sometimes hereinafter referred to as
the "Liquidation Payments."

          (b)  Distributions Other than Cash.  Whenever the distributions
               -----------------------------
provided for in this Section 1 shall be payable in property other than cash, the
value of such distributions shall be

                                      -2-
<PAGE>

the fair market value of such property as determined in good faith by the Board
of Directors of the Corporation.

          (c)  Merger as Liquidation, etc.  The merger or consolidation of the
               --------------------------
Corporation into or with another corporation (except one in which the holders of
capital stock of the Corporation immediately prior to such merger or
consolidation continue to hold at least eighty percent (80%) in voting power of
the capital stock of the surviving corporation, in which case the provisions of
Subsection 2(h) shall apply), or the sale of all or substantially all of the
assets of the Corporation, shall be deemed to be a liquidation, dissolution or
winding up of the affairs of the Corporation for purposes of this Section 1 with
respect to the Series B Preferred Stock unless the holders of at least eighty-
five percent (85%) of the then outstanding shares of the Series B Preferred
Stock elect to the contrary, and with respect to the Series A Preferred Stock
unless the holders of at least eighty percent (80%) of the then outstanding
shares of the Series A Preferred Stock elect to the contrary, such election in
either case to be made by giving written notice thereof to the Corporation at
least three days before the effective date of such event.  If such notice is
given with respect to the Series B Preferred Stock or the Series A Preferred
Stock, the provisions of Subsection 2(h) shall apply to such Series B Preferred
Stock or Series A Preferred Stock, as the case may be.  Unless such election is
made, any amounts received by the holders of the Series B Preferred Stock and
the Series A Preferred Stock as a result of such merger or consolidation shall
be deemed to be applied toward, and all consideration received by the
Corporation in such asset sale together with all other available assets of the
Corporation shall be distributed toward, the Liquidation Payments attributable
to such shares of Series B Preferred Stock and Series A Preferred Stock,
respectively, in the order of preference set forth in Section 1.

          (d)  Notice.  Written notice of any proposed liquidation, dissolution
               ------
or winding up of the affairs of the corporation (including any merger,
consolidation or sale of assets which may be deemed to be a liquidation,
dissolution or winding up of the affairs of the corporation under Subsection
1(c)), stating a payment date, the amount of the Liquidation Payments and the
place where said Liquidation Payments shall be payable, shall be given by first
class mail, postage prepaid, or by telex to non-U.S. residents, not less than
twenty (20) days prior to the payment date stated therein, to the holders of
record of the Series B Preferred Stock and the Series A Preferred Stock, such
notice to be addressed to each such holder at its address as shown by the
records of the Corporation.

     Section 2.  Conversion.  The holders of Preferred stock shall have
     ---------   ----------
conversion rights as follows (the "Conversion Rights"):

          (a)  Right to Convert; Conversion Price.  Each share of Preferred
               ----------------------------------
Stock shall be convertible, without the payment of any additional consideration
by the holder thereof and at the option of the holder thereof, at any time after
the date of issuance of such share, at the office of the Corporation or any
transfer agent for the Preferred Stock, into such number of fully paid and
nonassessable shares of Common Stock as is determined in accordance with the
following:

               (i)  in the case of the Series B Preferred Stock, by dividing
     $1.50 by the Series B Conversion Price, determined as hereinafter provided,
     in effect at the time of

                                      -3-
<PAGE>

     conversion. The Conversion Price at which shares of Common Stock shall be
     deliverable upon conversion of Series B Preferred Stock without the payment
     of any additional consideration by the holder thereof (the "Series B
     Conversion Price") shall initially be $1.50 per share of Common Stock. Such
     initial Series B Conversion Price shall be subject to adjustment, in order
     to adjust the number of shares of Common Stock into which the Series B
     Preferred Stock is convertible, as hereinafter provided.

               (ii) in the case of the Series A Preferred Stock, by dividing
     $0.50 by the Series A Conversion Price, determined as hereinafter provided,
     in effect at the time of conversion.  The Conversion Price at which shares
     of Common Stock shall be deliverable upon conversion of Series A Preferred
     Stock without the payment of any additional consideration by the holder
     thereof (the "Series A Conversion Price") shall initially be $0.50 per
     share of Common Stock.  Such initial Series A Conversion Price shall be
     subject to adjustment, in order to adjust the number of shares of Common
     Stock into which the Series A Preferred Stock in convertible, an
     hereinafter provided.

          (b)  Automatic Conversion.  Each share of Series B Preferred Stock
               --------------------
shall automatically be converted into shares of Common Stock at the applicable
Series B conversion Price than in effect upon:

               (i)  the closing of a firm commitment underwritten public
     offering pursuant to an effective registration statement under the
     Securities Act of 1933, as amended, covering the offer and sale of Common
     Stock for the account of the Corporation to the public at an offering price
     per share (prior to underwriter commissions and discounts) of not less than
     $4.50 (as adjusted pursuant to Subsection 2(e)(vi) hereof to reflect any
     stock dividends, distributions, combinations, reclassifications or other
     like transactions affected by the Corporation in respect of its Common
     Stock) and with gross proceeds to the Corporation of not less than
     $10,000,000 (in the event of which offering, the person(s) entitled to
     receive the Common Stock issuable upon such conversion of the Series B
     Preferred Stock shall not be deemed to have converted that Series B
     Preferred Stock until the closing of such offering); or

               (ii) the written election of the holders of not less than eighty-
     five percent (85%) of the then outstanding shares of the Series B Preferred
     Stock to require such mandatory conversion.

     Each share of Series A Preferred Stock shall automatically be converted
into shares of Common Stock at the applicable Series A Conversion Price then in
effect upon:

               (i)  the closing of a firm commitment underwritten public
     offering pursuant to an effective registration statement under the
     Securities Act of 1933, as amended, covering the offer and sale of Common
     Stock for the account of the Corporation to the public at an offering price
     per share (prior to underwriter commissions and discounts) of not less than
     $2.50 (as adjusted pursuant to Subsection 2(e)(vi) hereof to reflect any
     stock dividends, distributions, combinations, reclassifications or other
     like transactions affected by the Corporation in respect of its Common
     Stock) and with gross

                                      -4-
<PAGE>

     proceeds to the Corporation of not less than $10,000,000 (in the event of
     which offering, the person(s) entitled to receive the Common Stock issuable
     upon such conversion of the Series A Preferred Stock shall not be deemed to
     have converted that Series A Preferred Stock until the closing of such
     offering); or

               (ii) the written election of the holders of not less than eighty
     percent (80%) of the then outstanding shares of the Series A Preferred
     Stock to require such mandatory conversion.

          (c)  Mechanics of Automatic Conversions.  Upon the occurrence of an
               ----------------------------------
event specified in Subsection 2(b), the Series B Preferred Stock or the Series A
Preferred Stock, as applicable, or both, shall be converted automatically
without any further action by the holders of such shares and whether or not the
certificates representing such shares are surrendered to the Corporation or its
transfer agent; provided, however, that all holders of shares of Preferred Stock
being converted shall be given written notice of the occurrence of an event
specified in Subsection 2(b) including the date such event occurred (the
"Mandatory Conversion Date"), and the Corporation shall not be obligated to
issue certificates evidencing the shares of Common Stock issuable upon such
conversion unless certificates evidencing such shares of the Preferred Stock
being converted are either delivered to the Corporation or its transfer agent,
or the holder notifies the Corporation or any transfer agent that such
certificates have been lost, stolen, or destroyed and executes an agreement
satisfactory to the Corporation to indemnify the Corporation from any loss
incurred by it in connection therewith and, if the Corporation so elects,
provides an appropriate indemnity bond.  On the Mandatory Conversion Date, all
rights with respect to the Preferred Stock so converted shall terminate, except
any of the rights of the holder thereof, upon surrender of the holder's
certificate or certificates therefor, to receive certificates for the number of
shares of Common Stock into which such Preferred Stock has been converted,
together with cash in an amount equal to all dividends declared but unpaid on,
and any and all other amounts owing with respect to, the shares of Preferred
Stock converted to and including the time of conversion.  Upon the automatic
conversion of the Preferred Stock, the holders of such Preferred Stock shall
surrender the certificates representing such shares at the office of the
Corporation or of its transfer agent.  If so required by the Corporation,
certificates surrendered for conversion shall be endorsed or accompanied by
written instrument or instruments of transfer, in form satisfactory to the
Corporation, duly executed by the registered holder or by the holder's attorney
duly authorized in writing.  Upon surrender of such certificates there shall be
issued and delivered to such holder, promptly at such office and in the holder's
name as shown on such surrendered certificate or certificates, a certificate or
certificates for the number of shares of Common Stock into which the shares of
the Preferred Stock surrendered were convertible on the date on which such
automatic conversion occurred, together with cash in an amount equal to all
dividends declared but unpaid on, and any and all other amounts owing with
respect to, the shares of Preferred Stock converted to and including the time of
conversion.  No fractional share of Common Stock shall be issued upon the
mandatory conversion of the Preferred Stock.  In lieu of any fractional share to
which the holder would otherwise be entitled, the Corporation shall pay cash
equal to such fraction multiplied by the applicable Conversion Price then in
effect.

                                      -5-
<PAGE>

          (d)  Mechanics of Optional Conversions.  Before any holder of
               ---------------------------------
Preferred Stock shall be entitled to convert the same into shares of Common
Stock, the holder shall surrender the certificate or certificates therefor at
the office of the Corporation or of any transfer agent for the Preferred Stock,
and shall give written notice to the corporation at such office that the holder
elects to convert the same and shall state therein the holder's name or the name
or names of the holder's nominees in which the holder wishes the certificate or
certificates for shares of Common Stock to be issued. On the date of conversion,
all rights with respect to the Preferred Stock so converted shall terminate,
except any of the rights of the holder thereof, upon surrender of the holder's
certificate or certificates therefor, to receive certificates for the number of
shares of Common Stock into which such Preferred Stock has been converted and
cash in an amount equal to all dividends declared but unpaid thereon and any and
all other amounts owing with respect thereto at such time. If so required by the
Corporation, certificates surrendered for conversion shall be endorsed or
accompanied by written instrument or instruments of transfer, in form
satisfactory to the Corporation, duly executed by the registered holder or by
the holder's attorney duly authorized in writing. No fractional share of Common
Stock shall be issued upon the optional conversion of Preferred Stock. In lieu
of any fractional share to which the holder would otherwise be entitled, the
Corporation shall pay cash equal to such fraction multiplied by the applicable
Conversion Price then in effect. The Corporation shall, as soon as practicable
after surrender of the certificate or certificates for conversion, issue and
deliver at such office to such holder of Preferred Stock, or to the holder's
nominee or nominees, a certificate or certificates for the number of shares of
Common Stock to which the holder shall be entitled as aforesaid, together with
cash in lieu of any fraction of a share and cash in an amount equal to all
dividends declared but unpaid thereon and any and all other amounts owing with
respect thereto at such time. Such conversion shall be deemed to have been made
immediately prior to the close of business on the date of such surrender of the
shares of Preferred Stock to be converted, and the person or persons entitled to
receive the shares of Common Stock issuable upon conversion shall be treated for
all purposes as the record holder or holders of such shares of Common Stock on
such date.

          (e)  Adjustments to Conversion Price for Diluting Issues.
               ---------------------------------------------------

               (i)  Special Definitions.  For purposes of this Subsection 2(e),
                    -------------------
     the following definitions shall apply:

                    (1)  "Option" shall mean rights, options or warrants to
                          ------
          subscribe for, purchase or otherwise acquire either Common Stock or
          Convertible Securities.

                    (2)  "Original Issue Date" shall mean, with respect to the
                          -------------------
          Series A Preferred Stock, the first date on which a share of Series A
          Preferred Stock was issued, and shall mean, with respect to the Series
          B Preferred Stock, the first date on which a share of Series B
          Preferred Stock was issued.

                    (3)  "Convertible Securities" shall mean any evidences of
                          ----------------------
          indebtedness; shares of capital stock (other than Common Stock) or
          other

                                      -6-
<PAGE>

          securities directly or indirectly convertible into or exchangeable for
          Common Stock.

                    (4)  "Additional Shares of Common Stock" shall mean all
                          ---------------------------------
          shares of Common Stock issued (or, pursuant to Subsection 2(e)(iii),
          deemed to be issued) by the Corporation after the Original Issue Date,
          other than:

                         (A)  shares of Common Stock issued or issuable upon
               exercise of Options outstanding on the Original Issue Date;

                         (B)  up to 113,333 shares of Common Stock issuable upon
               conversion of shares of Series A Preferred Stock and Series B
               Preferred Stock issuable upon exercise of Options which may be
               issued in connection with equipment lease financing provided to
               the Corporation by Comdisco, Inc. or its affiliates;

                         (C)  up to 700,000 shares of Common Stock issued or
               issuable to officers or employees or directors of, or consultants
               to, the Corporation pursuant to a stock purchase or option plan
               or other employee stock bonus arrangement (collectively, the
               "Plans") approved by the Board of Directors;

                         (D)  shares of Common Stock issued or issuable upon
               conversion of shares of Series B Preferred Stock; and

                         (E)  shares of Common Stock issued or issuable upon
               conversion of shares of Series A Preferred Stock.

               (ii)   No Adjustment of Conversion Price.  Except as set forth in
                      ---------------------------------
     Subsection 2(e)(vi), no adjustment in the number of shares of Common Stock
     into which the Series B Preferred Stock or the Series A Preferred Stock is
     convertible shall be made, by adjustment in the applicable conversion Price
     in respect of the issuance of Additional Shares of Common Stock, unless the
     consideration per share for an Additional Share of Common Stock (determined
     pursuant to Subsection 2(a)(v)) issued or deemed to be issued by the
     Corporation is less than the applicable Conversion Price in effect on the
     date of, and immediately prior to, the issue of such Additional Share.

               (iii)  Issue of Securities Deemed Issue of Additional Shares of
                      --------------------------------------------------------
     Common Stock.
     ------------

                      (1)  Options and Convertible Securities.  In the event the
                           ----------------------------------
          Corporation at any time or from time to time after the Original Issue
          Date shall issue any Options or Convertible Securities or shall fix a
          record date for the determination of holders of any class of
          securities entitled to receive any such Options or Convertible
          Securities, then the maximum number of shares (as set forth in the
          instrument relating thereto without regard to any provisions contained

                                      -7-
<PAGE>

          therein for a subsequent adjustment of such number) of Common Stock
          issuable upon the exercise of such Options or, in the case of
          Convertible Securities and Options therefor, the conversion or
          exchange of such Convertible Securities, shall be deemed to be
          Additional Shares of Common Stock issued as of the time of such issue
          or, in case such a record date shall have been fixed, as of the close
          of business on such record date, provided that in any such case in
          which Additional Shares of Common Stock are deemed to be issued;

                         (A)   no further adjustment in the Series B Conversion
               Price or the Series A Conversion Price shall be made upon the
               subsequent issue of Convertible Securities or shares of Common
               Stock upon the exercise of such Options or conversion or exchange
               of such Convertible Securities;

                         (B)   if such Options or Convertible Securities by
               their terms provide, with the passage of time or otherwise, for
               any increase in the consideration payable to the Corporation, or
               decrease in the number of shares of Common Stock issuable, upon
               the exercise, conversion or exchange thereof, the Series B
               Conversion Price and the Series A Conversion Price computed upon
               the original issue thereof (or upon the occurrence of a record
               date with respect thereto), and any subsequent adjustments based
               thereon, shall, upon any such increase or decrease becoming
               effective, be recomputed to reflect such increase or decrease
               insofar as it affects such Options or the rights of conversion or
               exchange under such Convertible Securities;

                         (C)   upon the expiration of any such Options or any
               rights of conversion or exchange under such Convertible
               Securities which shall not have been exercised, the Series B
               Conversion Price and the Series A Conversion Price computed upon
               the original issue thereof (or upon the occurrence of a record
               date with respect thereto), and any subsequent adjustments based
               thereon, shall, upon such expiration, be recomputed as if:

                              (I)  In the case of Convertible Securities or
                    Options for Common Stock the only Additional Shares of
                    Common Stock issued were the shares of Common Stock, if any,
                    actually issued upon the exercise of such Options or the
                    conversion or exchange of such Convertible Securities and
                    the consideration received therefor was the consideration
                    actually received by the Corporation for the issue of all
                    such Options, whether or not exercised, plus the
                    consideration actually received by the Corporation upon such
                    exercise, or for the issue of all such Convertible
                    Securities which were actually converted or exchanged, plus
                    the additional consideration, if any, actually

                                      -8-
<PAGE>

                    received by the Corporation upon such conversion or
                    exchange; and

                              (II)     in the case of Options for Convertible
                    Securities only the Convertible Securities, if any, actually
                    issued upon the exercise thereof were issued at the time of
                    issue of such Options, and the consideration received by the
                    Corporation for the Additional Shares of Common Stock deemed
                    to have been then issued was the consideration actually
                    received by the Corporation for the issue of all such
                    Options, whether or not exercised, plus the consideration
                    deemed to have been received by the Corporation (determined
                    pursuant to Subsection 2(a)(v)) upon the issue of the
                    Convertible Securities with respect to which such Options
                    were actually exercised;

                         (D)  no readjustment pursuant to clause (B) or (C)
               above shall have the effect of increasing the Series B Conversion
               Price or the Series A Conversion Price to an amount which exceeds
               the lower of (i) the respective Conversion Price on the original
               adjustment date, or (ii) the respective Conversion Price that
               would have resulted from any issuance of Additional Shares of
               Common Stock between the original adjustment date and such
               readjustment date;

                         (E)  in the case of any Options which expire by their
               terms not more than 30 days after the date of issue thereof, no
               adjustment of the Series B Conversion Price or the Series A
               Conversion Price shall be made until the expiration or exercise
               of all such Options, whereupon such adjustment shall be made in
               the same manner provided in clause (C) above; and

                         (F)  if such record date shall have been fixed and such
               Options or Convertible Securities are not issued on the date
               fixed therefor, the adjustment previously made in the Series B
               Conversion Price and the Series A Conversion Price which became
               effective on such record date shall be cancelled as of the close
               of business on such record date, and thereafter the respective
               Conversion Prices shall be adjusted pursuant to this Subsection
               2(e)(iii) as of the actual date of their issuance.

                    (2)  Stock Dividends, Stock Distributions and Subdivisions.
                         -----------------------------------------------------
          In the event the Corporation at any time or from time to time after
          the Original Issue Date shall declare or pay any dividend or make any
          other distribution on the Common Stock payable in Common Stock or
          effect a subdivision of the outstanding shares of Common Stock (by
          reclassification or otherwise than by payment of a dividend in Common
          Stock), then and in any such events Additional Shares of Common Stock
          shall be deemed to have been issued:

                                      -9-
<PAGE>

                         (A)  in the case of any such dividend or distribution,
               immediately after the close of business on the record date for
               the determination of holders of any class of securities entitled
               to receive such dividend or distribution, or

                         (B)  in the case of any such subdivision, at the close
               of business on the date immediately prior to the date upon which
               such corporate action becomes effective.

                         If such record date shall have been fixed and no part
               of such dividend shall have been paid on the date fixed therefor,
               the adjustment previously made in the Series B Conversion Price
               and the Series A Conversion Price which became effective on such
               record date shall be cancelled as of the close of business on
               such record date, and thereafter the respective Conversion Prices
               shall be adjusted pursuant to this Section 2(e)(iii) as of the
               time of actual payment of such dividend.

               (iv)   Adjustment of Conversion Price Upon Issuance of Additional
                      ----------------------------------------------------------
     Shares of Common Stock.  In the event that at any time or from time to time
     ----------------------
     after the Original Issue Date, the Corporation shall issue Additional
     Shares of Common Stock (including, without limitation, Additional Shares of
     Common Stock deemed to be issued pursuant to Subsection 2(e)(iii)(1) but
     excluding Additional Shares of Common Stock deemed to be issued pursuant to
     Subsection 2(e)(iii)(2), which event is dealt with in Subsection
     2(e)(vi)(1)), without consideration or for a consideration per share less
     than the applicable Series B Conversion Price or Series A Conversion Price
     in effect on the date of and immediately prior to such issue, then and in
     such event, such Series B Conversion Price or Series A Conversion Price, as
     the case may be, shall be reduced, concurrently with such issue, to a price
     (calculated to the nearest cent) determined in accordance with the
     following formula:

                                     (P//1//) (Q//1//) + (P//2//) (Q//2//)
                             NCP  =  -------------------------------------
                                                Q//1// + Q//2//

     where:

               NCP      =    New Series B Conversion Price or Series A
                             Conversion Price, as applicable.

               P//1//   =    Series B Conversion Price or Series A Conversion
                             Price, an applicable, in effect immediately prior
                             to new issue.

               Q//1//   =    Number of shares of Common Stock outstanding, or
                             deemed to be outstanding as set forth below,
                             immediately prior to such issue.

                                     -10-
<PAGE>

               P//2//   =    Weighted average price per share received by the
                             Corporation upon such issue.

               Q//2//  =    Number of shares of Common Stock issued, or
                             deemed to have been issued, in the subject
                             transaction.

     provided that for the purpose of this Subsection 2(e)(iv), all shares of
     --------
     Common Stock issuable upon exercise or conversion of any Options or
     Convertible Securities outstanding immediately prior to such issue shall be
     deemed to be outstanding, and immediately after any Additional Shares of
     Common Stock are deemed issued pursuant to Subsection 2(e)(iii), such
     Additional Shares of Common Stock shall be deemed to be outstanding; and
     provided further, that the applicable Conversion Price shall not be so
     ----------------
     reduced at any time if the amount of such reduction would be an amount less
     than $.01, but any such amount shall be carried forward and reduction with
     respect thereto made at the time of and together with any subsequent
     reduction which, together with such amount and any other amount or amounts
     so carried forward, shall aggregate $.01 or more.

               (v)   Determination of Consideration.  For purposes of this
                     ------------------------------
     Subsection 2(e), the consideration received by the Corporation for the
     issue of any Additional Shares of Common Stock shall be computed as
     follows:

                    (1)  Cash and Property:  Such consideration shall:
                         -----------------

                         (A) insofar as it consists of cash, be computed at the
               aggregate amounts of cash received by the Corporation excluding
               amounts paid or payable for accrued interest or accrued
               dividends;

                         (B) insofar as it consists of property other than cash,
               be computed at the fair value thereof at the time of such issue,
               an determined in good faith by the Board of Directors; and

                         (C) in the event Additional Shares of Common Stock are
               issued together with other shares or securities or other assets
               of the Corporation for consideration which covers both, be the
               proportion of such consideration so received, computed as
               provided in clauses (A) and (B) above, as determined in good
               faith by the Board of Directors.

                    (2)  Options and Convertible Securities.  The consideration
                         ----------------------------------
          per share received by the Corporation for Additional Shares of Common
          Stock deemed to have been issued pursuant to Subsection 2(e)(iii)(1),
          relating to Options and Convertible Securities, shall be determined by
          dividing (x) the total amount, if any, received or receivable by the
          Corporation as consideration for the issue of such Options or
          Convertible Securities, plus the minimum aggregate amount of
          additional consideration (as set forth in the instruments relating
          thereto, without regard to any provision contained therein for a
          subsequent adjustment of

                                     -11-
<PAGE>

          such consideration) payable to the Corporation upon the exercise of
          such Options or the conversion or exchange of such Convertible
          Securities, or in the case of Options for Convertible Securities, the
          exercise of such Options for Convertible Securities and the conversion
          or exchange of such Convertible Securities, by (y) the maximum number
          of shares of Common Stock (as set forth in the instruments relating
          thereto, without regard to any provision contained therein for a
          subsequent adjustment of such number) issuable upon the exercise of
          such Options or the conversion or exchange of such Convertible
          Securities.

               (vi) Adjustment for Dividends, Distributions, Subdivisions,
                    ------------------------------------------------------
     Combinations or Consolidations of Common Stock.
     ----------------------------------------------

                    (1) Stock Dividends, Distributions or Subdivisions.  In the
                        ----------------------------------------------
          event the Corporation shall be deemed to issue Additional Shares of
          Common Stock pursuant to Subsection 2(e)(iii)(2) in a stock dividend,
          stock distribution or subdivision, the Series B Conversion Price and
          the Series A Conversion Price in effect immediately before such deemed
          issuance shall, concurrently with the effectiveness of such deemed
          issuance, be proportionately decreased.

                    (2) Combinations or Consolidations.  In the event the
                        ------------------------------
          outstanding shares of Common Stock shall be combined or consolidated,
          by reclassification or otherwise, into a lesser number of shares of
          Common Stock, the Series B Conversion Price and the Series A
          Conversion Price in effect immediately prior to such combination or
          consolidation shall, concurrently with the effectiveness of such
          combination or consolidation, be proportionately increased.

          (f) Adjustments for Certain Dividends and Distributions.  In the event
              ---------------------------------------------------
that at any time or from time to time after the Original Issue Date the
Corporation shall make or issue, or fix a record date for the determination of
holders of Common Stock entitled to receive, a dividend or other distribution
payable in securities of the Corporation other than shares of Common Stock, then
and in each such event provision shall be made so that the holders of Preferred
Stock shall receive upon conversion thereof in addition to the number of shares
of Common Stock receivable thereupon, the amount of securities of the
Corporation that they would have received had their Preferred Stock been
converted into Common Stock on the date of such event and had they thereafter,
during the period from the date of such event to and including the conversion
date, retained such securities receivable by them as aforesaid during such
period, giving application during such period to all adjustments called for
herein.

          (g) Adjustment for Reclassification, Exchange, or Substitution.  In
              ----------------------------------------------------------
the event that at any time or from time to time after the Original Issue Date,
the Common Stock issuable upon the conversion of Preferred Stock shall be
changed into the same or a different number of shares of any class or classes of
stock, whether by capital reorganization, reclassification, or otherwise (other
than a subdivision or combination of shares or stock dividend provided for
above, or a merger, consolidation, or sale of assets provided for below), then
and in each such event the holder of any share or shares of Preferred Stock
shall have the right thereafter to

                                     -12-
<PAGE>

convert such shares into the kind and amount of shares of stock and other
securities and property receivable upon such reorganization, reclassification,
or other change, by the holder of a number of shares of Common Stock equal to
the number of shares of Common Stock into which such shares of Preferred Stock
might have been converted immediately prior to such reorganization,
reclassification, or change, all subject to further adjustment as provided
herein.

          (h)  Adjustment for Merger, Consolidation or Sale of Assets.  In the
               ------------------------------------------------------
event that at any time or from time to time after the Original Issue Date, the
Corporation shall merge or consolidate with or into another entity or sell all
or substantially all of its assets, each share of Preferred Stock as to which
such consolidation, merger or sale is not treated as a liquidation under
Subsection 1(c) shall thereafter be convertible into the kind and amount of
shares of stock or other securities or property to which a holder of the number
of shares of Common Stock of the Corporation deliverable upon conversion of such
Preferred Stock would have been entitled to receive upon such consolidation,
merger or sale; and, in such case, appropriate adjustment (as determined in good
faith by the Board of Directors) shall be made in the application of the
provisions set forth in this Section 2 with respect to the rights and interest
thereafter of the holders of Preferred Stock, to the end that the provisions set
forth in this Section 2 (including provisions with respect to changes in and
other adjustments of the Conversion Price) shall thereafter be applicable, as
nearly as reasonably may be, in relation to any shares of stock or other
property thereafter deliverable upon the conversion of Preferred Stock.

          (i)  No Impairment.  The Corporation shall not, by amendment of its
               -------------
Certificate of Incorporation or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed hereunder by the Corporation but shall at
all times in good faith assist in the carrying out of all the provisions of this
Section 2 and in the taking of all such action as may be necessary or
appropriate in order to protect the Conversion Rights of the holders of
Preferred Stock against impairment.

          (j)  Certificate as to Adjustments.  Upon the occurrence of each
               -----------------------------
adjustment or readjustment of the Series B Conversion Price or the Series A
Conversion Price pursuant to this Section 2, the Corporation at its expense
shall promptly compute such adjustment or readjustment in accordance with the
terms hereof and furnish to each affected holder of Preferred Stock a
certificate setting forth such adjustment or readjustment and showing in detail
the facts upon which such adjustment or readjustment is based.  The Corporation
shall, upon the written request at any time of any affected holder of Preferred
Stock, furnish or cause to be furnished to such holder a like certificate
setting forth (i) such adjustments and readjustments, (ii) the Conversion Price
at the time in effect, and (iii) the number of shares of Common Stock and the
amount, if any, of other property which at the time would be received upon the
conversion of each share of Preferred Stock.

          (k)  Notices of Record Date.  In the event of any taking by the
               ----------------------
Corporation of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any
dividend (other than a cash dividend which is the same as cash dividends paid in
previous quarters) or other distribution, the Corporation shall mail to each

                                     -13-
<PAGE>

holder of Preferred Stock at least ten (10) days prior to such record date a
notice specifying the date on which any such record is to be taken for the
purpose of such dividend or distribution.

            (1)  Common Stock Reserved.  The Corporation shall reserve and keep
                 ---------------------
available out of its authorized but unissued Common Stock such number of shares
of Common Stock as shall from time to time be sufficient to effect conversion of
the Preferred Stock.

            (m)  Certain Taxes.  The Corporation shall pay any issue or transfer
                 -------------
taxes payable in connection with the conversion of Preferred Stock, provided,
however, that the Corporation shall not be required to pay any tax which may be
payable in respect of any transfer to a name other than that of the holder of
the Preferred Stock.

            (n)  Closing of Books.  The Corporation shall at no time close its
                 ----------------
transfer books against the transfer of any Preferred Stock or of any shares of
Common Stock issued or issuable upon the conversion of any shares of Preferred
Stock in any matter which interferes with the timely conversion or transfer of
such Preferred Stock or Common Stock.

Section 3.  Restrictions.
---------   ------------

            (a)     At any time when shares of Preferred Stock are outstanding,
except where the vote of the holders of a greater number of shares of the
corporation is required by law or by this Certificate of Incorporation, and in
addition to any other vote required by law or this Certificate of Incorporation,
without the affirmative vote of the holders of at least sixty percent (60%) of
the then outstanding shares of Preferred Stock (with calculations based upon the
number of shares of Common Stock into which such shares of Preferred Stock are
then convertible), voting collectively as a single class, the Corporation will
not:

                    (i)       consent to any liquidation, dissolution or winding
     up of the Corporation or merge or consolidate with or into any other entity
     or entities;

                    (ii)      sell, abandon, transfer, lease or otherwise
     dispose of all or any substantially portion of its properties and other
     assets; or

                    (iii)     amend this Certificate of Incorporation or the
     Corporation's By-Laws.

            (b)     At any time when shares of Series B Preferred Stock are
outstanding, except where the vote of the holders of a greater number of shares
of the Corporation is required by law or by this Certificate of Incorporation,
and in addition to any other vote required by law or this Certificate of
Incorporation, without the affirmative vote of the holders of at least eighty-
five percent (85%) of the then outstanding shares of Series B Convertible
Preferred Stock, the Corporation will not:

                    (i)       amend, alter or change the designation or any
     preferences, voting powers, qualifications, or special or relative rights
     or privileges of the Series B

                                     -14-
<PAGE>

     Convertible Preferred Stock in a manner adverse to the interests of the
     holders of the Series B Convertible Preferred Stock in any material
     respect;

                    (ii)      increase the authorized number of shares of Series
     B Preferred Stock;

                    (iii)     create or authorize the creation of any additional
     series of shares of stock unless such series ranks junior to the Series B
     Convertible Preferred Stock as to both dividends and the distribution of
     assets on the liquidation, dissolution, winding up or insolvency of the
     Corporation, or increase the authorized amount of any other class or series
     of shares of stock unless the same ranks junior to the Series B Convertible
     Preferred Stock as to dividends and the distribution of assets on the
     liquidation, dissolution, winding up or insolvency of the Corporation, or
     create or authorize any obligation or security convertible into shares of
     Series B Convertible Preferred Stock or into shares of any other class or
     series of shares of stock unless the same ranks junior to the Series B
     Convertible Preferred Stock as to dividends and the distribution of assets
     an the liquidation dissolution, winding up or insolvency of the
     Corporation, whether any such creation authorization or increase shall be
     by means of amendment to this Certificate of Incorporation or by merger,
     consolidation or otherwise.

          (c)       At any time when shares of Series A Preferred Stock are
outstanding, except where the vote of the holders of a greater number of shares
of the Corporation is required by law or by this Certificate of Incorporation,
and in addition to any other vote required by law or this Certificate of
Incorporation, without the affirmative vote of the holders of at least sixty
percent (60%) of the then outstanding shares of Series A Convertible Preferred
Stock, the Corporation will not:

                    (i)    amend, alter or change the designation or any
     preferences, voting powers, qualifications, or special or relative rights
     or privileges of the Series A Convertible Preferred Stock in a manner
     adverse to the interests of the holders of the Series A Convertible
     Preferred Stock in any material respect;

                    (ii)   increase the authorized number of shares of Series A
     Preferred Stock;

                    (iii)  create or authorize the creation of any additional
     series of shares of stock unless such series ranks junior to the Series A
     Convertible Preferred Stock as to both dividends and the distribution of
     assets on the liquidation, dissolution, winding up or insolvency of the
     Corporation, or increase the authorized amount of any other class or series
     of shares of stock unless the same ranks junior to the Series A Convertible
     Preferred Stock as to dividends and the distribution of assets on the
     liquidation, dissolution, winding up or insolvency of the Corporation, or
     create or authorize any obligation or security convertible into shares of
     Series A Convertible Preferred Stock or into shares of any other class or
     series of shares of stock unless the same ranks junior to the Series A
     Convertible Preferred Stock as to dividends and the distribution of assets
     on the liquidation, dissolution, winding up or insolvency of the
     Corporation, whether any

                                     -15-
<PAGE>

     such creation, authorization or increase shall be by means of amendment to
     this Certificate of Incorporation or by merger, consolidation or otherwise.

     Section 4.  Voting Rights.  Except as otherwise required by law or
     ----------  -------------
hereinafter set forth, the holders of Preferred Stock shall be entitled to
notice of any meeting of stockholders and shall vote together with the holders
of Common Stock an a single class upon any matter submitted to the stockholders
for a vote, on the following basis:

                 (a) Holders of Common Stock shall have one vote per share; and

                 (b) Holders of Preferred Stock shall have that number of votes
     per share as is equal to the number of shares of Common Stock (including
     fractions of a share) into which each such share of Preferred Stock held by
     such holder could be converted on the date for determination of
     stockholders entitled to vote at the meeting or on the date of any written
     consent.

     With respect to all questions as to which, under law, stockholders are
required to vote by classes, each of the Series A Preferred Stock and Series B
Preferred Stock shall vote separately as a single class apart from each other
and from the Common Stock.

     Section 5.  Dividends.
     ---------   ---------

            (a)  The holders of Series B Preferred Stock shall be entitled to
receive, from funds legally available therefor, a noncumulative dividend at the
rate of $.05 per share per annum, payable when and as declared by the Board of
Directors.  No dividends shall be declared or paid to the holders of Series A
Preferred Stock or Common Stock unless the holders of Series B Preferred Stock
have been paid in full all of the dividends to which they are entitled, nor
shall any dividends be declared or paid to the holders of Series A Preferred
Stock or Common Stock at a rate greater than the rate paid to the holders of
Series B Preferred Stock.

            (b)  Subject to Subsection 5(a), dividends may be declared and paid
on Series A Preferred Stock from funds lawfully available therefor as and when
determined by the Board of Directors of the Corporation. If, when and as
dividends are declared and paid on shares of Series A Preferred Stock, the
Corporation shall, after making payment in full to the holders of Series B
Preferred Stock the amounts to which they are entitled pursuant to Subsection
5(a), declare and pay at the same time to each holder of Series B Preferred
Stock, a dividend at the same rate, based on the number of shares of Common
Stock into which the Series B Preferred Stock and the Series A Preferred Stock
are convertible on the record date for the determination of holders of Series A
Preferred Stock entitled to receive such dividend.

            (c)  Subject to Subsection 5(a), dividends may be declared and paid
on Common Stock from funds lawfully available therefor as and when determined by
the Board of Directors of the Corporation. If, when and as dividends are
declared and paid on shares of Common Stock, the Corporation shall, after making
payment in full to the holders of Series B Preferred Stock the amounts to which
they are entitled pursuant to Subsection 5(a), declare and pay at the same time
to each holder of Preferred stock, a dividend equal to the dividend which

                                     -16-
<PAGE>

would have been payable to such holder if the shares of Preferred Stock hold by
such holder had been converted into Common Stock on the record date for the
determination of holders of Common Stock entitled to receive such dividend.

     Section 6.  Redemption.
     ---------   ----------

            (a)  In the event that the Corporation shall exercise its put option
to sell shares of capital stock of Sequenom Instruments GmbH to Technologie-
Beteiligungs-Gesellschaft mbH der Deutschen Ausgleichsbank ("TBG") pursuant to
that certain Kooperationsvertrag between the Corporation and TBG relating to the
investment by the Corporation of DM 3 million in Sequenom Instruments GmbH, the
Corporation shall, within 30 days after receipt of the proceeds of the sale of
such shares to the TBG, send notice of such exercise (the "Put Exercise Notice")
by first class mail, postage prepaid, to each holder of record of the Series B
Preferred Stock at its address as it appears on the books of the Corporation,
specifying (i) the amount of proceeds so received from the TBG net of any
expenses incurred in connection therewith (the "Put Net Proceeds"), (ii) the
date (the "Redemption Date") on which the Corporation will redeem shares of
Series B Preferred Stock from electing holders of the Series B Preferred Stock
in accordance with this Section 6, which Redemption Date shall be not less than
45 days nor more than 90 days after the date of such notice (the "Notice Date")
and (iii) each such holder's Pro Rata Redemption Amount (as hereinafter
defined).

            (b)  Each holder of Series B Preferred Stock may elect to have the
Corporation redeem from it on the Redemption Date, to the extent the Corporation
has funds legally available for such purpose, up to a number of shares of Series
B Preferred Stock equal to such holder's Pro Rata Redemption Amount (as
hereinafter defined) at a redemption price of $1.50 per share.  Such election
may be made only by delivering to the Corporation within thirty (30) days after
the Notice Date (i) a written election signed by such holder specifying the
number of shares of Series B Preferred Stock so to be redeemed (which number
shall be not more than such holder's Pro Rata Redemption Amount), and (ii)
certificates for the shares of Series B Preferred Stock so to be redeemed,
together with stock powers therefor duly executed by such holder in blank.

            (c)  For purposes of this Section 6, each holder of Series B
Preferred Stock's "Pro Rata Redemption Amount" shall be the greatest whole
number represented by a fraction, the numerator or which is the product of the
number of shares of Series B Preferred Stock held by such holder times the Put
Net Proceeds, and the denominator or which is the product of the total number of
shares of Series B Preferred Stock issued and outstanding times $1.50.

            (d)  On the Redemption Date the Corporation shall redeem from the
electing holders of Series B Preferred Stock the shares of Series B Preferred
Stock as to which election notices have been properly given, to the extent the
Corporation has funds legally available for such purpose.

            (e)  If the funds of the Corporation legally available for
redemption of shares of Series B Preferred Stock on the Redemption Date are
insufficient to redeem the total number of shares of Series B Preferred Stock
submitted for redemption, those funds which are legally available will be used
to redeem the maximum possible number of whole shares ratably among

                                     -17-
<PAGE>

the holders of such shares in accordance with the manner of determining the "Pro
Rata Redemption Amount" set forth above. The shares of Series B Preferred Stock
not redeemed shall remain outstanding and entitled to all rights and preferences
provided herein.

     Section 7. Residual Rights. All rights accruing to the outstanding shares
     ---------  ---------------
of the Corporation not expressly provided for to the contrary herein shall be
vested in the Common Stock.

                                     -18-
<PAGE>

                                  EXHIBIT 4.1
                                  -----------

         Foreign Qualification; Certificate of Incorporation; By-Laws
         ------------------------------------------------------------

     The Corporation is qualified to do business in Massachusetts.

     A certified copy of the Certificate of Incorporation (not including the
Certificate of Amendment contained in Exhibit 1) is included at Tab 9.

     A copy of the By-Laws is included as Exhibit A in Tab 7.
<PAGE>

                                  EXHIBIT 4.2
                                  -----------

                                Capitalization
                                --------------

     Attached-hereto is a stockholder list dated December 1, 1995.

     Also attached hereto is a common-equivalent capitalization table dated
December 14, 1995.
<PAGE>

                                SEQUENOM, INC.
                               Stockholder List
                               December 1, 1995

<TABLE>
<CAPTION>
AUTHORIZED:
                                Par Value             Authorized                 Issued
                              -------------       -----------------        ----------------
<S>                           <C>                 <C>                      <C>
Common:                           $.001                2,301,000                  148,251

Series A Convertible              $.00l                2,098,000                1,580,000
Preferred:
</TABLE>

                                 COMMON STOCK
                                 ------------

<TABLE>
<CAPTION>
Shareholder                       Shares             Cert. No.           Issue Date
---------------------         --------------      ---------------     -----------------
<S>                           <C>                 <C>                 <C>
Hubert Koster                         1                C-10                03-08-95
Stapelstrasse 56
D-22529
Hamburg, Germany

Nola E. Masterson                90,000                C-11                10-16-95
Science Futures Inter-
 national
768 West California Way
Woodside, CA 94062

Russell D. Hayes                 26,250                C-12                10-31-95
136 Lark Court
Alamo, CA 94507

Randall R. Lunn                  10,000                C-13                12-01-95

Helmut Schuhsler                 10,000                C-14                12-01-95

Patricia Dane                     2,000                C-15                12-01-95

Amy B. Crawford                   2,000                C-16                12-01-95

Monica Schlawinsky                2,000                C-17                12-01-95

John J. DiBello                   6,000                C-18                12-01-95
</TABLE>

<PAGE>

                     SERIES A CONVERTIBLE PREFERRED STOCK
                     ------------------------------------

<TABLE>
<CAPTION>
Shareholder                       Shares              Cert. No.               Issue Date
------------------------      --------------      -----------------       ------------------
<S>                           <C>                 <C>                     <C>
Hubert Koster                    1,120,000                    1                 03-08-95
Stapelstrasse 56
D-22529
Hamburg, Germany

Nola Masterson                      40,000                    2                 03-08-95
Science Futures Inter-
 national
768 West California Way
Woodside, CA 94062

Robert E. Patterson                 20,000                    3                 03-08-95
176 Tuscaloos Avenue
Atherton, CA 94025

TVM Techno Venture                   8,000                   10                 08-18-95
Investors No. 1 Limited
  Partnership
101 Arch Street
Suits 1950
Boston, MA 02110

TVM Techno Venture                  63,680                   12                 08-18-95
Enterprises No. II Limited
Partnership
101 Arch Street
Suite 1950
Boston, MA 02110

TVM Intertech Limited               42,454                   13                 08-18-95
Partnership
101 Arch Street
Suite 1950
Boston, MA 02110

TVM Zweite Beteiligung-             98,000                    6                 03-08-95
  U.S. Limited Partnership          29,360                   11                 08-18-95
101 Arch Street
Suite 1950
Boston, MA 02110

TVM Eurotech Limited                65,200                    7                 03-08-95
  Partnership                       19,706                    9                 08-18-95
101 Arch Street
Suite 1950
Boston, MA 02110

KBL Founder Ventures SCA            73,600                    8                 03-08-95

</TABLE>

<PAGE>

Sequenom, Inc.
Analysis of shares and options issued
December 14, 1996-before financing

<TABLE>
<CAPTION>
                                                                                                                  Shares to be
                                                         Shares issued for  Shares issued through  Total shares   issued under
                                                Shares       service of         exercise of         issued and     options or
                                              purchased      technology        stock options        outstanding     warrants
                                              ---------  -----------------  ---------------------  ------------   ------------
<S>                                           <C>        <C>                <C>                    <C>            <C>
Founders:
---------
Koster                                         20,001       1,100,000                                1,120,001        80,000
Masterson                                       2,000          38,000              90,000              130,000
Peterson                                       20,000                                                   20,000        30,000
                                              --------------------------------------------------------------------------------
Founder Subtotal                               42,001       1,138,000              90,000            1,270,001       110,000
                                              --------------------------------------------------------------------------------
TVM entities:
TVM Techno Venture Enterprises
No. II L.P.                                   _______                                                _________
TVM Intertech L.P.                             42,454                                                   42,454
TVM Eurotech L.P.                              84,906                                                   84,906
TVM Zweite Beteiligung US L.P.                127,380                                                  127,380
TVM Techno Venture Investors                    8,000                                                    8,000
  No. I L.P.
KBL Founder Ventures SCA                       73,000                                                   73,000
                                              --------------------------------------------------------------------------------
TVM Subtotal                                  400,000               0                   0              400,000             0
                                              --------------------------------------------------------------------------------
Other shares Issued:
--------------------
Russell Hays                                    28250                                                    28250
Helmut Schuhsler                                               10,000                                   10,000
Randall Lunn                                                   10,000                                   10,000
John J. DiBello                                                 6,000                                    6,000
Monica Schlawinsky                                              2,000                                    2,000
Amy B. Crawford                                                 2,000                                    2,000
Patricia Dane                                                   2,000                                    2,000
                                              --------------------------------------------------------------------------------
Other subtotal                                  28250          32,000                   0               58,250             0
                                              --------------------------------------------------------------------------------
                                              --------------------------------------------------------------------------------
Total shares issued as of December 14, 1995   488,251       1,170,000             $90,000            1,278,251       110,000
                                              --------------------------------------------------------------------------------

Options and warrants outstanding:
---------------------------------
Bob Cotter (technical advisory board)                                                                                     42000
Charles Cantor (technical advisory board)                                                                            _______
Dong-Jing Fu (employee)                                                                                                10000
Maryanne Maloney (employee)                                                                                            10000
Kai Tang (employee)                                                                                                    10000

Comdisco warrants:*
First $35,000 at $0.50/share                                                                                           70000
Second $85,000 at $1.96/share                                                                                          43333

                                              --------------------------------------------------------------------------------
Total options and warrants outstanding                                                                               251,333
                                              --------------------------------------------------------------------------------

Fully diluted total as of December 14, 1995   488,251       1,170,000              90,000            1,728,251       361,333
                                              --------------------------------------------------------------------------------
<CAPTION>
                                                  Total shares       Fully Diluted
                                                Issued and under       Percentage
                                                Options/warrants       Ownership
                                                ----------------     -------------
Founders:
---------
<S>                                             <C>                  <C>
Koster                                              1,200,001            57.43%
Masterson                                             130,000             6.22%
Peterson                                               50,000             2.30%
                                                ----------------------------------
Founder Subtotal                                    1,380,000            86.04%
                                                ----------------------------------
TVM entities:
TVM Techno Venture Enterprises                      _________             3.05%
No. II L.P.
TVM Intertech L.P.                                     42,454             2.03%
TVM Eurotech L.P.                                   _________             4.08%
TVM Zweite Beteiligung US L.P.                        127,380            _____%
TVM Techno Venture Investors                            8,000             0.38%
  No. I L.P.
KBL Founder Ventures SCA                               73,000             3.62%
                                                ----------------------------------
TVM Subtotal                                          400,000            19.14%
                                                ----------------------------------
Other shares Issued:
--------------------
Russell Hays                                            28250            1.2__%
Helmut Schuhsler                                       10,000            _____%
Randall Lunn                                           10,000            _____%
John J. DiBello                                         6,000           0.2___%
Monica Schlawinsky                                      2,000             0.10%
Amy B. Crawford                                         2,000             0.10%
Patricia Dane                                           2,000             0.10%
                                                ----------------------------------
Other subtotal                                         58,250             2.79%
                                                ----------------------------------
                                                -----------------------
Total shares issued as of December 14, 1995         1,636,251
                                                -----------------------

Options and warrants outstanding:
---------------------------------
Bob Cotter (technical advisory board)                  42,000              2.01%
Charles Cantor (technical advisory board)           _________              3.16%
Dong-Jing Fu (employee)                                10,000              0.48%
Maryanne Maloney (employee)                            10,000              0.48%
Kai Tang (employee)                                    10,000              0.48%

Comdisco warrants:*
First $35,000 at $0.50/share                           70,000              3.35%
Second $85,000 at $1.96/share                          43,333              2.07%

                                                ----------------------------------
Total options and warrants outstanding                251,333             12.03%
                                                ----------------------------------

Fully diluted  total as of December 14, 1995        2,089,564            100.00%
                                                ----------------------------------
</TABLE>

* Warrants not yet issued
<PAGE>

                                  EXHIBIT 4.3
                                  -----------

                              Equity Investments
                              ------------------

     The Corporation has one subsidiary, Sequenom Instruments GmbH, all of the
outstanding equity interest in which is owned by the corporation.
<PAGE>

                                 EXHIBIT 4.4A
                                 ------------

                        Unaudited Financial Statements
                          as of December 31, 1994 and
                              for the year ended
                        ------------------------------
<PAGE>

--------------------------------------------------------------------------------

                                 SEQUENOM, INC
                       (A Development Stage Enterprise)
--------------------------------------------------------------------------------

                          CONSOLIDATED BALANCE SHEET
                               December 31, 1994
                                    ASSETS

<TABLE>
          <S>                                                    <C>
          Cash                                                   $   168,570
          Other current assets                                         2,500
                                                                 -------------
             Total current assets                                    171,070
                                                                 -------------
          Office equipment                                             2,264
          Less accumulated depreciation                                  (38)
                                                                 -------------
                                                                       2,226
                                                                 -------------
          Organizational costs (net accumulated                       34,000
             amortization of $6,000)
          Other assets                                                22,334
                                                                 -------------
          Total assets                                           $   229,631
                                                                 -------------
                               LIABILITIES
          Convertible term notes                                 $   500,000
          Accrued expenses                                            76,993
                                                                 -------------
          Total Liabilities                                      $   576,993
                                                                 -------------
                               STOCKHOLDERS' DEFICIT
          Series A Convertible Preferred Stock                   $   754,516
          Common Stock                                                     1
          Cumulative translation adjustment                           (1,703)
          Deficit accumulated in the development stage            (1,100,176
                                                                 -------------
          Total stockholder's deficit                                347,362
                                                                 -------------
          Total liabilities and stockholders' deficit            $   229,631
                                                                 =============
</TABLE>

<PAGE>

--------------------------------------------------------------------------------

                                 SEQUENOM, INC
                       (A Development Stage Enterprise)
--------------------------------------------------------------------------------

                     CONSOLIDATED STATEMENT OF OPERATIONS
  From the period of inception (February 14, 1994) through December 31, 1994

<TABLE>
          <S>                                                   <C>
          Operating Expenses:
             Research and development                                872,230
             General and administrative                              230,588
                                                                --------------
                                                                   1,102,817
                                                                --------------
          Net Operating loss from Operations                      (1,102,817)
          Interest Income                                              2,641
          Net loss                                                (1,100,176)
                                                                ==============
</TABLE>

<PAGE>

                                 EXHIBIT 4.4B
                                 ------------

                        Unaudited Financial Statements
                          as of October 31, 1995 and
                         for the ten-months then ended
                    --------------------------------------
<PAGE>

--------------------------------------------------------------------------------
                                 SEQUENOM, INC
                        (A Development Stage Enterprise)
--------------------------------------------------------------------------------

                           CONSOLIDATED BALANCE SHEET
                                October 31, 1995
ASSETS
                                                                     10/31/95
                                                                    ----------
                cash                                                $  110,748
                Prepaid expenses                                        34,304
                Other current assets                                     2,500
                Accounts receivable                                      9,130
                Other assets                                           181,830
                Fixed assets (net accumulated depreciation of $629)    660,003
                Organizational costs (net accumulated
                amortization of $12,667)                                28,380
                                                                    ----------
                Total assets                                        $1,026,896
                                                                    ==========

LIABILITIES
                Accounts Payable and Accrued Expenses               $  501,393
                Convertible term notes                               1,361,600
                Silent Partnership loan                                710,700
                                                                    ----------
                Total Liabilities                                   $2,573,693
                                                                    ----------
                  STOCKHOLDERS' DEFICIT

                Series A Convertible Preferred Stock                   754,516
                Common Stock                                             1,314
                Cumulative translation adjustment                      (13,784)
                Deficit accumulated in the development stage        (2,288,842)
                                                                    ----------
                Total stockholder's deficit                         (1,546,797)
                                                                    ----------
                Total liabilities and stockholders' deficit         $1,026,896
                                                                    ==========

<PAGE>

--------------------------------------------------------------------------------
                                 SEQUENOM, INC
                       (A Development Stage Enterprise)
--------------------------------------------------------------------------------

                     CONSOLIDATED STATEMENT OF OPERATIONS
                     For the period ended October 31, 1995
                                                              10/31/95
Operating Expenses:                                          ----------
     Consulting fees                                          328,350
     Travel expenses                                           84,342
     Amortization expense                                       6,667
     Depreciation expense                                      51,639
     Audit fees                                                 4,000
     Legal & Tax                                              205,670
     Recruitment expense                                        1,937
     Advisory fees                                                  0
     unrealized f(x) loss                                       1,703
     General and administrative expenses                      499,548
                                                           ----------
                                                            1,183,856
                                                           ----------

Net Operating loss from Operations                         (1,183,856)
Interest Income                                                (4,804)
Net loss                                                   (1,188,659)
                                                           ==========

<PAGE>

                                  EXHIBIT 4.5

                            Undisclosed Liabilities
                            -----------------------

None.
<PAGE>

                                  EXHIBIT 4.6
                                  -----------

                        Changes Since October 31, 1995
                        ------------------------------

     The Corporation has received bridge loans from certain of the Investors
since October 31, 1995 as follows:

                Date                                 Amount
             ---------                             ---------

       November 1, 1995                             $ 18,400
       November 10-21, 1995                          100,000
       November 30, 1995                             100,000
                                                 --------------
         Total                                      $218,400
<PAGE>

                                  EXHIBIT 4.7
                                  -----------

                                 Encumbrances
                                 ------------

     None, other than non-consensual liens arising in the ordinary course of
business by operation of law.  The Corporation is not aware of the existence of
any such liens.
<PAGE>

                                 EXHIBIT 4 - 8
                                 -------------

                         Intellectual Property Rights;
                          Agreements with Dr. Koster
                          --------------------------

     Attached hereto is a patent status sheet dated December 8, 1995.

     Also attached hereto are copies of the Assignment of Inventions dated May
26, 1994, Executive Employment Agreement dated as of April 1, 1994 and
Consulting Services Agreement dated April 1, 1994 between the Corporation and
Dr. Hubert Koster.
<PAGE>

Page 1                                                          (as of 12/08/95)

      SEQUENOM PATENT STATUS SHEET AND PROJECTED 1996 PATENT COSTS (U.S.)
      -------------------------------------------------------------------

<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------------
L&C                Serial No./                                                                                       Projected
Docket No.         Patent No.               Title and Inventor(s)           Filing Date      Status                  1996 Costs
-----------------------------------------------------------------------------------------------------------------------------------
<S>                <C>             <C>                                      <C>              <C>                     <C>
SQI-003            08/001,323      DNA Sequencing by Mass Spectrometry        01/07/93       Abandoned in Favor        -------
                                   by Hubert Koster                                          of SQI-003CP
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CP          08/178,216      DNA Sequencing by Mass Spectrometry        01/06/94       Response to Final
                                   by Hubert Koster                                          Rejection Submitted
                                               (Sequencing Method)                              12/01/95
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPD1        08/470,123      DNA Sequencing by Mass Spectrometry        06/06/95       Awaiting First Office   $2,000-$5,000
                                   by Hubert Koster                                          Action                  Prosecution
                                               (Sequencing Kit)                                                   Costs
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPD2        08/467,208      DNA Sequencing by Mass Spectrometry        06/06/95       Awaiting First Office   $2,000-$5,000
                                   by Hubert Koster                                          Action                  Prosecution
                                               (Solid Supports)                                                      Costs
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPD3        08/481,033      DNA Sequencing by Mass Spectrometry        06/07/95       Awaiting First Office   $2,000-$5,000
                                   by Hubert Koster                                          Action                  Prosecution
                                               (Primers)                                                             Costs
------------------------------------------------------------------------------------------------------------------------------------
SQI-005            08/034,738      DNA Sequencing by Mass Spectrometry via    03/19/93       Abandoned                 ------
                                   Exonuclease Degradation
                                   by Hubert Koster
------------------------------------------------------------------------------------------------------------------------------------
SQI-005CN          08/388,171      DNA Sequencing by Mass Spectrometry via    02/10/95       -Preliminary            $2,000-$5,000
                                   Exonuclease Degradation                                   Amendment Filed         Prosecution
                                   by Hubert Koster                                          07/10/95;               Costs
                                               (Sequencing Method)                           -Awaiting First Office
                                                                                             Action
------------------------------------------------------------------------------------------------------------------------------------
SQI-005CNDI        08/454,527      DNA Sequencing by Mass Spectrometry via    05/30/95       Awaiting First Office   $2,000-$5,000
                                   Exonuclease Degradation                                   Action                  Prosecution
                                   by Hubert Koster                                                                  Costs
                                               (Multiplex Method; Kit)
------------------------------------------------------------------------------------------------------------------------------------
SQI-005CND2        08/453,499      DNA Sequencing by Mass Spectrometry via    05/30/95       Awaiting First Office   $2,000-$5,000
                                   Exonuclease Degradation                                   Action                  Prosecution
                                   by Hubert Koster                                                                  Costs
                                   (System for Exonuclease Mediated Mass
                                    Specific Sequencing)
-----------------------------------------------------------------------------------------------------------------------------------
SQI-013            08/406,199      DNA Diagnostics Based on Mass              03/17/95       Response is due         $2,000-$5,000
                                   Spectrometry                                              12/14/95                Prosecution
                                   by Hubert Koster                                                                  Costs
------------------------------------------------------------------------------------------------------------------------------------
SQI-017            08/521,638      Filtration Processes, Kits and Devices     08/31/95       IDS is due 11/30/95     $2,000-$5,000
                                   for Isolating Plasmids                                                            Prosecution
                                   by Hubert Koster                                                                  Costs
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

     SEQUENOM PATENT STATUS SHEET AND PROJECTED 1996 PATENT COSTS (Foreign)
     ----------------------------------------------------------------------
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------------
L&C              Region/     Serial No./                                                                                Projected
Docket No.       Country     Patent No.           Title and Inventor(s)                 Filing Date     Status          1996 Costs
-----------------------------------------------------------------------------------------------------------------------------------
<S>              <C>         <C>                <C>                                     <C>             <C>             <C>
SQI-003CPPC      PCT         PCT/US94/00193     DNA Sequencing by Mass Spectrometry     01/06/94        Entered into      ------
                                                by Hubert Koster                                        National Phase
                                                                                                        07/07/95
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPAU      Australia   59929/94           DNA Sequencing by Mass Spectrometry     01/06/94        Request for     Payment of
                                                by Hubert Koster                                        Examination     Renewal and
                                                                                                        due 12/06/98    Request for
                                                                                                                        Examination
                                                                                                                        Fees $800.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPCA      Canada      New Application    DNA Sequencing by Mass Spectrometry     01/06/94        Awaiting First  Payment of
                                                by Hubert Koster                                        Office Action   Renewal Fee
                                                                                                                        $1,300.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPJP      Japan       516209/94          DNA Sequencing by Mass Spectrometry     01/06/94        Early
                                                by Hubert Koster                                        Instructions:
                                                                                                        Examination
                                                                                                        due 12/06/2000
------------------------------------------------------------------------------------------------------------------------------------
SQI-003CPEP      EPO         94 90 6047.9       DNA Sequencing by Mass Spectrometry     01/06/94        Awaiting First  Payment of
                                                by Hubert Koster                                        Office Action   Renewal Fee
                                                                                                                        $750.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-005PC        PCT         PCT/US91/02938     DNA Sequencing by Mass Spectrometry     03/18/94        Entered into    ------------
                                                via Exonuclease Degradation                             National Phase
                                                by Hubert Koster                                        09/19/95
------------------------------------------------------------------------------------------------------------------------------------
SQI-005AU        Australia   New Application    DNA Sequencing by Mass Spectrometry     03/18/94        Petition for    Request for
                                                via Exonuclease Degradation                             Examination     Examination
                                                by Hubert Koster                                        due 03/18/99    and Payment
                                                                                                                        of Renewal
                                                                                                                        Fees $800.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-005CA        Canada      New Application    DNA Sequencing by Mass Spectrometry     03/18/94        Request for     Payment of
                                                via Exonuclease Degradation                             Examination     Renewal Fee
                                                by Hubert Koster                                        due 3/18/2001   $300.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-005EP        EPO         New Application    DNA Sequencing by Mass Spectrometry     03/18/94        Awaiting First  Payment of
                                                via Exonuclease Degradation                             Office Action   Renewal Fee
                                                by Hubert Koster                                                        $800.00
------------------------------------------------------------------------------------------------------------------------------------
SQI-005JP        Japan       9509061            DNA Sequencing by Mass Spectrometry     03/18/94        Early
                                                via Exonuclease Degradation                             Instructions:
                                                by Hubert Koster                                        Examination
                                                                                                        due 02/18/2001
------------------------------------------------------------------------------------------------------------------------------------
SQI-013PC        PCT                            DNA Diagnostics Based on Mass                           File            $3-$4,000.00
                                                Spectrometry                                            International
                                                by Hubert Koster                                        Patent
                                                                                                        Application on
                                                                                                        or before
                                                                                                        03/17/96
------------------------------------------------------------------------------------------------------------------------------------
SQI-017PC        PCT                            Filtration Processes, Kits and                         File            $3-$4,000.00
                                                Devices for Isolating Plasmids                         International
                                                by Hubert Koster                                       Patent
                                                                                                       Application on
                                                                                                       or before
                                                                                                       08/31/96
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
                            SEQUENOM SUBJECT MATTER
                            -----------------------
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
L & C Docket No.                        Sequenom Docket No.                              Title
------------------------------------------------------------------------------------------------------------------------------------
<S>                                    <C>                                    <C>
SQI-002                                                                       Cantor Patent Application
------------------------------------------------------------------------------------------------------------------------------------
SQI-003                                                                       Drukier Patent Application
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>

                           ASSIGNMENT OF INVENTIONS
                           ------------------------

          This Assignment of Inventions (the "Assignment") is made as of May 26,
1994, by and between SEQUENOM, INC., a Delaware corporation (the "Company"), and
Dr. Hubert Koster (the "Assignor") having a place of business at 1640 Monument
Street, Concord, MA 01742.

                               R E C I T A L S:
                               ---------------

          A.   Prior to the date hereof, Assignor has been developing certain
technology and products to determine DNA sequencing by mass spectrometry (the
"Products");

          B.   Assignor desires to transfer to the Company all intellectual
property related to the Products, and to cancel certain expenses incurred in
connection with the development thereof, in exchange for the issuance of Common
Stock of the Company; and

          C.   Assignor and the Company intend the foregoing transaction to
qualify as a non-taxable transfer within the meaning of Section 351 of the
Internal Revenue Code of 1986, as amended, in that such transfer will be made
solely in exchange for Common Stock of the Company and immediately thereafter
Assignor will be in control of the Company.

          NOW, THEREFORE, in consideration of the foregoing and the mutual
promises contained herein, the parties agree as follows:

          1.   The recitals set forth above shall be deemed to be a part of this
Agreement as though such provisions had been forth in full in this Agreement.

          2.   In consideration of the issuance of 1,100,000 shares of the
Common Stock of the Company, Assignor hereby assigns to the Company all of his
right, title and interest in and to (i) all inventions and improvements,
designs, know-how, and ideas (including all patents, trademarks, trade names,
copyrights, inventions, trade secrets, proprietary processes and

<PAGE>

formulae, applications for patents, trademarks and copyrights, and other
industrial and intellectual property rights) relating to the Products, including
but not limited to the United States Patent and Trademark Applications and
inventions described on Exhibit A hereto, and (ii) all machines, instruments,
devices, equipment or models incident or related thereto, made, conceived, or
created by Assignor prior to the date of this Assignment, all of which are
hereafter referred to as the "Inventions." This Assignment is intended to
include any additional rights in or to the Inventions received by Assignor after
the effective date of this Assignment, without further consideration to
Assignor, including rights to any credits and royalties arising out of the
Inventions. Assignor further waives and relinquishes his tight to request any
reimbursement by the Company of expenses incurred by or on behalf of Assignor
prior to the date hereof in connection with the development of the Products or
the Inventions.

          3.   Assignor represents and warrants that he has made no prior
license, transfer, assignment or hypothecation of any interest in the Inventions
and that no other person or firm has any interest in the Patent and Patent
Applications and the trademark Application listed in Exhibit A hereto and to the
best of Assignor's knowledge in any other Inventions.  Assignor owns, possesses,
and has the right to use, to bring actions for the infringement of and to
transfer and assign to the Company the Patent and Patent Applications and the
Trademark Application listed in Exhibit A hereto and to the best of Assignor's
knowledge all other Inventions.  No royalties or other amounts will be payable
by the Company to Assignor by reason of its ownership, use or licensing of the
Inventions.  To the best of Assignor's knowledge, no Invention violates any
license or infringes any patent, copyright, trademark, trade secret or other
intellectual property right of any person or entity, nor will royalties or other
amounts be payable by the Company to any person or entity by reason of the
Company's ownership, use or licensing

                                      2.
<PAGE>

of the Inventions, nor is there any reasonable basis to believe that any such
violation, infringement or conflict may exist, except that Assignor is aware of,
and hereby gives the Company notice of, U.S. Patent No. 5,288,644 issued on
February 22, 1994 to Rockefeller University (Inventors R.C. Beavis and B.T.
Chait) and now in the possession of Perceptive Biosystems, Cambridge,
Massachusetts. Assignor has not received any notice that any of such Inventions
or the-ownership, use or licensing thereof in the operation or proposed
operation of the Company's business conflicts with the rights of others.
Assignor owns all right, title and interest in and to the Patent and Trademark
Applications described on Exhibit A hereto.

          4.   In support of said Assignment, Assignor further agrees as
follows:

               (a)  To deliver to the company copies of all writings and other
tangible evidence or representations of the Inventions, and any improvements
covered by this Assignment;

               (b)  To execute such additional documents as may reasonably be
required to transfer to the Company Assignor's entire right, title and interest
in or to the Inventions, improvements thereof covered by this Assignment and to
all rights of priority thereto pursuant to the International Convention for
Protection of Industrial Property; and in and to any and all Letters Patent on
said Inventions and/or said improvements that may be granted in the United
States or any foreign country, including each and every Letter Patent granted on
any application which is a division, substitution, or continuation of said
application specifically identified herein, and in and to each and every reissue
or extension of said Letters Patent;

               (c)  Not to make any use of the Inventions or improvements
covered by this Assignment for his benefit or interest and to hold them in
confidence and not to disclose

                                      3.
<PAGE>

them to anyone other than personnel of the Company, without the prior written
consent of an officer of the Company;

               (d)  To cooperate with the company whereby said company may enjoy
to the fullest extent the right, title and interest herein conveyed. Such
cooperation shall include: (i) prompt execution of all papers (prepared at the
expense of the Company) which are deemed necessary or desirable by the Company
to perfect in it the right, title and interest herein conveyed; (ii) prompt
execution of all petitions, oaths, specifications, declarations or other papers
(prepared at the expense of the Company) which are deemed necessary or desirable
by the Company for prosecuting said applications specifically identified herein,
for filing and prosecuting substitutions, divisions, continuing or additional
applications in the United States and/or foreign countries covering said
Inventions and/or said improvements, for filing and prosecuting applications for
reissuance of Letters Patent included herein, or for interference (i.e.,
priority) proceedings involving said Inventions and/or said improvements; and
(iii) prompt assistance and cooperation in the prosecution of legal proceedings
involving said Inventions and/or said improvements, said applications and
patents granted thereon, including oppositions, cancellation proceedings,
priority contests, public use proceedings and court actions; provided, however,
that any expense which may be incurred by Assignor in lending such assistance
and cooperation shall be paid by the Company.

          5.   This Assignment shall constitute the Company as the owner of the
Inventions as of May 26, 1994 and all tangible representations thereof, without
the requirement of further delivery; provided, however, that if by September 1,
1994 the Company has not received aggregate gross proceeds of at least Five
Million Dollars ($5,000,000.00) from financings on terms no less favorable to
the Company than those set forth in a Memorandum of

                                      4.
<PAGE>

Terms for a Private Placement of Preferred Stock dated March 28, 1994, despite
Assignor's best efforts to assist the Company in obtaining such financing
Assignor shall have the option (the "Option"), exercisable by delivery of a
written election to the Company on or before October 1, 1994, to declare the
assignment and transfer of the Inventions pursuant to this Assignment of
Inventions null and void. On receipt of Assignor's election to exercise the
Option to declare the assignment and transfer of the Inventions null and void,
the Company shall: (a) deliver to Assignor copies of all materials provided to
the company by Assignor pursuant to Paragraph 4 above; (b) execute and deliver
to Assignor such additional documents as may reasonably be required to transfer
to Assignor the Company's entire right, title, and interest in or to the
Inventions; and (c) cease making any use of the Inventions or improvements
covered by this Assignment of Inventions.

          6.   This Assignment of Inventions shall be binding on all of the
heirs and assigns of Assignor, and shall inure to the benefit of the Company,
its assigns and successors.

          7.   This Assignment of Inventions shall be governed by and construed
in accordance with the laws of the Commonwealth of Massachusetts, U.S.A.,
without application of principles of conflicts of laws.

          EXECUTED this 26th day of May, 1994.

                                        /s/ Hubert Koster
                                        --------------------------------
                                        Hubert Koster

                                        SEQUENOM, INC.

                                        By: /s/ Nola E. Masterson
                                           -----------------------------

                                        Title:  CEO
                                              --------------------------

                                      5.

<PAGE>

                                   EXHIBIT A
                                   ---------

                                  INVENTIONS

                                                         U.S. Patent or
                                                       Patent Application
Description                                             Number of Status
-----------                                             ----------------

1.   "DNA Sequencing by                           Serial No. 08/001,323 (filed
     Mass Spectroscopy"                           January 7, 1993)

                                                  Continuation-in-Part, Serial
                                                  No. 08/178,216 (filed
                                                  January 6, 1994)

                                                  PCT-Application, Serial No.
                                                  PCT/US94/00192 (filed
                                                  January 6, 1994)

2.   "DNA Sequencing by                           Serial No. 08/034,738 (filed
     Mass Spectroscopy                            March 19, 1993)
     via Exonuclease
     Degradation"

                                                  PCT-Application, Serial No.
                                                  PCT/US94/02938 (filed
                                                  March 18, 1994)

     Filings for both of the patent applications have been made in the following
countries: Austria, Belgium, Switzerland/Liechtenstein, Germany, Denmark, Spain,
France, United Kingdom, Greece, Ireland, Italy, Luxembourg, Monaco, Netherlands,
Portugal, Sweden, Australia, Canada, China, Japan and the Russian Federation.

                                   TRADEMARK

                                                     U.S. Trademark
                                                    Application Number
                                                       or Status
                                                  -----------------------------
1.  SEQUENOM                                       Serial No. 74/347,804
                                                   (Notice of Allowance issued
                                                   12/7/93)

<PAGE>

                               CONSENT OF SPOUSE

               I, Jutta Koster, spouse of Hubert Koster, agree that my interest
     in the Inventions subject to the foregoing Assignment of Inventions shall
     be irrevocably bound by the terms thereof.  I further understand and agree
     that my community property interest, if any, shall be similarly bound by
     said Assignment, that such consent is binding upon my heirs, personal
     representatives and assigns, and I agree to execute and deliver such
     documents as may be necessary to carry out the intent of this Agreement.

Date:  May 26, 1994

                                        /s/ Jutta Koster
                                       --------------------------------
                                       Jutta Koster

<PAGE>

                        EXECUTIVE EMPLOYMENT AGREEMENT
                        ------------------------------

     This Executive Employment Agreement (the "Agreement") is dated as of April
1, 1994 between Sequenom, Inc. (the "Company"), a Delaware corporation, and Dr.
Hubert Koster (the "Executive") currently residing at Stapelstr. 5b, 22529
Hamburg, Germany.

                             ARTICLE 1. RECITALS

     1.1.  Development of Technologies.  Executive has developed certain
           ---------------------------
technologies related to DNA sequencing by mass spectrometry (the "Technologies")
and, in connection with the founding of the Company, has assigned to the Company
all patent applications, technological developments and trademarks owned or
controlled by him which are related to the Technologies.

     1.2.  Employment of Executive.  Executive is currently a Professor at the
           -----------------------
University of Hamburg (the 'University") in Germany.  The Company wishes to
secure the services of Executive as a key employee of the Company to facilitate
the transfer of the Technologies to the Company, to develop products based on
the Technologies and to obtain the benefit of Executive's vision for the long
range development of the Technologies and the business of the Company.
Executive is willing to become an employee of the Company commencing on the date
(the "Effective Date") he is permitted to do so under the terms of his
arrangement with the University.

                      ARTICLE 2. EMPLOYMENT OF EXECUTIVE

     2.1.  Employment.  Subject to the terms and conditions of this Agreement,
           ----------
the Company agrees to employ Executive in a full time capacity to serve as
Executive Vice President, Science & Operations and Chief Technical Officer.  The
duties of Executive shall include directing the research, development and
engineering activities of the Company, being responsible for long range
technological planning, assisting other officers of the Company in establishing
marketing objectives and strategic plans for overall business development, and
performing such other specific duties as may reasonably be assigned to the
Executive from time to time by the Board of Directors of the Company.  Executive
hereby accepts such employment for the term hereof.

     2.2.  Term.  Executive's employment under this Agreement shall be for an
           ----
initial term commencing on the Effective Date and terminating three (3) years
from such date, unless earlier terminated as herein provided.  The term of this
Agreement may be extended beyond the initial term by mutual written consent.

     2 3.  No Conflicting Commitments.  During the period of the Executive's
           --------------------------
full time employment with the Company, Executive will not undertake any
Commitments which might impair Executive's performance of his duties as a full
time employee of the Company.  Notwithstanding the foregoing, (i) Executive
shall be permitted to continue his consulting

<PAGE>

relationship with Hybridon, Inc., including an extensions thereof. and to retain
all payments received thereunder and (ii) Executive shall be entitled to
maintain in affiliations with one or more universities in Hamburg and Boston on
the understanding that such relationships will advance the interests of the
Company by permitting Executive to utilize facilities, equipment and research
personnel in areas of research which are of interest to the Company. Without
limiting the generality of the foregoing, the Company acknowledges and
understands that (i) during a transition period, Executive will direct the
efforts of some scientists. diploma and Ph.D. students working at the University
as they finish their research topics; (ii) Executive may continue to act as a
principal investigator, in collaboration with colleagues at other German
universities and with certain German scientific instrument manufacturers, under
a grant from the German Ministry of Research and Technology extending through
June 30, 1996, and (iii) Executive may act as a principal investigator under a
potential grant from the Deutsche Forschungsgemeinschaft entitled "Use of MALDI-
TOF and Electrospray Mass Spectrometry in the Analysis of Nucleic Acids.'
Executive's consulting relationship and university affiliations are expected to
consume less than ten percent (10%) of Executive's productive time.

                            ARTICLE 3. COMPENSATION

     For all services to be rendered by Executive to the Company pursuant to
this Agreement, the Company shall pay to the Executive the compensation and
provide for Executive the benefits set forth below:

     3.1.  Base Salary.  The Company shall pay to Executive a base salary at the
           -----------
rate of $170,000 per annum during the initial twelve (12) months of this
Agreement. prorated and payable in substantially equal monthly installments.
Executive's salary will be reviewed annually and may be increased (but not
reduced) by the Board of Directors of the Company or a duly appointed committee
thereof.

     3.2.  Relocation Expenses.  The Company shall reimburse Executive all
           -------------------
moving expenses incurred in moving his family and household goods to the Boston,
Massachusetts area, up to a maximum of $40,000.

     3.3.  Bonuses.  Executive shall be entitled to receive a cash bonus of
           -------
$10,000 payable when the Company hires its first full-time Chief Executive
Officer.

     3.4.  Fringe Benefits.  In addition to Executive's base salary, relocation
           ---------------
expenses and bonuses, the Company shall provide Executive and Executive's
dependents medical insurance and such other benefits as are generally made
available by the Company to its other full time executive employees.

                         ARTICLE 4. EARLY TERMINATION

     4.1.  Early Termination.  Executive's employment hereunder shall terminate
           -----------------
prior to the expiration of the terms of this Agreement upon the occurrence of
any of the following events:

                                      -2-

<PAGE>

           4.1.1.  Executive's death or legal incapacity; or

           4.1.2.  The termination of Executive's employment hereunder by the
     Board of Directors of the Company, at its option, to be exercised by
     written notice to Executive. upon Executive's other incapacity or inability
     to further perform services as contemplated herein for a period aggregating
     90 days or more within any six-month period because Executive's physical or
     mental health shall have become impaired so as w make it impossible or
     impractical to perform the duties and responsibilities contemplated
     hereunder; or

           4.1.3.  The termination of Executive's employment hereunder by the
     Board of Directors of the Company, at its option, to be exercised by
     written notice to Executive, in the event of Executive's gross neglect of
     his duties hereunder, the commission by Executive of an act of deliberate
     dishonesty or moral turpitude in connection with his employment or the
     material breach by Executive of any obligation under this Agreement or any
     other agreement between Executive and the Company; or

           4.1.4.  The termination of Executive's employment hereunder by the
     Board of Directors of the Company, at its option which may be exercised
     with or without cause, to be exercised by delivery of written notice from
     the Company to the Executive; or

           4.1.5.  The termination of Executive's employment hereunder by
     Executive to be exercised by delivery of written notice from Executive to
     the Company.

     4.2.  Adjustments Upon Early Termination.  Notwithstanding any other
           ----------------------------------
provisions in this Agreement to the contrary:

           4.2.1.  If Executive's employment with the Company terminates
     pursuant to Section 4.1.1. or 4.1.2., all payments and benefits provided to
     Executive under this Agreement shall cease as of the date of termination of
     employment.

           4.2.2.  If Executive's employment with the Company terminates
     pursuant to Section 4.1.3. or 4.1.5., all payments and benefits provided to
     Executive under this Agreement shall cease as of the date of termination of
     employment.

           4.2.3.  If Executive's employment with the Company terminates
     pursuant to Section 4.1.4., (a) the Company shall pay to Executive as
     severance pay an amount equal to twelve times his then current base salary.
     payable in substantially equal monthly installments ("Severance Payments"),
     and distribute to him any sums accrued as of the termination date under the
     Company's retirement plan and other benefit plans (including accrued
     vacation pay, if any) and all other payments and benefits provided to
     Executive under this Agreement shall cease, (b) for a twelve month period
     after termination or such longer period as may be required by law.
     Executive shall be entitled to continue to receive medical benefits under
     the provisions of applicable laws (including COBRA) upon payment of the
     applicable premiums to the Company and (c) during the period in which the
     Executive is receiving Severance Payments, the Executive shall provide

                                      -3-

<PAGE>

     consulting services w the Company, as may be reasonably requested by the
     Company, subject to the Executive's reasonable availability.

                   ARTICLE 5. COVENANTS AGAINST COMPETITION

     5.1.  Non-solicitation of Employees.  Executive agrees that during the term
           -----------------------------
of Executive's employment with the Company and during the applicable Non-
competition Period (as defined below) after the termination of Executive's
employment with the Company, Executive shall not directly or indirectly recruit,
solicit or otherwise induce or attempt to induce any employees of the Company to
leave the employment of the Company.

     5.2.  Non-competition.  Executive agrees that during the term of
           ---------------
Executive's employment with the Company and during the applicable Non-
competition Period (as defined below) after the termination of Executive's
employment with the Company, Executive shall not directly or indirectly, except
as a passive investor in publicly held companies and except for investments held
at the date hereof, engage in competition with the Company or any of its
subsidiaries, or own or control any interest in or act as director, officer or
employee of, or consultant to, any firm, corporation or institution directly or
indirectly engaged in competition with the Company or any of its subsidiaries.

     5.3.  Non-competition Period.  In the event that Executive's employment is
           ----------------------
terminated pursuant to Section 4. 1. (other than pursuant to Section 4.1.1), the
Non-competition Period shall be twelve (12) months following the effective date
of Executive's termination without the payment of any compensation by the
Company to Executive beyond the Severance Payments provided in Section 4.2.3 in
the case of a termination pursuant to Section 4.1.4.

     5.4.  Academic Employment Permitted.  Notwithstanding the foregoing,
           -----------------------------
employment of Executive as a professor by a university of similar academic
institution shall not be deemed to be in competition with the business of the
Company.

                      ARTICLE 6. CONFIDENTIAL INFORMATION

     6.1.  Maintenance of Confidentiality.  Executive agrees that Executive will
           ------------------------------
not (except as required in the course of employment with the Company), both
during the term of Executive's employment with the Company and thereafter,
communicate or divulge to, or use for Executive's own benefit or the. benefit of
any other person, firm or organization, any confidential and proprietary
information of the Company and its subsidiaries.

     6.2.  Ownership of Confidential Information.  Records, riles, memoranda,
           -------------------------------------
reports, price lists, customer lists, drawings, plans, sketches and documents
and the like, relating to the business of the Company, which Executive shall use
or prepare or come into contact within the course of, in connection with, or as
a result of employment with the Company, shall remain the Company's Sole and
exclusive property.

                                      -4-

<PAGE>

                                  ARTICLE 7.
                            OWNERSHIP OF INVENTIONS

     7.1.  "Invention" Defined.  As used in this Agreement, "Invention" means
           -------------------
any invention, discovery or innovation with regard to physics, chemistry,
enzymology, biology, biotechnology, genetic engineering or recombinant DNA
technology, whether or not patentable, made, conceived, or first actually
reduced to practice by Executive, alone or jointly with others, in the course
of, in connection with, or as a result of service as an executive of the
Company, including any art, method, process, machine, manufacture, design of
composition of matter, or any improvement thereof, or any variety of plant or
microorganism.

     7.2.  Disclosure of Inventions.  Each Invention made, conceived or first
           ------------------------
actually reduced to practice by Executive, whether alone or jointly with others,
during the term Of Executive's employment with the Company and each Invention
made, conceived or first actually reduced to practice by Executive, whether
alone or jointly with others, within one year after the termination of
Executive's employment with the Company which relates in any way to work
performed for the Company during the term of Executive's employment, shall be
promptly disclosed in writing to the President of the Company (or such officer
of the Company as the President or Board of Directors may designate).  Such
report shall be sufficiently complete in technical detail and appropriately
illustrated by sketch or diagram to convey to one skilled in the art of which
the Invention pertains, a clear understanding of the nature, purpose,
operations, and, to the extent known, the physical, chemical, biological or
electrical characteristics of the Invention.

     7.3.  Ownership of Inventions.  Each Invention, as herein defined, shall be
           -----------------------
the sole and exclusive property of the Company.

     7.4.  Assignment of Title.  Executive agrees to execute an assignment to
           -------------------
the Company or its nominee of Executive's entire right, title and interest in
and to any Invention, without compensation beyond that provided in this
Agreement.  Executive further agrees, upon the request of the Company and at its
expense, that Executive will execute any other instrument and document necessary
or desirable in applying for and obtaining patents in the United States and in
any foreign country with respect to any Invention.  Executive further agrees,
whether or not Executive is than an employee of the Company, to cooperate to the
extent and in the manner reasonably requested by the Company in the prosecution
or defense of any claim involving a patent covering any Invention or any
litigation or other claim or proceeding involving any invention covered by this
Agreement, but all expenses thereof shall be paid by the Company.

                           ARTICLE 8. MISCELLANEOUS

     8.1.  Counterparts.  This Agreement may be executed in one or more
           ------------
counterparts, each of which shall be deemed an original, and all of which
together shall be deemed to be one and the same instrument.

                                      -5-

<PAGE>

     8.2.  Binding Effect.  This Agreement shall inure to the benefit of and be
           --------------
binding upon the parties hereto and their respective lawful successors and
assigns and upon Executive's heirs and personal representatives.

     8.3.  Assignment.  Neither this Agreement nor any rights or obligations
           ----------
hereunder shall be assignable by either party hereto without the prior written
consent of the other party.

     8.4.  Notices.  All notices, requests, demands and other communications to
           -------
be given pursuant to this Agreement shall be in writing and shall be deemed to
have been duly given if delivered by hand or mailed by registered or certified
mail, return receipt requested, postage prepaid or by facsimile transmission if
a true and correct copy is sent the same day by first class mail, postage
prepaid, or by dispatch by an internationally recognized express courier
service, and in each case addressed as follows:

     If to the Executive:   Dr. Hubert Koster
     -------------------
                            Stapelstr. 5b, 22529
                            Hamburg, Germany

     If to the Company:     Sequenom, Inc.
     -----------------
                            c/o Techno Venture Management
                            101 Arch Street
                            Suite 1950
                            Boston, Massachusetts 02110
                            Attn: President

     with a copy to:        Palmer & Dodge
                            One Beacon Street
                            Boston, Massachusetts 02108
                            Arm: Peter Wirth, Esq.

or such other address as either party hereto shall have designated by notice in
writing to the other party.

     8.5.  Amendments.  This Agreement may be amended, supplemented or otherwise
           ----------
modified at any time, but only by an instrument in writing signed by the parties
hereto.

     8.6.  Governing Law.  This Agreement and the legal relations among the
           -------------
parties hereto shall be governed by and construed in accordance with the laws of
the Commonwealth of Massachusetts.

     8.7.  Specific Performance.  The Executive acknowledges that money damages
           --------------------
alone will not adequately compensate the Company for breach of any of the
Executive's covenants and agreements herein and therefore, the Executive agrees
that in the event of the breach or threatened breach of any such covenant or
agreement, in addition to all other remedies available to the Company at law, in
equity or otherwise, the Company shall be entitled to injunctive relief
compelling specific performance of, or other compliance with, the terms hereof.

                                      -6-

<PAGE>

     8.8.  Severability.  In case any provision hereof shall, for any reason, be
           ------------
held to be invalid or unenforceable in any respect, such invalidity or
unenforceability shall not affect any other provision hereof, and this Agreement
shall be construed as if such invalid or unenforceable provision had wt been
included herein.  If any provision hereof shall for any reason, be held by a
court to be excessively broad as to duration, geographical scope, activity or
subject matter, it shall be construed by limiting and reducing it to make it
enforceable to the extent compatible with applicable law as then in effect.

     8.9.  Survival.  Articles 5, 6, 7 and 8 shall survive the termination of
           --------
this Agreement for the periods of time indicated therein or indefinitely if no
period of time is indicated.

     IN WITNESS WHEREOF, the undersigned have duly executed and delivered this
Agreement as of the date first above written.

                                        SEQUENOM, INC.

Date:  5-25-94                          By:  /s/ Nola E. Masterson
     ----------------------------            ----------------------------------
                                             Nola E. Masterson, President

                                        EXECUTIVE

Date:  May 26, 1994                      /s/ Hubert Koster
     ----------------------------       ---------------------------------------
                                        Hubert Koster

                                      -7-

<PAGE>

                         CONSULTING SERVICES AGREEMENT

     THIS AGREEMENT is entered into this 1st day of April, 1994, by and between
Sequenom, Inc. (the "Company") and Dr. Hubert Koster ("Consultant").

     NOW, THEREFORE, it is agreed as follows:

     1.   Definitions.  As used herein:
          -----------

          (a)  The term "Products" shall mean the devices, if any, proposed to
be developed by, or with the assistance of, Consultant hereunder as defined, and
with the specifications set forth in Exhibit A hereto.

          (b)  The term "Technology" shall mean the results and product (interim
and/or final) of the consulting services performed by Consultant hereunder,
whether tangible or intangibles including, without limitation, each and every
invention, formula, trade secret, software program (including without
limitation, object code, source code, flow charts, algorithms and related
documentation), listing, routine, manual, specification, technique, product,
concept, know-how, or similar property, whether or not patentable or
copyrightable and whether or not embodied in any Products, that are made,
developed, perfected, designed, conceived or first reduced to practice by
Consultant, either solely or jointly with others, in the course and scope of the
consulting services performed hereunder.

     2.   Engagement and Performance of Services.
          --------------------------------------

          (a)  Engagement.  The Company hereby engages Consultant to perform
               ----------
consulting services in accordance with the terms and conditions of this
Agreement. The specific tasks and services to be performed by Consultant are set
forth on Exhibit A attached hereto. If such services include the development of
specific Products, the specifications of such Products are as set forth on
Exhibit A attached hereto.

          (b)  Facilities, Equipment and Supplies.  The Company will provide to
               ----------------------------------
Consultant the facilities, equipment and supplies specified on Exhibit A
attached hereto. Consultant shall, at his own cost and expense, provide all
other facilities, equipment and supplies necessary to perform the consulting
services hereunder.

          (c)  Other Services. The Company acknowledges and agrees that, subject
               --------------
to its obligations hereunder, Consultant shall have the right to engage in
research and development and consulting activities for himself and others during
the term of this Agreement; provided, however, that Consultant shall not perform
any consulting services for an actual or potential competitor of the Company
during the term of this Agreement and for a period of one (1) year after
termination of this Agreement.

<PAGE>

          (d)  Primary Duty.  The Company and Consultant recognize that
               ------------
Consultant's Primary duty as a member of the faculty of the University of
Hamburg (the "University") is to the University.  The Company and consultant
agree that the University's policies and Consultant's obligations to the
University shall be observed in the event a conflict arises with this Agreement.

          (e)  Compensation.  As compensation for the consulting services
               ------------
provided by Consultant hereunder, the Company shall pay to Consultant the
amounts specified, at the time(s) specified, on Exhibit B attached hereto.

          (f)  Expenses. In addition to the compensation specified in subsection
               --------
2(d), the Company will pay reasonable out-of-pocket expenses incurred by
Consultant and approved in advance by the Company in the furtherance of or in
connection with the performance of consulting services hereunder.

          (g)  No Violation of Others' Rights.  Consultant represents and
               ------------------------------
warrants that in the course of performing services hereunder Consultant will not
infringe or wrongfully appropriate any patents, copyrights, trade secret rights,
or other intellectual property rights of any person or entity anywhere in the
world.

     3.   Employment Agreement.  On or before the date hereof, the Company and
          --------------------
the Consultant shall have entered into an Executive Employment Agreement (the
"Employment Agreement").  The provisions of this Agreement shall not supersede
the provisions of the Employment Agreement, and the Consultant specifically
acknowledges that the provisions of Articles 5, 6 and 7 of the Employment
Agreement shall apply during the period of his consultancy hereunder.

     4.   Property Rights.  All right, title and interest in and to the Products
          ---------------
(if any) and the Technology shall at all times be and remain the sole and
exclusive property of the Company, and the Products and the Technology shall be
deemed to be works made for hire. The parties agree that any patents, trademarks
or copyrights that may issue relating to any of the Products or the Technology
shall be in the name of and assigned to the Company.

     5.   Term and Termination. The term of this Agreement shall be as set forth
          --------------------
in Exhibit A attached hereto; provided, however, that this Agreement shall
automatically terminate upon the commencement of Consultant's services under the
Employment Agreement.  Unless otherwise specified in Exhibit A, either party may
terminate this Agreement at any time upon thirty (30) days written notice
delivered to the other.  The provisions of Sections 3 and 4 hereof shall survive
the termination of this Agreement.

     6.   Miscellaneous.
          -------------

          (a)  Use of University's Name.  With the limited exception of citing
               ------------------------
Consultant's faculty title, the Company and its affiliates will not use the
names, likeness, or logos of the University or any of its schools or divisions
in any of their fund raising or in investment documents, general publications,
advertisements, or marketing and promotional materials without the prior written
permission of the University.  A request for such permission must be submitted
by Consultant to the University's Office of Public Affairs.

                                      -2-

<PAGE>

          (b)  Relationship of Parties. Consultant shall at all times during the
               -----------------------
performance of his services hereunder be an independent contractor, maintaining
sole and exclusive control over its business and operations. At no time will
either party hold itself out to be the agent, employee, lessee, sublessee,
partner or joint venturer of the other party. Neither party hereto shall have
the express or implied right or authority to assume or create any obligation on
behalf of or in the name of the other party, or to bind the other party in
regard to any contract, agreement or undertaking with any third party.

          (c)  Entire Agreement.  Except as set forth in Section 3, this
               ----------------
Agreement, together with the exhibits attached hereto, constitutes the entire
agreement between the parties relating to the subject matter hereof and
supersedes all prior written or oral negotiations, representations or
agreements.  No modification of this Agreement shall be binding on either parry
unless it is in writing and signed by both parties.

          (d)  Severability. The provisions of this Agreement are severable, and
               ------------
if one or more provisions are judicially determined to be illegal or otherwise
unenforceable, in whole or in part, the remaining provisions or portions of this
Agreement shall nevertheless be binding on and enforceable by and between the
parties hereto.

          (e)  Assignment.  This Agreement shall inure to the benefit of and be
               ----------
binding upon the successors and assigns of the parties hereto; provided,
however, that Consultant shall not transfer or assign this Agreement without the
prior written consent of the Company.

          (f)  Governing Law.  The rights and obligations of the parties to this
               -------------
Agreement shall be governed by and construed in accordance with the laws of
Massachusetts.

          (g)  Headings.  Section headings are for convenience of reference only
               --------
and shall not be considered in the interpretation of this Agreement.

          (h)  Unavoidable Delays.  Either party shall be excused for any delays
               ------------------
or defaults in the performance of this Agreement (except the payment of amounts
due and payable hereunder) unavoidably caused by the act of the other, the act
of any agent of the other, the act of any governmental authority, acts of God,
the elements, war, litigation, strikes, walkouts, or any other cause beyond its
reasonable control. Each party shall use all reasonable diligence to avoid any
such delay or default and to resume performance under this Agreement as soon as
practicable after such delay or default.

          (i)  Notices.  All notices, requests, demands and other communications
               -------
to be given pursuant to this Agreement shall be in writing and shall be deemed
to have been duly given if delivered by hand or mailed by registered or
certified mail, return receipt requested, postage prepaid or by facsimile
transmission if a true and correct copy is sent the same day by first class
mail, postage prepaid, or by dispatch by an internationally recognized express
courier service, and in each cm addressed as follows:

                                      -3-

<PAGE>

     If to the Consultant:   Dr. Hubert Koster
     --------------------
                             Stapelstr. 5b, 22529
                             Hamburg, Germany

     If to the Company:      Sequenom, Inc.
     -----------------
                             c/o Techno Venture Management
                             101 Arch Street
                             Suite 1950
                             Boston, Massachusetts 02110
                             Attn:  President

     with a copy to:         Palmer & Dodge
                             One Beacon Street
                             Boston, Massachusetts 02108
                             Attn:  Peter Wirth, Esq.

or such other address as either party hereto shall have designated by notice in
writing to the other party.

          (j)  Attorneys' Fees and Costs. Should litigation arise concerning the
               -------------------------
enforcement or interpretation of this Agreement, the prevailing party shall be
entitled to recover its reasonable attorneys' fees and costs as determined by
the court.

     IN WITNESS WHEREOF, the Parties hereto have executed this Agreement on the
date first above written.

SEQUENOM, INC.                                CONSULTANT:

By: /s/ Nola E. Masterson                     /s/ Hubert Koster
   ---------------------------------          ----------------------------------
                                              Dr. Hubert Koster
Title:  CEO
      ------------------------------

                                      -4-
<PAGE>

                                   EXHIBIT A
                                   ---------

                       DESCRIPTION OF SERVICES AND TASKS

                                [see attached]

                                      -5-

<PAGE>

                                                                       EXHIBIT A

          1.   SEQUENOM H. KOSTER MARCH 31, 1994 CONFIDENTIAL

                                R & D PROJECTS
                         TO BE PERFORMED BY CONSULTANT

There are six Mini-Teams (T1 - T5) with selected experience; several projects
therefor can be initiated and pursued in parallel.

                                      ***

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

<PAGE>

          2.   SEQUENOM H. KOSTER MARCH 31, 1994 CONFIDENTIAL

                                      ***

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

<PAGE>

          3.   SEQUENOM H. KOSTER MARCH 31, 1994 CONFIDENTIAL

                                      ***

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

<PAGE>

          4.   SEQUENOM H. KOSTER MARCH 31, 1994 CONFIDENTIAL

                                      ***

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

<PAGE>

                                   EXHIBIT B
                                   ---------

                       COMPENSATION AND PAYMENT SCHEDULE

In return, Sequenom will provide to the consultant:

(1)  full compensation for round-trip airfare, hotel accommodations, meals and
     other expenses related to consultant's regular visits to Sequenom or
     attendance at Scientific Advisory Board meetings;

(2)  full compensation for round-trip airfare, hotel accommodations, meals and
     other expenses related to consultant's travel to scientific meetings for
     which his attendance is deemed critical to the development of mass
     spectrometric DNA-sequencing technologies, or for visits to companies,
     patent offices or for any other travel carried out in connection with his
     work with Sequenom; and

(3)  full compensation for other expenses (fax, mail, etc.) encountered directly
     in connection with his work for Sequenom.

(4)  commencing as of April 1, 1994, a monthly consultancy fee of $5,000, to be
     paid monthly in arrears with the first payment of $5,000 due on May 1, 1994
     and covering the period from April 1, 1994 to April 30, 1994.

                                      -6-

<PAGE>

                                 EXHIBIT 4.13
                                 ------------

                              Material Agreements
                              -------------------

(a)  None.

(b)  None.

(c)  (1)  See Exhibit 4.8 with respect to agreements with Dr. Koster.
              -----------

     (2)  Consulting services Agreement between the Corporation and Charles
          Cantor dated April 1, 1994.

     (3)  consulting Services Agreement between the Corporation and Robert
          Cotter dated April 1, 1994, as amended.

     (4)  Oral consulting agreement with Nola Masterson, pursuant to which Ms.
          Masterson is paid $5,000 per month to assist the corporation in
          developing business strategies and monitoring U.S. operations.

(d)  (1)  Sequenom, Inc. 1994 Stock Plan.

     (2)  The Corporation also provides medical and dental benefits to its
          employees.

(e)  The Corporation has borrowed an aggregate of $1,580,000 in outstanding
     principal amount from certain of the Investors and has issued to such
     Investors convertible term notes to evidence a portion of such loans.  None
     of such loans will remain outstanding after the Initial Closing.  The
     corporation has also borrowed DM 550,000 in outstanding aggregate principal
     amount from its wholly owned subsidiary Sequenom Instruments GmbH.

(f)  None.

(g)  Equipment lease arrangements with COMDISCO.

(h)  None.

(i)  (1)  Research Agreement between the Corporation and The Johns Hopkins
          University, dated October l, 1994, an amended.

     (2)  Confidentiality/Materials Transfer Agreement between the Corporation
          and Becton Dickinson and Company dated December 1, 1995.

     (3)  Sponsored Research Agreement between the Corporation and the Trustees
          of Boston University dated September 15, 1994.

     (4)  Proposed Letter Agreement with Synteni.

(j)  None.

(k)  None.

<PAGE>

                                 EXHIBIT 4.15
                                 ------------

                                   Insurance
                                   ---------

     See attached materials from Waverley Insurance Agency, Inc. with respect to
insurance maintained by the Corporation.

<PAGE>

Professional
Office
Package

                        WAVERLEY INSURANCE AGENCY, INC.

                               493 Trapolo Road
                               Belmont, MA 02173

<PAGE>

CONTENTS
--------

We've designed your Professional Office Package so it can be tailored to fit
your individual insurance needs.  Because each policy may be different, the
pages aren't numbered consecutively.  Here's a list of commonly referred to
items in the same order as they appear in your policy.

Introduction Page

Name and mailing address of insured
Name and location of insurance company
Policy dates
Former policy number
Your premium
Name and address of our authorized representative

Policy Forms List

General Rules

Special rights and duties of the first named insured
Your policy period
Premiums
Our right to inspect and audit
Policy changes
Assignment and transfer
Cancellation
Recovering damages from a third party
Fraud and misrepresentation
Appraisal of property disputes
How state law affects this policy
Lawsuits against us
Provisions required by law

What To Do If You Have A Loss

Coverage Summary

The Coverage Summary shows the variable information that affects your coverage.

Coverages

Each type of coverage included in your policy is provided by a separate form
called an insuring agreement.

<PAGE>

POLICY INFORMATION

THIS IS NOT A BILL

YOUR POLICY IS DIRECTLY BILLED. IF THIS IS A POLICY CHANGE, THE
ADDITIONAL OR RETURN PREMIUM WILL BE SHOWN ON FUTURE INSTALLMENT
BILLINGS. IF ALL INSTALLMENTS HAVE BEEN BILLED, THE PREMIUM
CHANGE WILL BE BILLED OR CREDITED PROMPTLY.
A BILL WILL BE SENT TO:
THE INSURED

--------------------------------------------------------------------------------
Company:  ST. PAUL FIRE & MARINE INSURANCE COMPANY

--------------------------------------------------------------------------------
I                                   Policy Inception/Effective Date:  10/26/94
N                                   Policy Number:  FK06003565
S                                   Agency Number:  2003083
U   SEQUENOM INCORPORATED
R   _________________               Transaction Type:
E   101 ARCH STREET                 POLICY IS NEW
D   BOSTON, MA 02110                Transaction number:  001
                                    Processing Date:  11/10/94 08:57
  __________________________________
A   WAVERLY INS AG INC
G   493 TRAPELO RD
E   BELMONT MA 02178
N
T

------------------------------------------------------------------------------
Policy           Description                 Amount                 Surtax/
Number                                       Surcharge
------------------------------------------------------------------------------

FK 06003565 PROFESSIONAL OFFICE PACKAGE POLICY        $350.00

THE PREMIUM SHOWN DOES NOT INCLUDE A PREMIUM PAYMENT PLAN SERVICE CHARGE.  IF
YOU SELECTED A PREMIUM PAYMENT PLAN YOUR PAYMENT SCHEDULE/BILL WILL SHOW THIS
CHARGE.

THIS POLICY IS A NINE PAY PAYMENT PLAN.
A PAYMENT SCHEDULE/BILL WILL FOLLOW SHORTLY.

--------------------------------------------------------------------------------
Ed. 12 - 90 Printed in U.S.A.                                             Page 1

                                 INSURED COPY

<PAGE>

                                                                    THE ST. PAUL

POLICY FORM LIST

Here's a lit of all forms included in your
policy [ILLEGIBLE] the date shown below.  These forms
are [ILLEGIBLE] in the dame order as they appear in
your policy.

<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------
Title                                                                      Form Number      Edition Date
<S>                                                                        <C>              <C>
Introduction - St. Paul Fire and Marine Insurance Company                      40800            05-87
     Policy Form List                                                          40705            05-84
General Rules - Massachusetts                                                  40731            05-92
What to do if you have a loss                                                  40814            11-91
Professional Office Package Coverage Summary                                   46157            05-91
Professional Office Package Location Coverage Summary                          46159            05-91
Professional Office Package Property Protection                                46156            09-91
POP - Commercial General Liability Protection                                  46155            05-91
   Medical Expenses Endorsement                                                46190            09-93
   Auto Contract Liability Endorsement-Massachusetts                           44412            01-89
   Contract Liability Defense Expenses Endorsement                             47320            03-92
Liability Protection For Autos You Don't Own                                   44471            04-91

-----------------------------------------------------------------------------------------------------------
Name of Insured           Policy Number  FK06003565                  Effective Date 10/26/94
SEQUENUM INCORPORATED         Processing Date  11/10/94              08:57  001
-----------------------------------------------------------------------------------------------------------
</TABLE>

4070 5-84 Printed in U.S.A.                     Form List                Page 1
(C)St. Paul Fire and Marine Insurance Co. 1992

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                          <C>
 discovery of fraud or material misrepresentation by the     company a signed, sworn statement in proof of loss which
 insured in obtaining the policy; (4) discovery of willful   sets forth to the best knowledge and belief of the insured
 or reckless acts or omissions by the insured increasing     the following: the time and cause of the loss, the interest
 the hazard insured against; (5) physical changes in the     of the insured and of all others in the property, the actual
 property insured which result in the property becoming      cash value of each item thereof and the amount of loss
 uninsurable; or (6) a determination by the commissioner     thereto, all encumbrances thereon, all other contracts of
 that continuation of the policy would violate or place      insurance, whether valid or not, covering of said property,
 the insurer in violation of the law.  Where the stated      any changes in the title, use, occupancy, location,
 reason is [ILLEGIBLE] of premium, the insured may           possession or exposures of said property, since the issuing
 [ILLEGIBLE] coverage and avoid the effect of the            of this policy, by whom and for what purpose any building
 cancellation by payment at any time prior to the            herein described and the several parts thereof were occupied
 effective date of cancellation.                             at the time of loss and whether or not it then stood on
                                                             leased ground, and shall furnish a copy of all the
 Mortgage interests and obligations.  Notwithstanding any    descriptions and schedules in all policies and detailed
 other provisions of this policy, if the policy shall be     estimates for repair of the damage.  The insured, as often
 made payable to a mortgage of the covered real estate, no   as may be reasonably required, shall exhibit to any person
 act or default of any person other than such mortgagee or   designated by this company all that remains of any property
 his agent or those claiming under him, whether the same     herein described, and submit to examinations under oath by
 occurs before or during the term of this policy, shall      any person named in this company, and subscribe the same;
 render this policy void as to such mortgagee nor affect     and, as often as may be reasonably required, shall produce
 such mortgagee's right to recover in case of loss of such   for examination all books of account, bills, invoices and
 real estate: provided, that the mortgagee shall on demand   other vouchers, or certified copies thereof if originals be
 [ILLEGIBLE] according to the established scale of rate      lost, at such reasonable time and place as may be designated
 for any increase of risk not paid for by the insured; and   by this company or its representative, and shall permit
 whenever this company shall be liable to a mortgagee for    extracts and copies thereof to be made.
 any sum for loss under this policy for which no liability
 exists as to the mortgage, or owner, and this company       When loss payable.  In case of any loss or damage, the
 shall elect by itself, or with others, to pay the           company, within thirty days after the insured shall have
 mortgagee the full amount secured by such mortgagee, then   submitted a statement, as provided in the preceding clause,
 the mortgagee shall assign and transfer the company         shall either pay the amount for which it shall be liable,
 interested, upon such payment, the said mortgage together   which amount if not agreed upon, shall be ascertained by
 with the [ILLEGIBLE] debt thereby secured.                  award of referees as hereinafter provided or replace the
                                                             property with other of the same kind and goodness; or it
 Pro rata liability.  This company shall not be liable for   may, within fifteen days after such statement is submitted,
 a greater proportion of any loss than the amount hereby     notifying insured of its intention to rebuild or repair the
 insured shall bear to the whole insurance covering the      premises, or any portion thereof separately covered by this
 property against the [ILLEGIBLE] involved.                  policy, and shall thereupon enter upon said premises and
                                                             proceed to rebuild or repair the same with reasonable
 [ILLEGIBLE] in case loss occurs.  The insured shall give    expedition.  It is moreover understood that there can be no
 immediate written notice to this company of any loss,       abandonment of the property described to the company and
 protect the property from further damage, forthwith         that the company shall not in any case be liable for more
 separate the damaged and undamaged personal property, put   than the sum insured, with interest thereon from the time
 in the best possible order, furnish a complete inventory    when the loss shall become payable, as above provided.  The
 of the destroyed and damaged property, showing in detail    company shall be liable for the payment of the interest to
 the quantity, description, actual cash value and amount     the
 of loss claimed; and the insured shall forthwith render
 to this

-------------------------------------------------------------------------------------------------------------------------------
</TABLE>

[ILLEGIBLE] Rev. 5-92 Printed in U.S.A.         General Rules
(C)St. Paul Fire and Marine Insurance Co. 1992 All Rights Reserved   Page 3 of 7

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                     <C>
Calculation of premium.  We'll figure your premium      of these examinations.  We'll reduce the amount we pay
due on each anniversary in accordance with our rule,    on the medical expense claim by whatever we pay for
rates and rating plans in effect on the anniversary     these services.  The fact that we make payments to any
date.                                                   injured person for these services doesn't mean you've
                                                        admitted responsibility for his or her injury.
The following paragraph replaces any Protective
Safeguards section in your policy.                      Property Protection - Buildings That Are Vacant

Protective safeguards.  You must also maintain any      If your policy includes Property Protection, the
protective safeguards that are described in the         following is added to the "Buildings that are vacant"
Protective Safeguards Endorsement.  We [ILLEGIBLE]      section of your agreement.  But only for loss caused by
credit for these protective safeguards in setting       fire or lightning.
our rates.  If you fail to maintain these
safeguards, we won't be liable for losses to the        If your building where a loss occurred was vacant or
specifically affected areas.  However, your             unoccupied for a period of:
[ILLEGIBLE] will continue for other areas.
                                                        .  50 consecutive days for the residential properties
The following paragraph replaces any "Medical Reports   of 3 units or less; or
and Examinations" section in your policy.

Medical reports and examinations.  The insured person   .  30 consecutive days for all other premises;
must give us written proof of his [ILLEGIBLE] claim
for medical expenses as soon as possible, and must      before the loss occurred, we won't pay for the loss.
agree to make the claim under oath if we think it is    This applies regardless of whether or not the building
necessary.  We must also receive an authorization       had been intended for occupancy by either the owner or
allowing us to obtain pertinent medical reports and     tenant.
copies of records.  The injured person must agree to
be examined by doctors of our choosing as often as      The following is added to the If Your Building is
we decide, within reason.  We'll pay the cost           Mortgaged section.  We'll make payments for losses to
                                                        mortgage holders in order, according to the financial
                                                        interest each has in the covered property.

----------------------------------------------------------------------------------------------------------------------
</TABLE>

[ILLEGIBLE] Rev. 5-92 Printed in U.S.A.              General Rules
(C)St. Paul Fire and Marine Insurance Co. 1992 All Rights Reserved   Page 7 of 7

<PAGE>

                                                                    THE ST. PAUL

     PROFESSIONAL OFFICE PACKAGE COVERAGE SUMMARY

This summary shows the Limits of Coverage
and the Optional Coverages you have for state
or [ILLEGIBLE] coverages. These coverages
and [ILLEGIBLE] apply to all locations on your policy.
[ILLEGIBLE] your Professional Office Package
[ILLEGIBLE] Coverage Summary for coverages that
[ILLEGIBLE] a specific location.

<TABLE>
<CAPTION>
-------------------------------------------------------------------------------------------------
Commercial General Liability Protection        Limits of Coverage
<S>                                            <C>                                 <C>
                                               Each event limit                    $1,000,000
                                               Premises damage limit.              $1,000,000
                                               Medical expenses limit.             $    5,000

                                               Personal injury and                 $1,000,000
                                               advertising injury limit

                                               General total limit.                $2,000,000
-------------------------------------------------------------------------------------------------
Loss of Earnings And Extra
 Expense Coverage                              Limit of coverage                      $  500,000
-------------------------------------------------------------------------------------------------
Optional Coverages                                                           Premium
Liability Protection For Autos You Don't Own
        Limit: $1,000,000
        Non-owned Auto              Number of Employees: 2                            $    18.00
        Hired Auto                  If Any                                            $    29.00

-------------------------------------------------------------------------------------------------
Year Premium for the above
 coverages                                                                            $    47.00
-------------------------------------------------------------------------------------------------
Name of Insured                   Policy Number  FK06003565                  Effective Date 10/26/94
SEQUENOM INCORPORATED             Processing Date   11/10/94     08:57   001
</TABLE>

--------------------------------------------------------------------------------
[ILLEGIBLE] Ed. 5-91 Printed in U.S.A.            Coverage Summary        Page 1
(C)St. Paul Fire and Marine Insurance Co. 1992 All Rights Reserved
--------------------------------------------------------------------------------

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                          <C>
Power supply services means:                                 we'll only pay for such increase during the period of
 .  [ILLEGIBLE] generating plants;                            restoration.
 .  switching stations;
 .  substations;                                               Strike.  We won't cover any increase in loss due to
 .  transformers; and                                          delay caused by strikers or anyone else at a location
 .  transmission lines;                                        of rebuilding, repairing or replacing damaged property
supplying electricity, steam, or gas to the described         when it interferes with efforts to resume business.
premises.
                                                              However, you can recover for an increase in a covered
But coverage isn't included for overhead transmission         loss when a strike on another person's premises
lines unless indicated in the Coverage Summary.               prevents you from resuming business.  For example:

Off premises utility failure limit of coverage.  The          You've ordered materials to repair your building and
most we'll pay for your earnings and extra expense            you can't obtain them because there's a strike at the
loss in any one event is $25,000 unless the                   manufacturer's plant.  This prevents you from resuming
additional optional coverage for off-premises utility         business and increases your loss of earnings and extra
failure is indicated in the Coverage Summary.  If the         expense.  We'll cover this increase in your loss.
option is shown, your loss of earnings and extra
expense limit shown on the Coverage Summary includes          Expenses for putting out a fire.  We won't cover
the $25,000 automatic coverage.  This is the most             expenses you have in putting out a fire.
we'll pay for all covered loss caused by any one
event.                                                        Direct Loss.  We won't cover any direct damage to
                                                              property.
Loss of earnings and extra expense exclusions.  All of
the exclusions under the Exclusions - Losses We Won't         Rules for loss of earnings and extra expense loss
Cover section apply to this coverage.  The following          adjustment.  When covered earnings or extra expense
exclusions also apply to Loss Of Earnings And Extra           loss occurs, we'll consider the following in
Expense Coverage.                                             determining what we'll pay under this coverage:

Repair.  We won't cover the cost of repairing or              1.  loss determination
replacing damaged property, including the cost of             2.  your responsibility for resuming operations; and
research necessary to replace or restore [ILLEGIBLE]          limit of coverage.
account books, card index systems, data processing,
recording or storage media and other records.  But we         1.  Loss determination.
will pay any expense you incur over the normal cost           1.  Earnings.  Your amount of earnings loss will be
of such repair or replacement if it's necessary to            determined based on:
reduce your total extra expenses due to a covered             .  net income of your business before the direct
loss.                                                         physical loss or damage occurred;
                                                              .  the probable net income if no loss or damage had
This extra expense for repair or replacement may not          occurred;
be more than the amount by which it reduces your              .  the operating expenses, including payroll, expenses,
total extra expense loss.                                     necessary to resume operations with the same quality of

Cancellation of Contracts.  We won't cover any                service that existed just before the direct physical
[ILLEGIBLE] in loss that's caused by the suspension,          loss or damage; and
lapse or cancellation of any lease, license, contract         .  other sources of information on your business such
or order.                                                     as: your financial records and accounting procedures,
                                                              bills, invoices and other vouchers and deeds, liens or
However, if the suspension, lapse or cancellation             contracts.
results directly from the interruption of your
business, we'll cover any increase in a [ILLEGIBLE]           2.  Extra expense.
that affects your earnings.  But
</TABLE>

--------------------------------------------------------------------------------
46156 Rev.9-91 Printed in U.S.A.     Insuring Agreement 5           Page 5 of 22
(C)St. Paul Fire and Marine          Property Coverage
Insurance Co. 1991

<PAGE>

                                                                    THE ST. PAUL

PROFESSIONAL OFFICE PACKAGE
PROPERTY PROTECTION

We have designed this agreement to protect you
and your business against a variety of direct
and indirect losses.  Of course, there are [ILLEGIBLE]
which are explained later in this agreement.

<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------
Table of Contents                           Page    What This Agreement Covers
                                                    --------------------------
<S>                                         <C>     <C>
What This Agreement Covers                   1      The description of covered property and limit of coverage
[ILLEGIBLE] Coverage                         1      are shown in the Coverage Summary.  In this section, we
Business Contents Coverage                   2      explain what is included under the building and business
Preservation Of Property                     2      contents coverage.
Debris Removal Coverage                      2      Building Coverage
Loss Of Earnings And Extra Expense
[ILLEGIBLE]                                  3      We'll cover your financial interest in the insured building
Property That Has Limited Coverage           6      or structure.  While at the same location we'll also cover:
Property Covered Only As Defined             6      .  garages, storage buildings and other structures that
Property Not Covered At All                  7      pertain to your office.
                                                    .  fixtures, machinery and equipment that are a permanent
Additional Benefits                          7      part of the building and are used to provide building
[ILLEGIBLE] Clean Up And Removal             7      services such as elevators and hearing equipment.
Temporary Location Or Property In Transit    7      .  yard fixtures such as lamp posts and flag poles.
Fire Department Service Charge               8      .  construction materials, supplies and equipment that you
Newly Acquired Property                      8      intend to use to alter, repair or expand the covered
Loss Assessments                             8      building.  During construction we'll cover these materials
[ILLEGIBLE] Property                         8      at the insured location or in the open within 1,000 feet of
Personal Belongings                          8      it.  We'll also cover any temporary structures at the
Accounts Receivable Coverage                 9      insured location.
Valuable Records Research Coverage           9      .  property which you own and use to service or maintain the
[ILLEGIBLE] And Securities Coverage         10      covered building or structure or its premises such as
Covered Causes Of Loss                      11      outdoor furniture, fire extinguishing equipment, floor
                                            11      coverings and appliances for refrigerating, ventilating,
Exclusions - Losses We Won't Cover                  cooking, dishwashing and laundering.
                                            15      .  personal property you own in rooms or apartments you
Optional Coverages                          15      furnish as landlord.
Optional Glass Coverage                     16
Optional Sign Coverage                      16      Building inflation protection.  At the end of each 3 months
Optional Scheduled Valuables Coverage       17      this agreement is in effect, we'll increase your insurance
Optional Computer Coverage                  18      by the percentage shown in the Coverage Summary.  This
Rules For Loss Adjustment                   18      percentage applies only to the building limit shown
1. How Your Property Is Valued              20      [ILLEGIBLE] the Coverage Summary and not to the increases
2. Deductible                               20      you're given under this building inflation protection.  For
3. [ILLEGIBLE] Insurance                    20      example:
[ILLEGIBLE] Losses                          21
Who will [ILLEGIBLE] For Loss               21
If [ILLEGIBLE] Is Mortgaged
                                            21
Other Rules For This Agreement
--------------------------------------------------
</TABLE>

--------------------------------------------------------------------------------
46156 Rev.9-91 Printed in U.S.A.     Insuring Agreement 5          Page 1 of 22
(C) St. Paul Fire and Marine         Property Coverage
Insurance Co. 1991

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                      <C>
Accounts Receivable Coverage                             Accounts Receivable Coverage exclusions.
                                                         Bookkeeping errors.  We won't cover any loss that's
If you have Business Contents Coverage, we'll protect    caused by mistakes or omissions in bookkeeping,
your accounts receivable records against risks of        accounting or billings.
direct loss or damage.

We automatically cover your accounts receivable up to    In addition, the following exclusions under the
$5,000 unless an accounts receivable limit of            Exclusions - Losses We Won't Cover section also apply
coverage is shown in the Coverage Summary.  If an        to this coverage:
accounts receivable [ILLEGIBLE], the $5,000 automatic    .  Government action;
coverage will be included and is not in addition to      .  Illegal transportation or trade;
such limit.                                              .  Nuclear transportation or trade;
                                                         .  Nuclear activity;
The [ILLEGIBLE] we'll pay for all covered accounts       .  War;
[ILLEGIBLE] loss in any one event is $5,000 or the       .  Electronic recordings;
accounts receivable limit shown in the coverage          .  Dishonesty;
summary, whichever is [ILLEGIBLE].                       .  Voluntary surrender;
                                                         .  Acts or decisions of people;
We cover the following costs that you incur when your    .  Planning, design, materials, maintenance; and
records of accounts receivable are damaged or loss       .  Disappearance-inventory loss.
because of a covered cause of loss.
 .  [ILLEGIBLE] your customers owe you but you can't      No other exclusions under the Exclusions - Losses We
collect because of loss or damage to your [ILLEGIBLE];   Won't Cover section apply to this coverage.
 .  [ILLEGIBLE] only on any loan you have to take out
because you can't collect your receivables, and need     Valuable Records Research Coverage
money while waiting for your claim to be paid;
 .  [ILLEGIBLE] collection costs, over and above your     If you have Business Contents Coverage, we'll protect
[ILLEGIBLE] collection costs, that are made necessary    your valuable records against risks of direct physical
because of their loss or damage to your [ILLEGIBLE]      loss or damage.  We'll also protect anyone else's
and                                                      valuable records that are in your care.  If research is
 .  [ILLEGIBLE] you reasonably incur in re-establishing   necessary to replace the item, we'll pay for the
your records.                                            expense involved.  For example, if maps are lost or
                                                         damaged we'll pay for the surveying and photographing
We also cover your accounts receivable [ILLEGIBLE]       necessary to replace them.
while they're away from an insured [ILLEGIBLE] at a
safe place because of imminent [ILLEGIBLE] of loss.      We'll automatically cover your valuable records loss up
And we'll cover those records [ILLEGIBLE] they're        to $10,000 unless a valuable records limit of coverage
being moved to and from that safe [ILLEGIBLE].  But      is shown in the Coverage Summary.  If a valuable
you must tell us within 10 days after you receive the    records limit is shown, the $10,000 automatic coverage
records for this coverage to [ILLEGIBLE].                will be included [ILLEGIBLE] not in addition to such
                                                         limit.
[ILLEGIBLE] covered.  You're covered for losses
[ILLEGIBLE] at the location shown in the Coverage        The most we'll pay for all covered valuable records
Summary, at a storage location or while temporarily      loss in any one event is $10,000 or the valuable
within the premises of others.  Your accounts            records limit shown in the Coverage Summary, whichever
receivable records are also covered [ILLEGIBLE]          is more.
transit within the United States of America, Puerto
Rico or Canada.                                          Valuable records includes account books, manuscripts,
                                                         abstracts, drawings, card index systems and other
                                                         printed or written documents.  Valuable records also
                                                         include maps, films, tapes and other such material.
                                                         But it doesn't include electronic data processing
                                                         media, data or programs.
</TABLE>

--------------------------------------------------------------------------------
46156 Rev.9-91 Printed in U.S.A.  Insuring Agreement 5              Page 9 of 22
(C)St. Paul Fire and Marine Insurance Co. 1991  Property Coverage

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                           <C>
[ILLEGIBLE] we'll pay for the damage caused by the fire.      Planning, design, materials, maintenance.  We won't cover
                                                              loss caused by faulty, inadequate or defective:
Electronic recordings.
                                                              .  planning, zoning, development, surveying, siting;
We won't cover loss to electronic recordings caused by        .  design, specifications, workmanship, repair,
electrical or [ILLEGIBLE] injury, disturbance or erasing.     construction, renovation, remodeling, grading, compaction;
This [ILLEGIBLE] doesn't apply to loss caused by lightning.   .  materials used in repair, construction, renovation or
[ILLEGIBLE] action.  We won't cover loss caused [ILLEGIBLE]   remodeling; or
indirectly by any of the following.  [ILLEGIBLE] is           .  maintenance.
excluded regardless of any other [ILLEGIBLE] event that
contributes concurrently or [ILLEGIBLE] sequence to the       All of the above apply to part or all of any property on or
loss:                                                         off the location described in the Coverage Summary.

Mechanical Breakdown.                                         But if a loss not otherwise excluded results, we'll pay for
                                                              that resulting loss.
We won't cover loss to [ILLEGIBLE] property caused or made
worse by                                                      Pollution.  We won't pay for loss that results from
                                                              pollution unless the pollution is caused by any of the
 .  [ILLEGIBLE] caused by centrifugal force; or                following causes of loss:
 .  [ILLEGIBLE] due to faulty work, design, materials or
[ILLEGIBLE].                                                  .  fire;
                                                              .  lightning;
But [ILLEGIBLE] not otherwise excluded results [ILLEGIBLE]    .  explosion;
of these causes, we'll pay for the loss that results          .  wind or hail;
directly from the covered cause.                              .  smoke;
                                                              .  vehicles and aircraft;
Nuclear activity.  We won't cover loss caused directly or     .  civil disturbance and riot;
indirectly by nuclear reaction, nuclear radiation, or         .  vandalism;
radioactive contamination.  Such loss is excluded             .  sprinkler leakage;
regardless of any other cause or event that contributes       .  sinkhole collapse;
concurrently or in [ILLEGIBLE] to the loss.  But if loss      .  volcanic action;
or damage by fire results, we'll pay for that resulting       .  falling objects;
loss or damage, if it would otherwise be covered under        .  weight of snow, ice or sleet; or
this agreement.                                               .  water damage.

Ordinances, regulations or laws.  We won't cover loss         Pollution means the actual, alleged or threatened discharge,
caused directly or indirectly by the [ILLEGIBLE] of any       dispersal, release leakage, seepage, migration or escape of
ordinance, regulation [ILLEGIBLE] the use, construction,      pollutants.
repair [ILLEGIBLE] of any property.
This includes removal of debris.  Such loss is [ILLEGIBLE]    However, we won't pay for the costs associated with the
regardless of any other cause or event that contributes       enforcement of any ordinance, regulation or law which
concurrently or in any sequence to the [ILLEGIBLE].  But      requires you or anyone else to:
this exclusion won't apply to property destroyed by a
civil authority in order to [ILLEGIBLE] the actual spread     .  test for, monitor, clean up, remove;
of fire.  For example, to establish a fire break.             .  contain, treat, detoxify or neutralize; or
                                                              .  in any way respond to, or [ILLEGIBLE] the effects of
                                                              pollutants.
                                                              Pollutants means any solid, liquid, gaseous or thermal
                                                              irritant or contaminant including:

                                                              .  smoke, vapors, soot, fumes;
                                                              .  acids, alkalis, chemicals;
</TABLE>

--------------------------------------------------------------------------------
46156 Rev.9-91 Printed in U.S.A.    Insuring Agreement 5           Page 13 of 22
(C)St. Paul Fire and Marine         Property Coverage
Insurance Co. 1991

<PAGE>

                                                                    THE ST. PAUL

<TABLE>
<S>                                                          <C>
[ILLEGIBLE] from motor vehicles.  We won't cover loss        computer equipment coverage.  This benefits in addition to
through theft or attempted theft from any [ILLEGIBLE]        the limit of coverage for computer equipment shown in the
motor vehicle or trailer.  Such loss [ILLEGIBLE], however,   Coverage Summary.
if theft results from [ILLEGIBLE] into a fully enclosed      Data, media and computer programs.  We'll cover direct
and locked [ILLEGIBLE] containing the property.  The         physical loss or damage to data and media you own or are
[ILLEGIBLE] trailer must show visible signs of forced        legally responsible for.  We'll pay the actual cost of
entry.  This limitation does not apply to [ILLEGIBLE] in     reproducing lost or damage data, provided you actually
the custody of a hired transportation [ILLEGIBLE].           replace or reproduce it, and repairing or replacing the
                                                             damage media with material of the same kind or quality.
Unauthorized instructions.  We won't cover loss resulting
from unauthorized instructions from anyone to transfer       Data means facts, concepts or instructions converted to a
property to any person or place.                             form useable in your data processing operations.  This
                                                             includes computer programs, documentation and source
In addition, the following exclusions under the [ILLEGIBLE]  materials.
Losses We Won't Cover section [ILLEGIBLE] apply to this
coverage:                                                    Media means materials on which data is recorded, such as
 .  [ILLEGIBLE] action;                                       magnetic tapes, disk packs, paper tapes and punch cards.
 .  [ILLEGIBLE] transportation or trade;                      Computer breakdown coverage.  We'll cover the following
 .  [ILLEGIBLE] activity;                                     kinds of direct physical loss to covered computer equipment,
 .  [ILLEGIBLE] deterioration-animals;                        data, media and programs inside your building and to covered
 .  [ILLEGIBLE]                                               air conditioning equipment inside your building and within
 .  [ILLEGIBLE] surrender;                                    1,000 feet of it for:
 .  [ILLEGIBLE] decisions of people;                          .  mechanical breakdown or machinery breakdown; or
 .  [ILLEGIBLE] design, materials, maintenance;               .  short circuit, blow-out, or other electrical damage to
 .  [ILLEGIBLE] inventory loss; and                           electrical equipment, apparatus, or devices, including
                                                             wiring.
[ILLEGIBLE] exclusions under the Exclusions - [ILLEGIBLE]
We Won't Cover section apply to this [ILLEGIBLE].            But we won't cover loss caused by any change in your
                                                             electric power supply, such as interruption, power surge, or
[ILLEGIBLE] Computer Coverage                                brown out, if the change originates more than 1,000 feet
                                                             from the building containing your computer equipment.
[ILLEGIBLE] coverage is indicated in the Coverage Summary,
we'll cover direct physical loss or [ILLEGIBLE] to           Air conditioning.  We'll cover any direct physical loss to
computer equipment which you own, [ILLEGIBLE] from others    your computer equipment caused by corrosion, rust, or
or for which you are [ILLEGIBLE] responsible.                changes in humidity or temperature if your air conditioning
Computer Equipment means a network of [ILLEGIBLE]            system that exclusively services your computer equipment is
components capable of accepting [ILLEGIBLE] from magnetic    damaged by a covered cause of loss.
tapes, disk packs, [ILLEGIBLE] and punch cards, processing
it [ILLEGIBLE] to a plan and producing the desired           Processing.  We'll cover direct physical loss to your
[ILLEGIBLE]Computer equipment includes disks [ILLEGIBLE]     computer equipment, data, media or programs that results
printers, display screens and [ILLEGIBLE] terminals.         during processing operations or while the equipment is being
                                                             worked on or serviced.  The loss or damage must result from
[ILLEGIBLE] media additional benefits.  We'll provide        this processing, [ILLEGIBLE] service.  It
[ILLEGIBLE] benefit in addition to your
</TABLE>

--------------------------------------------------------------------------------
46156 Rev.9-91 Printed in U.S.A.    Insuring Agreement 5          Page 17 of 22
(C)St. Paul Fire and Marine         Property Coverage
Insurance Co. 1991

<PAGE>

                                                                    The St. Paul

<TABLE>
<S>                                                      <C>
Adjustment Losses                                        Transfer of mortgage holder's right to us.  If we pay
                                                         your mortgage holder for loss or damage that we claim
[ILLEGIBLE] there's a covered loss to your property,     isn't covered by this agreement the mortgage holder's
we will of course, adjust the loss with you.  If         rights to recover that amount from you will then belong
[ILLEGIBLE] a covered loss to someone else's             to us.  But that won't affect your mortgage holder's
property, we'll adjust the loss with you for the         rights to recover the remaining amount of the mortgage
owners account.  Or, we can choose to settle             debt from you.
[ILLEGIBLE] with the owner.  If we settle with the
owner, the owner's release will satisfy any claim        We also have the right to pay off the mortgage debt.
[ILLEGIBLE] make for the same loss.                      If we do, we'll take over the mortgage holder's right
                                                         to be repaid by you.
[ILLEGIBLE] Pay For Loss
                                                         Cancellation notice to mortgage holder.  If we cancel
[ILLEGIBLE]Adjust any loss with you.  However, if the    this agreement, we'll mail or deliver a cancellation
Coverage Summary identifies a person or  [ILLEGIBLE]     notice to your mortgage holder at least 30 days before
to receive payments for covered [ILLEGIBLE], our         coverage ends - 10 days if we cancel for non-payment of
payments will be made to you and [ILLEGIBLE] or          premium.
organization named, based on the financial interest
each has in the covered property described in the        Nonrenewal notice to mortgage holder..  If we elect
Coverage Summary.                                        [ILLEGIBLE] renew this policy, we'll mail or deliver a
                                                         renewal notice to your mortgage holder at least 10 days
If Your Building Is Mortgaged                            before the expiration date of the policy.

If the Coverage Summary identifies a mortgage holder,    Other Rules For This Agreement
this section applies.  We'll consider [ILLEGIBLE] to     -----------------------------
have the same rights and duties as mortgage holders.
                                                         Maintaining your coverage.  You should keep your
[ILLEGIBLE] and duties of mortgage holders.  We'll       building and property in as safe a condition as
make payments for losses to you and any mortgage         possible.  If you are aware of a condition under your
holder based on the interest each has in the covered     control that increases the risk of loss, you should do
property.                                                all you can do to reduce the hazard and notify us of
                                                         this condition.
Any mortgage holder's right to receive payment won't
be affected by foreclosure or other similar              Insurance for your benefit.  This insurance is for your
proceedings.                                             benefit.  No third party having temporary possession of
                                                         your property, such as transportation company, can
[ILLEGIBLE] your claim because of your acts or           benefit directly or indirectly from it.
[ILLEGIBLE] haven't complied with the terms of this
Agreement, the mortgage holder will still have the       Protective safeguards.  You must maintain any
right to receive loss payments if the mortgage holder:   protective safeguards under your control that are
                                                         indicated in your application.  We gave you credit for
 .  [ILLEGIBLE] any premium when due at our request       these safeguards in setting our rates.  If you fail to
[ILLEGIBLE]fail to do so.                                maintain these safeguards, we won't be liable for
 .  [ILLEGIBLE] a signed, sworn statement of loss         losses to the specifically affected areas.  However,
[ILLEGIBLE] fail to do so; and                           your coverage will continue for other areas.
 .  [ILLEGIBLE] when aware of any change in
[ILLEGIBLE] occupancy or risk.                           Buildings that are vacant.  A building is vacant when
[ILLEGIBLE] rules and conditions that apply to you       it does not contain enough business or personal
[ILLEGIBLE] to the mortgage holder.                      property to conduct customary [ILLEGIBLE].
---------------------------------------------------------------------------------------------------------------
</TABLE>

46156 Rev. 9-91 Printed in U.S.A.     Insuring Agreement 5         Page 21 of 22
(C)St. Paul Fire and Marine           Property Coverage
Insurance Co. 1991

<PAGE>

                                                                    The St. Paul

<TABLE>
<S>                                                      <C>
Tel [ILLEGIBLE] means transmitting or televising any     Additional payments.  We'll have the duty to make only
audio or visual material by television for any           the payments shown below in connection with any claim
purpose.                                                 or suit we defend.  These payments are in addition to
                                                         the limits of coverage.  But our duty to make such
Medical expenses mean the reasonable expenses incurred   payments ends when we have used up the limits of
by any person or organization for necessary medical      coverage that apply with the payment of judgments,
services received by a person any time during the one    settlements or medical expenses.
year following [ILLEGIBLE] of an event which causes
that person [ILLEGIBLE] bodily injury.                   Our expenses.  We'll pay all expenses we incur.

[ILLEGIBLE] services include:                            Bail bonds.  We'll pay up to $250 for the cost of bail
 .  [ILLEGIBLE] first aid received at the time of an      bonds that are required because of accidents or
event;                                                   violations of traffic laws.  But only if the accidents
 .  ambulance and emergency care services;                or violations result from the use of a vehicle to which
 .  dental, medical, nursing, surgical, x-ray and other   the bodily injury liability coverage under this
health care professional services;                       agreement applies.  We don't have to furnish such bonds.
 .  [ILLEGIBLE] services;
 .  artificial limbs and organs; and                      Bonds to release property.  We'll pay the cost of bonds
 .  funeral services.                                     to release property that's being used to secure a legal
                                                         obligation.  But only for bond amounts within the limit
[ILLEGIBLE] explain what we mean by your products,       of coverage that applies.  We don't have to furnish
[ILLEGIBLE] work and your completed work in the          such bonds.
product recall exclusion.
                                                         Expenses incurred by protected persons.  We'll pay all
[ILLEGIBLE] and duty to defend.  We'll have the right    reasonable expenses that any protected person incurs at
and [ILLEGIBLE] defend any claim or suit for covered     our request while helping us investigate or defend a
[ILLEGIBLE] damage made or brought against any           claim or suit.  But we won't pay more than $250 per day
[ILLEGIBLE] person.  We'll do so even if any of          for earnings actually lost by the protected person
[ILLEGIBLE] of any such claim or suit are [ILLEGIBLE]    because of time taken off from work.
false or fraudulent.  But we have no way to perform
other acts or services.  And [ILLEGIBLE] duty to         Taxed cost.  We'll pay all costs taxed against any
defend claims or suits ends when [ILLEGIBLE] used up     protected person in the suit.
the limits of coverage that [ILLEGIBLE] with the
payment of judgments, settlements or medical expenses.   Pre-judgment interest.  We'll pay the pre-judgment
                                                         interest that's awarded against the protected person on
[ILLEGIBLE] have the right to investigate any claim or   that part of a judgment paid by us.  But if we make a
[ILLEGIBLE] to the extent that we believe is proper.     settlement offer to pay the available limit of
[ILLEGIBLE] also have the right to settle any claim      coverage, we won't pay the pre-judgment interest that
or [ILLEGIBLE] within the available limits of            accumulates after the date of our offer.
coverage.
                                                         Post-judgment interest.  We'll pay all interest that
[ILLEGIBLE] means a demand which seeks damages.          accumulates on the full amount of that part of a
                                                         judgment for which we make a payment.  But only from
[ILLEGIBLE] means a civil proceeding which seeks         the date of the judgment to the date we:
[ILLEGIBLE] includes:
[ILLEGIBLE] proceeding for such damages to [ILLEGIBLE]   .  pay;
protected person must submit or [ILLEGIBLE] with our     .  offer to pay; or
consent; and [ILLEGIBLE] other alternative dispute       .  deposit in court;
resolution [ILLEGIBLE] for such damages to which the
[ILLEGIBLE] person submits with our consent.
</TABLE>

<PAGE>

Injury or damage means bodily injury, [ILLEGIBLE]
injury or property [ILLEGIBLE].

------------------------------------------------------------------------------
155  ___ 5-91 Printe_________        Insuring Agreement 51          Page 3 of 16
(C)St. Paul Fire and Marine          Liability Coverage
Insurance Co. 1991

<PAGE>

                                                                    The ST. PAUL

<TABLE>
<S>                                                      <C>
How the limits of coverage apply if the General total    .  parking of an auto on any premises you own, rent,
limit is left blank.  If the amount of the General       lease or borrow, or on ways next to such premises, if
total limit is left blank in the Coverage Summary,       the auto isn't owned, rented, leased or borrowed by any
that total limit will be considered to be the same as    protected person; or
the Each event limit or $100,000, whichever is more.     .  operation of specialized equipment.

    - What This Agreement Won't Cover                    Auto means a land motor vehicle, trailer or semitrailer
-------------------------------------                    designed for travel on public streets or roads.  It
Advertising, broadcasting, publishing or telecasting     includes any permanently attached machinery or
business.  We won't cover advertising injury             equipment.  But we won't consider mobile equipment to
[ILLEGIBLE] results form an offense committed by any     be an auto.
[ILLEGIBLE] person in the business of advertising,
broadcasting, publishing or telecasting.                 Loading or unloading means the handling of property:
                                                         .  while it's being moved from the place where it's
[ILLEGIBLE].  We won't cover bodily injury, property     accepted for transportation;
[ILLEGIBLE] medical expenses that result from the:       .  while it's being loaded, transported and unloaded;
                                                         and
 .  ownership, maintenance, use or operation;             .  until it's moved to the place where it's finally
 .  [ILLEGIBLE] to others;                                delivered.
 .  [ILLEGIBLE] aircraft owned, operated, rented or
borrowed by any protected person.                        However, we won't consider moving property by an
                                                         unattached mechanical device to be loading or unloading.
[ILLEGIBLE] We won't apply this exclusion to:
 .  [ILLEGIBLE] for bodily injury or property damage      Unattached mechanical device includes any forklift,
assumed under any covered contract for the ownership,    conveyor or other unattached mechanical device, other
maintenance, or use of aircraft; or                      than a hand truck.
 .  [ILLEGIBLE] injury, property damage or medical
expenses that result from the operation of               Entrustment to others means:
[ILLEGIBLE] equipment.                                   .  the permitting of others to use or do something; or
                                                         .  the giving of something to others for safekeeping.
We explain what we mean by entrustment to others and
loading or unloading in the Auto exclusion.              We explain what we mean by mobile equipment and
                                                         specialized equipment in the Mobile equipment exclusion.
[ILLEGIBLE] what we mean by specialized equipment or
the Mobile equipment exclusion.                          Breach of contract.  We won't cover advertising injury
                                                         that results from the failure of any protected person
[ILLEGIBLE] won't cover bodily injury, property damage   to do what is required by a contract or agreement.
or medical expenses that result from [ILLEGIBLE];
                                                         But we won't apply this exclusion to the unauthorized
 .  [ILLEGIBLE] maintenance, use or operation;            taking or use of advertising ideas if the contract or
[ILLEGIBLE] loading; or                                  agreement doesn't specifically prohibit such taking or
                                                         use.
 .  [ILLEGIBLE] to others;
If any auto owned, operated, rented, leased or           Contract liability.  We won't cover the protected
borrowed by any protected person.                        person's liability for injury or damage assumed under
                                                         any contract or agreement.
But we won't apply this exclusion to bodily injury,
property damage or medical expenses that result from     However, we won't apply this exclusion to liability for
the:                                                     injury or damage the protected

------------------------------------------------------------------------------------------------------
</TABLE>

[ILLEGIBLE] 155 Ed. 5-91 Printed in U.S.A.   Insuring Agreement 51  Page 7 of 16
St. Paul Fire and Marine Insurance Co. 1991  Liability Coverage

<PAGE>

                                                                    The ST. PAUL

<TABLE>
<S>                                                           <C>
[ILLEGIBLE] refuses to be examined as often as we require,    Construction equipment includes any grader, scraper, roller
within reason, by doctors we choose.                          or power crane, shovel, loader, digger or drill.

[ILLEGIBLE] includes:                                         Specialized equipment means any:
 .  declared or undeclared war, or invasion;                   .  cherry picker or similar device used to lift workers;
 .  warlike action by a military force or other agents of      .  pump, generator or air compressor; or
any government, sovereign or other authority;                 .  other equipment, such as building cleaning, geophysical
 .  [ILLEGIBLE] insurrection, rebellion, revolution or         exploration, lighting, spraying, welding or well-servicing
[ILLEGIBLE] power; or                                         equipment, that has a built-in pump, generator or air
 .  [ILLEGIBLE] to hinder or defend against such               compressor.
[ILLEGIBLE].
                                                              Racing mobile equipment means any mobile equipment while
[ILLEGIBLE] explain what we mean by your products and your    being prepared for or used in any:
completed work in the Products and completed work             .  prearranged racing, speed, demolition or stunting contest
exclusion.                                                    or activity; or
                                                              .  practice for such contest or activity.
Mobile equipment.  We won't cover bodily injury, property
damage or medical expenses that result from the               We explain what we mean by auto, loading or unloading, and
transportation of mobile equipment by an auto owned,          entrustment to others in the Auto exclusion.
operated, rented, leased or borrowed by any protected
person.                                                       Nuclear energy liability  We won't cover bodily injury or
                                                              property damage for which any protected person:
[ILLEGIBLE] we cover bodily injury, property damage or        .  is covered by a nuclear energy liability insurance
medical expenses that result from the use of racing mobile    policy; or
equipment.                                                    .  would have been covered by such policy if that policy's
                                                              limits of coverage hadn't been used up.
Mobile equipment means any land vehicle [ILLEGIBLE]:
 .  designed for use primarily off public streets or roads;    Nor will we cover bodily injury or property damage that
 .  [ILLEGIBLE] for use only on or next to premises you        results from the hazardous properties of nuclear material
[ILLEGIBLE] rent or lease;                                    and for which:
 .  [ILLEGIBLE] on crawler treads;                             .  any person or organization is required by law to maintain
 .  [ILLEGIBLE] kept primarily for the ready movement of       financial protection in accordance with the federal Atomic
permanently attached construction equipment.                  Energy Act, or any of its amendments; or
                                                              .  any protected person is entitled, or would have been
Mobile equipment includes any land vehicle not described      entitled had this agreement not been issued, to indemnity
above that's kept primarily for purposes other than           from the United States government, or any of its agencies,
carrying people or cargo.  [ILLEGIBLE] consider which a       under any contract or agreement between the government, or
vehicle to be [ILLEGIBLE] if it:                              any of its agencies, and any person organization.
 .  [ILLEGIBLE] under its own power;
 .  [ILLEGIBLE] like an auto during travel on a public         We also won't cover medical expenses that result from:
street or road; and                                           .  the hazardous properties of nuclear material; and
 .  [ILLEGIBLE] permanently attached specialized equipment;    .  the operation of a nuclear facility by any person or
or                                                            organization.
[ILLEGIBLE] permanently attached equipment designed
[ILLEGIBLE] removal, street cleaning, or street or road
maintenance - but not construction or [ILLEGIBLE].
</TABLE>

[ILLEGIBLE] 5-91 Printed in U.S.A.      Insuring Agreement 51     Page 11 of 16
St. Paul Fire and Marine                Liability Coverage
Insurance Co. 1991

<PAGE>

                                                                    The ST. PAUL

<TABLE>
<S>                                                           <C>
[ILLEGIBLE] means:                                            Workers' compensation.  We won't cover any obligation that
 .  [ILLEGIBLE] work that you're performing or others are      the protected person has under a workers' compensation
performing for you; or                                        disability benefits or unemployment compensation law, or any
 .  [ILLEGIBLE] that you're providing or others are            similar law.
providing for you.                                            Wrong price description.  We won't cover advertising injury
                                                              that results from making known to any person or organization
[ILLEGIBLE] includes:                                         the wrong description of the price of your products, work or
 .  [ILLEGIBLE] equipment, materials or parts provided with    completed work.
 [ILLEGIBLE] your work;                                       We explain what we mean by your products, your work and your
 .  [ILLEGIBLE] warranty provided with or for your work;       completed work in the Products and completed work exclusion.
 .  [ILLEGIBLE] made, or which should have [ILLEGIBLE] about
 the durability, fitness, [ILLEGIBLE] maintenance,            Other Insurance
 operation, performance, [ILLEGIBLE] safety or use of your    ---------------
 work; and                                                    This Agreement is primary insurance.  If there is any other
 .  [ILLEGIBLE] instructions or directions provided, or        valid and collectible insurance for injury or damage covered
 which should have been provided with or for your work.       by this agreement, the following applies:

We explain what we mean by loading or unloading in the Auto   Other primary insurance.  When there is other primary
 exclusion.                                                   insurance, we'll share any damages with that insurance using
                                                              one of the methods of sharing described in the methods of
[ILLEGIBLE] what we mean by impaired property                 sharing section.
[ILLEGIBLE] impaired property exclusion.
                                                              However, we'll apply this agreement as excess insurance over
[ILLEGIBLE]  We won't cover bodily injury, property damage    any part of any other insurance which provides:
 or medical expenses that result from the:                    .  property or similar coverage for property damage to your
 .  ownership, maintenance, use or operation;                  work;
 .  [ILLEGIBLE] or unloading; or                               .  coverage for property damage to premises you rent, lease
 .  [ILLEGIBLE] to others;                                     or borrow from others; or
 .  [ILLEGIBLE] watercraft owned, operated, rented,            .  coverage for bodily injury or property damage that
[ILLEGIBLE] or borrowed by any protected person.              results from the maintenance, use, operation or loading or
                                                              unloading of any auto, aircraft or watercraft that's not
[ILLEGIBLE] won't apply this exclusion to liability for       specifically excluded by the Auto, Aircraft or Watercraft
bodily injury or property damaged assumed [ILLEGIBLE] any     exclusions.
covered contract for the ownership, maintenance or use of
watercraft.                                                   We explain how we'll apply this agreement as excess
                                                              insurance in the Excess insurance section.
[ILLEGIBLE] we apply this exclusion to bodily [ILLEGIBLE]
property damage or medical expenses [ILLEGIBLE] from:         Excess insurance.  When this agreement is excess insurance,
                                                              we'll have no duty to defend any claim or suit.  However,
[ILLEGIBLE] aircraft you don't own that is less than 50       we'll defend a claim or suit for covered injury or damage if
feet long and isn't being used to carry persons               the other insurers won't.  In return we'll require that
[ILLEGIBLE] for a charge; or operation of specialized
equipment.

We explain what we mean by entrustment to [ILLEGIBLE] and
loading or unloading in the Auto exclusion.

We explain what we mean by specialized equipment in the
Mobile equipment exclusion.
</TABLE>
<PAGE>

--------------------------------------------------------------------------------
 [ILLEGIBLE]. 5-91 Printed in U.S.A.    Insuring Agreement 51      Page 15 of 16
St. Paul Fire and Marine                Liability Coverage
Insurance Co. 1991
<PAGE>

                                                                    The ST. PAUL

AUTO CONTRACT LIABILITY ENDORSEMENT - MASSACHUSETTS

This endorsement changes your Commercial
[ILLEGIBLE] Protection.

<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------
How Coverage Is Changed                                  Other Terms
<S>                                                      <C>

The following is added to the Auto exclusion under the   All other terms of your policy remain the same.
Exclusions - What This Agreement Doesn't Cover
section.  This change broadens coverage.
We won't apply this exclusion to bodily injury,
property damage or medical expenses that [ILLEGIBLE]
from ability for bodily injury or property damage
assumed under any covered contract for the ownership,
maintenance or use of any auto.

-----------------------------------------------------------------------------------------------------------------
</TABLE>

[ILLEGIBLE]. 1-89 Printed in U.S.A.            Endorsement
St. Paul Fire and Marine Insurance Co. 1989                        Page __ of __
<PAGE>

                                                                    The ST. PAUL

<TABLE>
<S>                                                            <C>
We [ILLEGIBLE] designed this agreement to protect against      This agreement is excess insurance and covers claims after
 two kinds of liability claims:                                any other insurance that applies to the claim has been used
1.  Claims resulting from bodily injury to others.             up.  Of course there are some limitations which are
2.  Claims resulting from damage to property of others.        explained later in this agreement.

---------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                                            <C>
Table of Contents                                        Page  What This Agreement Covers
                                                               --------------------------

What This Agreement Covers                                  1  Bodily injury and property damage liability.  We'll pay
 [ILLEGIBLE] injury and property damage liability.          1  amounts any protected person is legally required to pay as
 [ILLEGIBLE] on cost or expense.                            1  damages for covered bodily injury or property damage that:
 [ILLEGIBLE] duty to defend.                                2  .  results from the maintenance, use, loading or unloading
 Additional payments.                                       3  of a covered auto; and
 Right to appeal.                                           3  .  is caused by an accident that happens while this
 Out of state coverage.                                     3  agreement is in effect.

What Autos Are Covered                                      3  Pollution cost or expense.  We'll pay amounts any protected
 Hired autos                                                4  person is legally required to pay as covered pollution cost
 Nonowned autos                                             4  or expense only if it results from an accident which also
                                                               causes bodily injury or property damage covered by this
When This Agreement Covers                                  4  agreement.

Where This Agreement Covers                                 4  Protected person means any person or organization who
                                                               qualifies as a protected person under the Who Is Protected
Who Is Protected Under This Agreement                       4  Under This Agreement section.
 Individual.                                                4
 Partnership or joint venture.                              4  Bodily injury means any physical harm, including sickness or
 Corporation or other organization.                         4  disease, to the physical health of other persons.  It
 Any permitted user.                                        4  includes any of the following that results at any time from
 Anyone legally responsible for the actions of a               such physical harm, sickness or disease:
  protected person.                                         4  .  Mental anguish, injury or illness.
 [ILLEGIBLE] of protected persons.                          5  .  Emotional distress.
                                                               .  Care, loss of services or death.
Limit Of Coverage                                           5
                                                               Property damage means
Exclusions - What This Agreement Won't Cover                5  .  physical damage to tangible property of others, including
 Contract liability.                                           loss of use of such property; or
 [ILLEGIBLE] property.                                      5  .  loss of use of tangible property of others that isn't
 [ILLEGIBLE] liability                                      6  physically damaged.
 Injury to a fellow employee.                               6
 Intentional or expected bodily injury or property          6  We'll consider all loss of use of tangible property to
 damage.                                                    6  happen at the time of the accident which caused it.
 [ILLEGIBLE] energy liability.                              6
 [ILLEGIBLE].                                               7  Accident includes continuous or repeated exposure to the
 [ILLEGIBLE] equipment.                                     8  same conditions.
 [ILLEGIBLE] compensation.                                  8

Other Insurance
Insurance provided by another insurer.  Insurance           8
 provided under another policy with us or any of our        9
 member insurance companies.
                                                            9
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

 44471 Ed. 4-91Printed in U.S.A.     Insuring Agreement 63
 (C)St. Paul Fire and Marine
 Insurance Co. 1991 All Rights Reserved                         Page 1 of 9
<PAGE>

                                                                     The St Paul

<TABLE>
<S>                                                           <C>
The person causes an accident which results in covered        to substantially the same conditions to be the result of one
bodily injury and property damage.  We'll consider you,       accident.
that employee, and the other company that employs the
other person to be protected persons.                         Exclusions - What This Agreement Won't Cover
                                                              --------------------------------------------
Be we won't consider the owner or anyone else from whom you
rent, lease, hire or borrow a [ILLEGIBLE] auto to be a        Contract liability.  We won't cover the protected person's
protected person unless [ILLEGIBLE] connected to a covered    liability for bodily injury or property damage assumed under
auto [ILLEGIBLE].                                             any contract or agreement.

[ILLEGIBLE] of protected persons.  We'll apply this           However, we won't apply this exclusion to liability for
agreement:                                                    bodily injury or property damage the protected person would
                                                              have without the contract or agreement.  Nor will we apply
[ILLEGIBLE] each protected person named in the Introduction   this exclusion to the protected person's liability for
as if that protected person was the only [ILLEGIBLE] named    bodily injury or property damage assumed under a covered
there; and                                                    contract made before the bodily injury or property damage
                                                              happens.
[ILLEGIBLE] to each other protected person.
                                                              Covered contract means any:
However, the limit of coverage shown in the Coverage          .  lease of premises;
Summary is shared by all protected [ILLEGIBLE]. We explain    .  sidetrack agreement;
how in the Limits Of [ILLEGIBLE] Section.  Also, any right    .  easement or license agreement;
or duty specifically assigned to the first Name Insured       .  obligation to indemnify a municipality if the obligation
remains unchanged.  We explain those rights [ILLEGIBLE]          is required by ordinance and isn't connected with work for
duties in the General Rules, which is a part of your             the municipality;
policy.,                                                      .  contract or agreement under which you assume the tort
                                                                 liability of a municipality to pay damages for covered
Limit of Coverage                                                bodily injury or property damage that is sustained by others
-----------------                                                and results from work for the municipality ;
                                                              .  other contract or agreement under which you assume the
The Coverage Summary shows the limit of coverage that            tort liability of another to pay damages for covered bodily
applies to this agreement.                                       injury or property damage that's sustained by others; or
                                                              .  contract or agreement which you or any of your employees
[ILLEGIBLE] each accident limit is the most we'll pay for        enter into for the rental or lease of any auto.
[ILLEGIBLE] total of all covered bodily injury, property
damage and pollution cost or expense that results from any    Tort liability means a liability that would be imposed by
one accident.  This limit applies regardless of the           law without any contract or agreement.
premiums paid or [ILLEGIBLE] of:
                                                              But we won't consider the following parts of any contract or
 .  protected persons;                                         agreement to be a covered contract:

 .  premiums paid;                                             Auto with driver.  That part which has to do with the
                                                              rental, lease or loan of an auto to you or any of your
 .  claims made or suits brought;                              employees if the auto is rented, leased or loaned with a
                                                              driver.
 .  covered autos;

[ILLEGIBLE] involved in the accident; or persons or
organizations making claims or bringing suits.

[ILLEGIBLE] consider all covered bodily injury, property
[ILLEGIBLE] and pollution cost or expense that
[ILLEGIBLE] from continuous or repeated exposure
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

 44471 Ed. 4-91 Printed in U.S.A.        Insuring Agreement 63
 (C)St. Paul Fire and Marine
 Insurance Co. 1991 All Rights Reserved                             Page 5 of 9

<PAGE>

                                                                     THE ST PAUL

<TABLE>
<S>                                                           <C>
Other Insurance                                               excess basis as this agreement, we'll pay only our share of
---------------
This agreement provides excess insurance for covered autos    your accident.  We'll pay the same proportion of such
you don't own.                                                damages or pollution cost or expense that our limit is to
                                                              the total of all [ILLEGIBLE] policy limits.  But we won't
Excess insurance applies after other collectible insurance    pay more than our limit.
has been used up.

This agreement is primary insurance for liability for         Insurance provided under another policy with us [ILLEGIBLE]
covered bodily injury or property damage assumed under a      of our member insurance companies.
coverage contract.                                            [ILLEGIBLE] this agreement and other insurance contained in
                                                              a policy from us or another member insurance company of The
We explain what we mean by covered contract in the Contract   St. Paul Group both apply to the same accident, the
liability exclusion.                                          [ILLEGIBLE] we will pay is the highest limit of coverage
                                                              that applies under any one policy.  When [ILLEGIBLE]
Insurance provided by another insurer.  When insurance        insurance written by us or the member insurance company is
provided by another insurer applies to covered bodily         intended to be excess of this agreement, this section does
injury or property damage that results from an accident on    not apply.
the same primary or
</TABLE>

44471 Ed. 4-91 Printed in U.S.A.  Insuring Agreement 63
(C)St. Paul Fire and Marine Insurance Co. 1991 All Rights Reserved   Page 9 of 9
<PAGE>

                                  COVER PAGE

                        WAVERLY INSURANCE AGENCY, INC.
                          COMPLETE INSURANCE SERVICE

                     493 Trapelo Road . Belmont, MA 02178
                                (619) 484-5216
<PAGE>

                      Eastern Casualty Insurance Company

         WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE POLICY
                               INFORMATION PAGE

<TABLE>
<S>                                                    <C>
NCCI Carrier 16942                                     Risk I.D. # ____________

Policy No. WC P0007199                                 Federal I.D. # 77-____________

1.  The Insured/Mailing address:                       [_] Individual  [_] Partnership

     SEQUENOM INC.                                     [_] Corporation or ___________
     101 ARCH STREET SUITE 1950                        ______________________________
     BOSTON, MA 021110
Other workplaces not shown above:

2.  Policy Period:  The policy period is from 10/27/94 to 10/27/95     12:01 A.M. Standard Time,
                              at the insured's mailing address.

3.  Coverage:
    A.  Worker's Compensation Insurance: Part One of the policy applies to the
        Workers Compensation Law of the states listed here: Massachusetts

    B.  Employers Liability Insurance:  Part Two of the policy applies to work in each state listed in item 3.A.
        The limits of our liability under Part Two are:  Bodily Injury by Accident  100,000 each accident
                                                         Bodily Injury by Disease   500,000 policy limit
                                                         Bodily Injury by Disease   100,000 each employee
    C.  Other States Insurance:  Part Three of the policy applies to the states, if any, listed here:  See
        Endorsement WC 20 03___, WC242, WC332, WC350, WC367, WC441

    D.  This policy includes these endorsements and schedules:
        See Information Page III for other applicable endorsements.

Total Estimated Annual Premium   $   1,489
Pro Rata Premium (If Applicable) $

               ANNUAL

Countersigned  WAVERLY INSURANCE AGENCY
               493 TRAPELO ROAD
               BELMONT, MA 02178

Date  01-10-95                                           By  /s/
                                                             ----------------------------------
      ARC:  104.33                                                     Authorized Signature
</TABLE>

  THIS INFORMATION PAGE WITH THE WORKERS COMPENSATION AND EMPLOYERS LIABILITY
       INSURANCE POLICY AND ENDORSEMENTS, IF ANY, ISSUED TO FORM A PART
                  THEREOF COMPLETES THE ABOVE NUMBERED POLICY
<PAGE>

                      Eastern Casualty Insurance Company
--------------------------------------------------------------------------------
                                                                           WC174
                                                                      (Ed. 4-84)

         WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE POLICY
                         EXTENSION OF INFORMATION PAGE

Policy Number:  WCP0007199                                  SEQUENOM

4.  Premium: The premium for this policy will be determined by our Manuals of
             Rules, Classification, Rates and Rating Plans. All information
             required below is subject to verification and change by audit.

<TABLE>
<CAPTION>
                        Classifications                           Code     Premium Basis       Rate Per    Estimated Annual
                                                                  No.     Total Estimated      $100 of         Premiums
                                                                        Annual Remuneration  Remuneration
------------------------------------------------------------------------------------------------------------------------------
<S>                                                               <C>   <C>                  <C>           <C>
ANALYTICAL CHEMISTS                                               4511          98,000          1.28             1,254
CLERICAL OFFICE EMPLOYEES                                         8810          10,400           .33                34
COVERAGE B-EMPLOYERS LIABILITY                                    9345                                               0
STANDARD PREMIUM SUBJECT TO DIA                                                                               [ILLEGIBLE]

EXPENSE CONSTANT                                                  0900                                             160
DIA ASSESSMENT 3.2% OF STANDARD PREMIUM                                                                             41

------------------------------------------------------------------------------------------------------------------------------
Minimum Premium $  135                                                   Total Estimated Annual Premium:    $    1,439
                                                                         Pro-Rata Premium (if applicable):  $
                                                                                   ANNUAL
</TABLE>

                                 INSURED COPY
<PAGE>

                       Eastern Casualty Insurance Company

INFORMATION PAGE III                         POLICY NO. WCP0007199
                                                        ----------
These endorsements apply only if so indicated by an "X" in the box below.

[_]  WC100       Defense Base Act Endorsement

[_]  WC103       Federal Employers' Liability Act Endorsement

[_]  WC111       Voluntary Compensation Maritime Coverage Endorsement

[_]  WC113       Designated Workplaces Exclusion Endorsement

[_]  WC124       Waiver of Our Right to Recover from Others Endorsement

[_]  WC127       Anniversary Rating Date Endorsement

[_]  WC128       Experience Rating Modification Factor Endorsement

[_]  WC129       Pending Rate Change Endorsement

[_]  WC131       Premium Discount Endorsement

[_]  WC132       Rate Change Endorsement

[_]  WC133       Retrospective Premium Endorsement (I, II, III, IV-One Year)

[_]  WC137       Retrospective Premium Endorsement
                 Rating Option V -- One Year Plan

[_]  WC236       Domestic and Agricultural Workers Exclusion Endorsement

[_]  WC269       Alternate Employer Endorsement

[_]  WC331       Aircraft Premium Endorsement

[_]  WC418       Massachusetts Qualified Loss Management Program Endorsement

[_]  WC419       Longshore & Harborworkers Act Endorsement

[_]  WC421       Outer Continental Shelf Lands Act Coverage Endorsement

[_]  WC422       Maritime Coverage Endorsement

[_]  WC443       MA Exclusion of Coverage for Leased Employers Endorsement

[_]  WC444a      Massachusetts Employee Leasing Endorsement

[_]  WC474       Massachusetts Benefits Deductible Endorsement

                                    INSURED
<PAGE>

   WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE POLICY     WC 20 03 06

                                  WC 20 03 06
                  MASSACHUSETTS LIMITED OTHER STATES INSURANCE

This endorsement changes the policy to which it is attached effective on the
inception date of the policy unless a different date is indicated below.
(The following "attaching clause" need to be completed only when this
endorsement is issued subsequent to preparation of the policy)

This endorsement, effective on    10/27/94  at 12:01 A.M. standard time, forms
                                  (Date)
a part of

Policy No. WCP007199       of the        Eastern Casualty Insurance Company
                                              (Name of Insurance Company)

issued to SEQUENOM INC.

Premium $   1,448.00                    ____________________________________
                                              Authorized Representative

"PART THREE - OTHER STATES INSURANCE" is amended to read:

A. How This Insurance Applies:

   1. We will pay promptly, when due, the benefits required of you by the
      workers' compensation law of any state other than Massachusetts, but only
      if the claim for such benefits involves work performed by a Massachusetts
      employee.

   2. If we are not permitted to pay the benefits directly to persons entitled
      to them under circumstances described in item 1 above, we will reimburse
      you for the benefits required to be paid.

                               IMPORTANT NOTICE

If you hire any employees outside Massachusetts or begin operations in any state
other than Massachusetts, you must obtain insurance coverage in that state and
so whatever else may be required under that state's law, as this endorsement
does not satisfy the requirements of that state's workers' compensation law.

                                    Copyright 1994
                                    National Council on Compensation Insurance

                                    [LOGO]
<PAGE>

                                  EXHIBIT 6.6
                                  -----------

                      Form of Stock Restriction Agreement
                      -----------------------------------
<PAGE>

                          STOCK RESTRICTION AGREEMENT

     This Agreement made as of December 22, 1995 by and among Sequenom, Inc., a
Delaware corporation (the "Corporation"); Hubert Koster ("Koster"), Nola E.
Masterson ("Masterson") and Robert E. Patterson ("Patterson," and together with
Koster and Masterson, the "Founders"); and the purchasers of shares of the
Corporation's Series B Convertible Preferred Stock, par value $.001 per share
("Series B Preferred Stock"), pursuant to the Series B Convertible Preferred
Stock Purchase Agreement dated as of the date hereof (the "Purchase Agreement"),
including any Additional Investors as defined in the Purchase Agreement (such
purchasers being hereinafter referred to as the "Investors").

                          W I T N E S S E T H  T H A T

     WHEREAS, the Investors wish to purchase from the Corporation certain shares
of Series B Preferred Stock;

     WHEREAS, the Investors' purchase of the Series B Preferred Stock would
materially benefit the Founders as holders of certain shares of the
Corporation's capital stock and rights to acquire such capital stock;

     WHEREAS, it is a condition to the obligations of the Investors under the
Purchase Agreement that this Agreement be executed by the Founders, and the
Founders are willing to execute this Agreement and to be bound by the provisions
hereof;

     NOW, THEREFORE, in consideration of the foregoing, the agreements set forth
below, and the parties', desire to provide for continuity of ownership of the
Corporation to further the interests of the Corporation and its present and
future stockholders, the parties hereby agree with each other as follows:

     1.  Certain Defined Terms.  As used in this Agreement, the following terms
         ---------------------
shall have the following respective meanings:

         (a) "Stock" shall mean and include all shares of the Corporation's
Common Stock, par value $.001 per share ("Common Stock"), any evidences of
indebtedness, shares of capital stock or other securities directly or indirectly
convertible into or exchangeable for Common Stock ("Convertible Securities"),
including without limitation the Series A Convertible Preferred Stock, par value
$.001 per share, of the Corporation, and any rights, options or warrants to
subscribe for, purchase or otherwise acquire Common Stock or Convertible
Securities ("Options"), and all other securities of the Corporation which may be
issued in exchange for or in respect of shares of Common Stock, Convertible
Securities or Options (whether by way of stock split, stock dividend,
combination of shares, reclassification, recapitalization, reorganization, or
any other means).

         (b) "Shares" shall mean and include all shares of Stock now owned or
hereafter acquired by any Founder or any investor.
<PAGE>

     2.   Prohibited Transfers.  None of the Founders shall sell or otherwise
          --------------------
transfer, by gift or otherwise, all or any part of his Shares except in
compliance with the terms of this Agreement.

     3.   Offer of Sale; Notice of Proposed Sale or Transfer.  If any Founder
          --------------------------------------------------
desires to sell or otherwise transfer any of his Shares, or of any interest
therein, whether voluntarily or by operation of law, in any transaction other
than pursuant to clauses (iii) or (iv) of Section 7(a) of this Agreement, such
Founder (the "Selling Founder") shall first deliver written notice of his desire
to do so (the "Notice") to the Corporation and each of the Investors.  The
Notice must specify:  (i) the name and address of the party to which the Selling
Founder proposes to sell or otherwise transfer the Shares or an interest in the
Shares (the "Proposed Transferee"), (ii) the number of Shares the Selling
Founder proposes to sell or otherwise transfer (the "Offered Shares"), (iii) the
consideration per Share to be delivered to the Selling Founder for the proposed
sale or transfer, and (iv) all other material terms and conditions of the
proposed transaction, which must be bona fide.

     4.   Corporation's Option to Purchase.
          --------------------------------

          (a) Except as set forth in Section 7(a), the Corporation shall have
the first option to purchase all or any part of the Offered Shares for the
consideration per Share and on the terms and conditions specified in the Notice.
The Corporation must exercise such option, no later than fifteen (15) business
days after such Notice is deemed to have been delivered to it, by written notice
to the Selling Founder.

          (b) In the event the Corporation does not exercise its option within
such fifteen-business-day period with respect to all of the offered Shares, the
Chief Financial officer of the corporation shall, by the last day of such
period, give written notice of that fact to the Investors (the "Investor
Notice").  The Investor Notice shall specify the number of Offered Shares the
Corporation has elected not to purchase (the "Remaining Shares").

          (c) In the event the Corporation duly exercises its option to purchase
all or a portion of the Offered Shares, the closing of such purchase shall take
place at the offices of the Corporation on the later of (i) the date five
business days after the expiration of such fifteen-business-day period or (ii)
the date that the Investors consummate their purchase of Offered shares under
Section 5(c) hereof.

          (d) To the extent that the consideration proposed to be paid by the
Proposed Transferee for the Offered Shares consists of property other than cash
or a promissory note, the consideration required to be paid by the Corporation
and/or the Investors exercising their options under Sections 4 and 5 hereof,
respectively, may consist of cash equal to the value of such property, as
determined in good faith by agreement of the selling Founder and the Corporation
and/or the Investors acquiring such Offered Shares.

                                      -2-
<PAGE>

     5.   Investors' Option to Purchase and Right to Participate in Sales.
          ---------------------------------------------------------------

          (a) Except as set forth in Section 7(a), each Investor shall have an
option, exercisable for a period of fifteen (15) business days from the date of
delivery of the Investor Notice, to purchase, on a pro rata basis, its
Proportionate Percentage (as defined below) of the Remaining Shares, for the
consideration per Share and on the terms and conditions set forth in the Notice.
Such option shall be exercised by delivery of written notice to the Chief
Financial Officer of the Corporation.  Alternatively, each Investor may, within
the same fifteen-business-day period, notify the Chief Financial Officer of the
Corporation of its desire to participate in the sale of Shares and to sell, on
the terms as set forth in the Notice including at the same price per share on a
common equivalent basis, up to an equivalent proportion of the Stock owned by
such Investor as the proposed sale of the Remaining Shares represents with
respect to the Shares then owned by the Selling Founder.

          (b) In the event options to purchase have been exercised by the
Investors with respect to some but not all of the Remaining Shares, the Chief
Financial Officer of the Corporation shall promptly give written notice of that
fact to those Investors who have exercised their options within such period (the
"Second Investor Notice").  The Second Investor Notice shall specify the number
of Remaining Shares the Investors have not elected to purchase.  The Investors
who have exercised their options within the fifteen-business-day period
specified in Section 5(a) shall have an additional option, for a period of ten
(10) business days after delivery of the Second Investor Notice, to purchase all
or any part of the balance of such Remaining Shares on the terms and conditions
set forth in the Notice, which option shall be exercised by the delivery of
written notice to the Chief Financial Officer of the Corporation.  In the event
that there are two or more such Investors that choose to exercise the last-
mentioned option for a total number of Remaining Shares in excess of the number
available, the Remaining Shares available for each such Investor's option shall
be allocated to such Investors pro rata based on the amount of Stock owned by
the Investors so electing on a common equivalent basis.

          (c) Promptly after the expiration of the last period for exercise of
an Investor's purchase option, the Chief Financial Officer of the Corporation
shall give written notice to the Selling Founder and the purchasing Investors,
specifying the number of Remaining Shares to be purchased by each purchasing
Investor.  The closing of the purchase of the Remaining Shares shall take place
at the offices of the Corporation no later than five (5) business days after
delivery of such notice to the Selling Founder and the purchasing Investors.

          (d) As used in this Section 5, the term "Proportionate Percentage"
shall mean with respect to each Investor a fraction, the numerator of which
shall be the amount of Stock owned by such Investor, and the denominator of
which shall be the total amount of Stock owned by all Investors, in each case on
a common equivalent basis.

     6.   Co-Sale.
          -------

          (a) If the Corporation and the Investors do not exercise their options
to purchase all of the Offered Shares within the periods described in this
Agreement (the "Option Period"), then each Investor which has, pursuant to
Section 5(a), expressed a desire to sell shares

                                      -3-
<PAGE>

in the transaction (a "Participating Investor") shall be entitled to do so
pursuant to this Section. The Chief Financial Officer of the Corporation shall
promptly, on expiration of the Option Period, notify the Selling Founder of the
aggregate amount of Stock the Participating Investors wish to sell. The Selling
Founder shall use his best efforts to interest the Proposed Transferee in
purchasing, in addition to the Remaining Shares not subscribed for by the
Investors, the Stock the Participating Investors wish to sell. If the Proposed
Transferee does not wish to purchase all of the Stock made available by the
Selling Founder and the Participating Investors, then each Participating
Investor and the Selling Founder shall be entitled to sell, on the terms and
conditions set forth in the Notice and on the same price per share on a common
equivalent basis, a portion of the Stock being sold to the Proposed Transferee,
in the same proportion as such Selling Founder or Participating Investor's
ownership of Stock on a common equivalent basis bears to the aggregate amount of
Stock owned by the Selling Founder and the Participating Investors on a common
equivalent basis. The transaction contemplated by the Notice shall be
consummated not later than 60 days after the expiration of the Option Period.

          (b) If the Participating Investors do not elect to sell the full
amount of Stock which they are entitled to sell pursuant to Section 6(a), the
Selling Founder shall be entitled to sell to the Proposed Transferee, according
to the terms set forth in the Notice, that number of his Shares which equals the
difference between the amount of Stock desired to be purchased by the Proposed
Transferee and the number of Shares the Participating Investors wish to sell, in
each case on a common equivalent basis.

          (c) If the Selling Founder wishes to sell or otherwise transfer any of
his Shares at a price per Share which differs from that set forth in the Notice,
upon terms different from those previously offered to the Corporation and the
Investors, or more than 60 days after the expiration of the Option Period, then,
as a condition precedent to such transaction, such Shares must first be offered
to the Corporation and the Investors on the same terms and conditions as given
the Proposed Transferee, and the Investors must first be offered the opportunity
to participate in such transaction, in accordance with the procedures and time
periods set forth above.

     7.   Permitted Transfers.
          -------------------

          (a) Subject to the provisions of Section 7(b) and Section 8, the
Corporation's and the Investors' right of first refusal and the Investors' right
of co-sale described in Sections 4 through 6 shall not apply to:  (i) any
transfer of Shares by a Founder by gift or bequest or through inheritance to, or
for the benefit of, any member or members of such Founder's immediate family;
(ii) any transfer of Shares by an Founder to a trust (A) in respect of which
such Founder serves as trustee, provided that the trust instrument governing
such trust shall provide that such Founder, as trustee, shall retain sole and
exclusive control over the voting and disposition of such Shares until the
termination of this Agreement or (B) for the benefit solely of any member or
members of such Founder's immediate family; (iii) any sale or transfer of Shares
to the Corporation; (iv) any underwritten public offering of Common Stock
pursuant to an effective registration statement under the Securities Act of
1933, as amended (the "Securities Act"); and (v) with respect to sales or other
transfers of up to an aggregate of the following number of shares (as adjusted
to reflect any stock split, stock dividend, combination of shares or other

                                      -4-
<PAGE>

similar transaction), but subject in any case to the restrictions set forth in
Section 8:  (A) in the case of each of Koster and Masterson, 130,000 Shares; and
(B) in the case of Patterson, 50,000 Shares;

          (b) In the event of any sale or transfer described in clauses (i) or
(ii) of Section 7(a), the transferee of the Shares shall hold the Shares so
acquired subject to all the restrictions imposed by this Agreement and shall be
deemed a Founder for all purposes hereof, and as a condition to such transfer,
any such transferee shall, at the request of the Corporation or any Investor,
execute and deliver a written instrument agreeing to be bound by the provisions
of this Agreement.

     8.   Consent of the Corporation to Transfer.  As a condition to selling or
          --------------------------------------
otherwise transferring any Shares proposed to be sold or transferred by the
Selling Founder and any Participating Investor to any Proposed Transferee, other
than a sale or transfer described in clause (iii) or (iv) of Section 7(a), the
Selling Founder shall have obtained the written consent to such transfer by the
Board of Directors of the Corporation by majority vote at a meeting or by
unanimous consent in lieu of a meeting.  Such consent shall not be unreasonably
withheld, and shall be based on the Board of Directors' determination, after
such inquiry as it deems appropriate, but within thirty days of the date of the
Selling Founder's notice to the Corporation under Section 3, that the Proposed
Transferee is not a competitor of the Corporation and is not otherwise an
inappropriate investor in the Corporation.  In the event the Selling Founder
disagrees with such determination, and the Board of Directors and the Selling
Founder are unable to resolve the disagreement, an independent third party
selected and agreed upon by the Board of Directors and the Selling Founder shall
arbitrate and finally resolve the disagreement.

     9.   Lock-up.  Each Founder agrees that upon the request of the Corporation
          -------
or the underwriters managing an underwritten offering of the Corporation's
securities, such Founder will not sell, make any short sale or loan of, grant
any option for the purchase of, or otherwise dispose of any Shares held by him
without the prior written consent of the Corporation or such underwriters, as
the case may be, for a period of up to 180 days from effective date of the
applicable registration statement.

     10.  Sale or Transfer in Violation of this Agreement.  If any sale or other
          -----------------------------------------------
transfer of Shares is made or attempted in violation of any provision of this
Agreement, or if any Shares are not offered to the Corporation or the Investors
as required hereby, the Corporation and the Investors, as the case may be, shall
have the right to purchase such Shares from the owner thereof or his transferee
at any time before or after the transfer, as herein provided.  In addition to
any other legal or equitable remedies which it or they may have, the Corporation
and the Investors may enforce their respective rights hereunder by actions for
specific performance (to the extent permitted by law).  The Corporation shall
not be required (i) to transfer on its books any Shares or other Stock which has
been sold or transferred in violation of any provision of this Agreement or (ii)
to treat as the owner of such Shares or Stock, or to pay dividends to, any
transferee to whom any such Shares or Stock have been so sold or transferred.
If a Founder becomes obligated to sell any Shares to the Corporation under this
Agreement and fails to deliver such Shares in accordance with the terms of this
Agreement, the Corporation may, at its option, in addition to all other remedied
it may have, send to such Founder the purchase price for such

                                      -5-
<PAGE>

Shares as is herein specified and cancel on its books the certificate or
certificates representing the Shares to be sold. Thereafter, all of the
Founder's rights in and to such Shares shall terminate.

     11.  Disposition of Shares.  Any Shares that the Corporation elects to
          ---------------------
purchase hereunder may be disposed of by it in such manner as it deems
appropriate with or without restrictions on the transfer thereof, and the
Corporation may require their transfer to a nominee or designee as part of any
purchase of the Shares from the Founders.

     12.  Restrictive Legend.  All certificates representing Shares held by the
          ------------------
Founders which are subject to this Agreement shall have affixed thereto a legend
in substantially the following form, in addition to any other legends that may
be required by the Corporation in connection with compliance with federal or
state securities laws or otherwise:

          "The shares of stock represented by this certificate are
          subject to restrictions on transfer and/or an option to
          purchase set forth in a Stock Restriction Agreement between
          the Corporation and the registered owner of the shares
          represented by this certificate (or his predecessor in
          interest). The Corporation will furnish a copy of such
          agreement to the holder of this certificate upon written
          request without charge."

The Founders shall cause such legend to be affixed to any of such certificates
not so legended.

     13.  Term.  This Agreement shall terminate upon the closing of a firm
          ----
commitment underwritten public offering of Common Stock pursuant to an effective
registration statement under the securities Act in which (i) the public offering
price per share is not less than $4.50 (appropriately adjusted to take account
of any stock split, stock dividend, combination of shares or similar event) and
(ii) the aggregate gross proceeds to the Corporation are not less than
$10,000,000.

     14.  Specific Enforcement.  Each Founder expressly agrees that a violation
          --------------------
of this Agreement by such Founder could not be adequately compensated by money
damages alone and that the Investors and the Corporation will be irreparably
damaged if this Agreement is not specifically enforced.  Upon a breach or
threatened breach of the terms, covenants and/or conditions of this Agreement by
any Founder, the Investors and the Corporation shall, in addition to all other
remedies, each be entitled to a temporary or permanent injunction, and/or a
decree for specific performance, in accordance with the provisions hereof.

     15.  Other Agreements.  The restrictions on the Founders' right to dispose
          ----------------
of their Shares pursuant to this Agreement are in addition to and to be
construed consistently with the Founders' rights and obligations (including
restrictions on the Founders' right to dispose of shares of the Corporation's
capital stock) contained in any other agreement relating to restrictions on the
transferability of such Shares that the Founders execute before, on, or after
the date hereof; provided, that this Agreement shall supersede and replace (i)
the Stock Restriction Agreement dated October 16, 1995 between the Corporation
and Nola E. Masterson, which shall

                                      -6-
<PAGE>

no longer be of any force or effect, and (ii) the form of Stock Restriction
Agreement attached to the outstanding options to purchase Common Stock held by
Koster and Patterson.

     16.  Waiver, Modification and Termination.  No provision of this Agreement
          ------------------------------------
shall be deemed to have been waived by the corporation or any Investor in the
absence of a written agreement executed by such party with respect to such
waiver.  This Agreement may be modified or terminated only with the written
consent of the Founders, the Corporation, and the holders of a majority in
voting power of the Shares then held by the Investors.

     17.  Accession.  Any Additional Investors as defined in the Purchase
          ---------
Agreement shall automatically become an Investor hereunder by delivering to the
Corporation a written instrument in the form of Exhibit A hereto, by which such
                                                ---------
Additional Investor agrees to be bound by the obligations imposed under this
Agreement, whereupon such Additional Investor shall automatically become a party
to this Agreement and shall thereupon be deemed an "Investor" for all purposes
of this Agreement.

     18.  Binding Effect; Assignment.  This Agreement shall be binding upon the
          --------------------------
parties hereto and their heirs, legal representatives, successors and assigns.
The rights and obligations of the Founders hereunder may not be assigned or
delegated without the written consent of the Corporation.

     19.  Notices.  All notices, requests, consents, deliveries and other
          -------
communications hereunder shall be in writing and shall be delivered in person or
duly sent by first class mail, postage prepaid, or by any internationally
recognized express courier service, to the Corporation at its principal place of
business, and to the Investors and the Founders at their respective last known
address or at their respective address, if any, appearing on the books of the
Corporation.

     20.  Severability.  If any provision of this Agreement shall be held to be
          ------------
illegal, invalid or unenforceable, such illegality, invalidity or
unenforceability shall attach only to such provision and shall not in any manner
affect or render illegal, invalid or unenforceable any other provision of this
Agreement, and this Agreement shall be carried out as if any such illegal,
invalid or unenforceable provision were not contained herein.

     21.  Governing Law.  This Agreement shall be governed by, and construed and
          -------------
enforced in accordance with, the substantive law of The Commonwealth of
Massachusetts, without regard to its principles of conflicts of laws.

     22.  Captions.  Captions are for convenience only and are not deemed to be
          --------
part of this Agreement.

     23.  Counterparts.  This Agreement may be executed in one or more
          ------------
counterparts, each of which shall be deemed an original and all of which
together shall constitute a single instrument.  Each such counterpart may
contain one or more signature pages.

                                      -7-
<PAGE>

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as a
contract under seal as of the day and year first above written.

                              SEQUENOM, INC.

                              By:  ______________________________________

                              FOUNDERS:

                              ___________________________________________
                              Hubert Koster

                              ___________________________________________
                              Nola E. Masterson

                              ___________________________________________
                              Robert E. Patterson

                                      -8-
<PAGE>

                                 SEQUENOM, INC.

                          Stock Restriction Agreement

                            Investor Signature Page
                            -----------------------

     By executing this page in the space provided, the undersigned hereby agrees
(i) that it is an "Investor" as defined in the Stock Restriction Agreement dated
as of _______, 1995, by and among Sequenom, Inc. and the parties named therein,
(ii) that it is a party to the Stock Restriction Agreement for all purposes and
(iii) that it is bound by all terms and conditions of the Stock Restriction
Agreement.

     EXECUTED this ____ day of __________, 1995.

                              ___________________________________________
                              (print name)

                              By:   _____________________________________

                              Title:  ___________________________________

                              Address:  _________________________________
<PAGE>

                                   Exhibit A
                                   ---------

                                 SEQUENOM, INC.

                          Stock Restriction Agreement

                       Additional Investor Signature Page
                       ----------------------------------

     By executing this page in the space provided, the undersigned hereby agrees
(i) that it is an "Additional Investor" as defined in the Series B Convertible
Preferred Stock Purchase Agreement dated as of December 22, 1995 and an
"Investor" as defined in the Stock Restriction Agreement dated as of __________
__, 1995, each by and among Sequenom, Inc. and the parties named therein, (ii)
that it is a party to the Stock Restriction Agreement for all purposes and (iii)
that it is bound by all terms and conditions of the Stock Restriction Agreement.

     EXECUTED this __ day of __________, 1995.

                              ___________________________________________
                              (print name)

                              By:  ______________________________________

                              Title:  ___________________________________

                              Address: __________________________________
<PAGE>

                                 EXHIBIT 4.16A
                                 -------------

                     Form of Registration Rights Agreement
                     -------------------------------------

<PAGE>

                         REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement is entered into as of December 22, 1995
by and among Sequenom, Inc., a Delaware corporation (the "Corporation"), and the
purchasers of shares of the Corporation's Series B Convertible Preferred Stock,
par value $.001 per share (the "Series B Preferred Stock"), pursuant to the
Series B Convertible Preferred Stock Purchase Agreement dated as of the date
hereof (the "Purchase Agreement"), including any Additional Investors as defined
in the Purchase Agreement (such purchasers of Series B Preferred Stock being
hereinafter sometimes referred to individually as an "Investor" and collectively
as the "Investors").

     WHEREAS, the Corporation has previously issued to certain of the Investors
certain shares of the Corporation's Series A Convertible Preferred Stock, $.001
par value per share (the "Series A Preferred Stock" and, together with the
Series B Preferred Stock, the "Preferred Stock");

     WHEREAS, the Corporation now wishes to sell to the Investors certain shares
of its Series B Preferred Stock;

     WHEREAS, the Preferred Stock is convertible into shares of the
Corporation's Common Stock, par value $.001 per share ("Common Stock"); and

     WHEREAS, as a condition to entering into the Purchase Agreement, the
Investors have required that the Corporation execute this Agreement to provide
the Investors rights to register the shares of Common Stock into which their
Preferred Stock is convertible;

     NOW, THEREFORE, in consideration of the premises and the mutual agreements
hereinafter set forth, the parties hereto agree as follows:

     1.   Definitions.  As used in this Agreement, the following terms shall
          -----------
have the following meanings:

          (a) The term "Act" means the Securities Act of 1933, as amended;

          (b) The term "Holder" means any Investor and any other person or
entity holding Registrable Securities to whom the registration rights granted in
this Agreement have been transferred pursuant to Section 14 hereof;

     (c) The terms "register," "registered," and "registration" refer to a
registration effected by preparing and filing a registration statement in
compliance with the Act and the declaration or ordering of effectiveness of such
registration statement; and

     (d) The term "Registrable Securities" means (1) the Common Stock issuable
upon conversion of the Preferred Stock, (2) Common Stock purchased by an
Investor pursuant to Section 8.1 of the Purchase Agreement (or Common Stock for
or into which New Securities
<PAGE>

(as therein defined) purchased by the Investor pursuant to such Section 8.1 may
be exercised or converted) or pursuant to the Stock Restriction Agreement
referred to in Section 6.6 of the Purchase Agreement, and (3) any Common Stock
of the Corporation issued as a dividend or other distribution with respect to,
or in exchange or in replacement of, such Preferred Stock or Common Stock.

     In addition, for purposes of all calculations and notices under this
Agreement, and all other provisions of this Agreement where the context permits,
the term "Registrable Securities" shall include securities issuable upon
conversion of the Preferred Stock, a holder of the Preferred Stock shall be
deemed the Holder of such securities and such securities shall be deemed
outstanding Registrable Securities hereunder.  Notwithstanding the foregoing,
nothing in this Agreement shall require the Corporation actually to register any
shares of the Preferred Stock.

     2.   Request for Registration.  If at any time after the earlier of (i) the
          ------------------------
first underwritten public offering of securities for the account of the
Corporation, and (ii) the date three (3) years from the date hereof, the
Corporation shall receive a written request (specifying that it is being made
pursuant to this Section 2) from the Holder or Holders at least fifty percent
(50%) of the then outstanding Registrable Securities that the Corporation file a
registration statement under the Act, or a similar document pursuant to any
other statute then in effect corresponding to the Act, covering the registration
of at least the lesser of (i) at least twenty-five percent (25%) of the then
outstanding Registrable Securities and (ii) Registrable Securities the expected
price to the public of which equals or exceeds $10,000,000, then the Corporation
shall promptly notify all other Holders of such request and shall use its best
efforts to cause all Registrable Securities that Holders have requested be
registered to be registered under the Act.

     Notwithstanding the foregoing, (a) the Corporation shall not be obligated
to effect a registration pursuant to this Section 2 during the period starting
with the date sixty (60) days prior to the Corporation's estimated date of
filing of, and ending on a date six (6) months following the effective date of,
a registration statement pertaining to an underwritten public offering of
securities for the account of the Corporation, provided that the Corporation is
actively employing in good faith its best efforts to cause such registration
statement to become effective and that the Corporation's estimate of the date of
filing such registration statement is made in good faith; (b) the Corporation
shall not be obligated to effect a registration pursuant to this Section 2
within six (6) months after the effective-date of a prior registration under
such Section; (c) if the Corporation shall furnish to the Holders a certificate
signed by the President of the Corporation stating that in the good faith
judgment of the Board of Directors it would be seriously detrimental to the
Corporation or its shareholders for a registration statement to be filed in the
near future, then the Corporation's obligation to use its best efforts to file a
registration statement shall be deferred for a period not to exceed three (3)
months; and (d) the Corporation may postpone a registration pursuant to this
election for such period of time as may be required to permit the use of regular
audited year-end financial statements with supplemental short period figures for
a period not exceeding six (6) months unless the Holders agree to bear the costs
of any special audit.

                                      -2-
<PAGE>

     The Corporation shall not be obligated to effect more than two (2)
registrations pursuant to this Section 2.  Any request for registration under
this Section 2 must be for a firm commitment underwritten public offering to be
managed by an underwriter or underwriters of recognized national standing
reasonably acceptable to the Corporation.

     3.   Corporation Registration.  Subject to Section 8 of this Agreement, if
          ------------------------
at any time the Corporation proposes to register any of its Common Stock under
the Act in connection with the public offering of such securities for its own
account or for the accounts of other shareholders, solely for cash on a form
that would also permit the registration of the Registrable Securities, the
Corporation shall, each such time, promptly give each Holder written notice of
such determination. Upon the written request of any Holder given within thirty
(30) days after mailing of any such notice by the Corporation, the Corporation
shall, subject to the limitations set forth in Section 8(a), use its best
efforts to cause to be registered under the Act all of the Registrable
Securities that each such Holder has requested be registered.

     4.   Obligations of the Corporation.  Whenever required under
          ------------------------------
Section 2, 3, or 11 to use its best efforts to effect the registration of any
Registrable Securities, the Corporation shall, as expeditiously as reasonably
possible:

     (a)  Prepare and file with the Securities and Exchange Commission ("SEC") a
registration statement with respect to such Registrable Securities and use its
best efforts to cause such registration statement to become and remain
effective; provided, however, that in connection with any proposed registration
intended to permit an offering of any securities from time to time (i.e., a so-
called "shelf registration the Corporation shall in no event be obligated to
cause any such registration to remain effective for more than one hundred eighty
(180) days.

     (b)  Prepare and file with the SEC such amendments and supplements to such
registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
Act with respect to the disposition of all securities covered by such
registration statement.

     (c)  Furnish to the Holders such numbers of copies of a prospectus,
including a preliminary prospectus, in conformity with the requirements of the
Act, and such other documents as they may reasonably request in order to
facilitate the disposition of Registrable Securities owned by them.

     (d)  Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or Blue Sky laws of such
jurisdictions as shall be reasonably appropriate for the distribution of the
securities covered by the registration statement, provided that the Corporation
shall not be required in connection therewith or as a condition thereto to
qualify to do business or to file a general consent to service of process in any
such states or jurisdictions, and further provided that (anything in this
Agreement to the contrary notwithstanding with respect to the bearing of
expenses) if any jurisdiction in which the securities shall be qualified shall
require that expenses incurred in connection with the qualification of the
securities in that jurisdiction be borne by selling shareholders, then such

                                      -3-
<PAGE>

expenses shall be payable by selling shareholders pro rata, to the extent
required by such jurisdiction.

     (e)  Provide a transfer agent for the Common Stock no later than the
effective date of the first registration of any Registrable Securities.

     5.   Furnish Information.  It shall be a condition precedent to the
          -------------------
obligations of the Corporation to take any action pursuant to this Agreement
that the Holders shall furnish to the Corporation such information regarding
them, the Registrable Securities held by them, and the intended method of
disposition of such securities as the Corporation shall reasonably request and
as shall be required in connection with the action to be taken by the
Corporation.

     6.   Expenses of Demand Registration.  All expenses incurred in connection
          -------------------------------
with registrations pursuant to Section 2 (excluding underwriters, discounts and
commissions), including, without limitation, all registration and qualification
fees, printers, and accounting fees, fees and disbursements of counsel for the
Corporation, and the reasonable fees and disbursements of one special counsel
for the selling Holders, shall be borne by the corporation.

     7.   Corporation Registration Expenses.  All expenses (excluding
          ---------------------------------
underwriters, discounts and commissions) incurred in connection with a
registration pursuant to Section 3 (other than a registration on Form S-3 filed
pursuant to Section 11), including, without limitation, any additional
registration and qualification fees and any additional fees and disbursements of
counsel to the Corporation that result from the inclusion of securities held by
the Holders in such registration and the reasonable fees and disbursements of
one special counsel for the selling stockholders, shall be borne by the
Corporation; provided, however, that if the registration is of exclusively a
secondary offering, the holders shall bear their proportionate share of the
expenses incurred in connection with any registration (provided all shareholders
registering shares thereunder bear their proportionate share of expenses),
except expenses which the Corporation would have incurred whether or not the
securities held by the Holders were included in such registration (including,
without limitation, the expense of preparing normal audited or unaudited
financial statements).

     8.   Underwriting Requirements.
          -------------------------

     (a)  In connection with any offering involving an underwriting of shares
being issued by the Corporation, the Corporation shall not be required under
Section 3 to include any of the Holders' Registrable Securities in such
underwriting unless they accept the terms of the underwriting as agreed upon
between the Corporation and the underwriters selected by it, and then only in
such quantity as will not, in the reasonable opinion of the underwriters,
jeopardize the success of the offering by the Corporation.  If the total amount
of securities that all Holders request to be included in an underwritten
offering exceeds the amount of securities that the underwriters reasonably
believe compatible with the success of the offering, the Corporation shall only
be required to include in the offering so many of the securities of the selling
Holders as the underwriters reasonably believe will not jeopardize the success
of the offering (the securities so included to be apportioned pro rata among the
selling Holders according to the total amount of securities owned by said
selling Holders, or in such other proportions as shall

                                      -4-
<PAGE>

mutually be agreed to by such selling Holders), provided that in the case of an
offering involving shares being issued by the Corporation, no such reduction
shall be made with respect to any securities offered by the Corporation for its
own account, and provided further that no securities of any shareholder who is
not a Holder shall be included in such offering, other than securities of
shareholders who have initiated such registration pursuant to the exercise of
contractual rights to do so, unless all securities which the Holders have
requested to be included are included on a pro rata basis with the securities of
any other shareholders who have a contractual right to include their securities
in such offering.

     (b)  With respect to any underwriting of shares to be registered under
Section 2, or an underwriting of shares to be registered under Section 11 if the
Holders of a majority of the then outstanding Registrable Securities have
requested registration thereunder, such Holders shall have the right to
designate the managing underwriter or underwriters, subject to the consent of
the Corporation.  In all other circumstances under such Sections and in
connection with registrations under Section 3, the Corporation shall have the
right to designate the managing underwriter or underwriters; subject to the
consent of the Holders of a majority of the Registrable Securities participating
in the underwriting.  In any such case, such consent shall not be unreasonably
withheld or delayed.

     9.   Delay of Registration.  No Holder shall have any right to take any
          ---------------------
action to restrain, enjoin, or otherwise delay any registration as the result of
any controversy that might arise with respect to the interpretation or
implementation of this Agreement.

     10.  Indemnification.  In the event any Registrable securities are included
          ---------------
in a registration statement under this Agreement:

     (a)  To the extent permitted by law, the Corporation will indemnify and
hold harmless each Holder requesting or joining in a registration, any
underwriter (as defined in the Act) for it, and each person, if any, who
controls such Holder or underwriter within the meaning of the Act, against any
losses, claims, damages or liabilities, joint or several, to which they may
become subject under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
on any untrue or alleged untrue statement of any material fact contained in such
registration statement, including, without limitation, any preliminary
prospectus or final prospectus contained therein or any amendments or
supplements thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein, or
necessary to make the statements therein not misleading or arise out of any
violation by the Corporation of any rule or regulation promulgated under the Act
applicable to the Corporation and relating to action or inaction required of the
Corporation in connection with any such registration; and will reimburse each
such Holder, such underwriter, or controlling person for any legal or other
expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability, or action, provided, however,
that the indemnity agreement contained in this Section 10(a) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the corporation (which
consent shall not be unreasonably withheld or delayed) nor shall the Corporation
be liable in any such case for any such loss, claim, damage, liability or action
to the extent that it arises out of or is based upon an

                                      -5-
<PAGE>

untrue statement or alleged untrue statement or omission or alleged omission
made in connection with such registration statement, preliminary prospectus,
final prospectus, or amendments or supplements thereto, in reliance upon and in
conformity with written information furnished expressly for use in connection
with such registration by any such Holder, underwriter or controlling person.

     (b)  To the extent permitted by law, each Holder requesting or joining in a
registration will indemnify and hold harmless the Corporation, each of its
directors, each of its officers who has signed the registration statement, each
person, if any, who controls the Corporation within the meaning of the Act, and
any underwriter for the Corporation (within the meaning of the Act) against any
losses, claims, damages or liabilities to which the corporation or any such
director, officer, controlling person or underwriter may become subject, under
the Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereto) arise out of or are based upon any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading,
in each case to the extent, but only to the extent, that such untrue statement
or alleged untrue statement or omission or alleged omission was made in such
registration statement, preliminary prospectus or final prospectus, or
amendments or supplements thereto, in reliance upon and in conformity with
written information furnished by such Holder expressly for use in connection
with such registration; and will reimburse the Corporation or any such director,
officer, controlling person or underwriter for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any
such loss, claim, damage, liability or action; provided, however, that the
indemnity agreement contained in this Section 10(b) shall not apply to amounts
paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of such Holder (which consent shall
not be unreasonably withheld) and provided further that no Holder shall have any
liability under this Section 10(b) in excess of the net proceeds actually
received by such Holder in the relevant public offering.

     (c)  Promptly after receipt by an indemnified party under this Section 10
of notice of the commencement of any action, such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this
Section 10, notify the indemnifying party in writing of the commencement thereof
and the indemnifying party shall have the right to participate in, and, to the
extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties. The failure to notify an indemnifying party
promptly, of the commencement of any such action, if prejudicial to his ability
to defend such action, shall relieve such indemnifying party of any liability to
the indemnified party under this Section 10, but the omission so to notify the
indemnifying party will not relieve him of any liability that he may have to any
indemnified party otherwise than under this Section 10.

                                      -6-
<PAGE>

     11.  Registrations on Form S-3.
          -------------------------

     (a)  If (i) the Corporation shall receive a written request (specifying
that it is being made pursuant to this Section 11) from the Holder or Holders of
at least twenty-five percent (25%) of the then outstanding Registrable
Securities that the Corporation file a registration statement on Form S-3 (or
any successor form to Form S-3 regardless of its designation) for a public
offering of shares of the Registrable Securities the reasonably anticipated
aggregate price to the public of which would exceed Two Million Dollars
($2,000,000), and (ii) the corporation is a registrant entitled to use Form S-3
to register such shares, then the Corporation shall use its best efforts to
cause such shares to be registered on Form S-3 (or any successor form to Form
S-3).

     (b)  All expenses (excluding underwriters' discounts and commissions)
incurred in connection with the first two registrations requested pursuant to
Section 11(a), including, without limitation, all registration, qualification,
printing, and accounting fees, and fees and disbursements of one special counsel
to the selling Holder or Holders and counsel to the Corporation, shall be borne
by the Corporation.  All such expenses for registrations pursuant to Section
11(a) after the first two such registrations shall be borne by the Corporation,
except that the selling Holders shall pay all fees of their legal counsel, if
any, in connection therewith.

     (c)  Holders' rights to registration under this Section 11 are in addition
to, and not in lieu of, their rights to registration under Sections 2 and 3 of
this Agreement.

     12.  Reports Under Securities Exchange Act of 1934.  With a view to making
          ---------------------------------------------
available to the Holders the benefits of Rule 144 promulgated under the Act and
any other rule or regulation of the SEC that may at any time permit a Holder to
sell securities of the Corporation to the public without registration, the
corporation agrees to use its best efforts to:

     (a)  make and keep public information available, as those terms are
understood and defined in Rule 144, at all times subsequent to ninety (90) days
after the effective date of the first registration statement covering an
underwritten public offering filed by the Corporation;

     (b)  file with the SEC in a timely manner all reports and other documents
required of the Corporation under the Act and the Securities Exchange Act of
1934, as amended (the "1934 Act"); and

     (c)  furnish to any Holder forthwith upon request a written statement by
the Corporation that it has complied with the reporting requirements of Rule 144
(at any time after ninety (90) days after the effective date of said first
registration statement filed by the Corporation), and of the Act and the 1934
Act (at any time after it has become subject to such reporting requirements), a
copy of the most recent annual or quarterly report of the Corporation, and such
other reports and documents so filed by the Corporation as may be reasonably
requested in availing any such holder to take advantage of any rule or
regulation of the SEC permitting the selling of any such securities without
registration.

                                      -7-
<PAGE>

     13.  Limitations in Connection with Future Grants of Registration Rights.
          -------------------------------------------------------------------
Without the prior written consent of the Holder or Holders of a majority of the
then outstanding Registrable Securities issued or issuable upon conversion of
the Series B Preferred Stock, the Corporation shall not grant rights to cause
the Corporation to register any of its securities to any person or entity.

     14.  Transfer of Registration Rights.  The registration rights of any
          -------------------------------
Investor (and of any permitted transferee of any Investor or its permitted
transferees) under this Agreement with respect to any shares of Registrable
Securities may be transferred to any Affiliate of such Investor or such
permitted transferee, or to any transferee who acquires (otherwise than in a
registered public offering) at least five percent (5%) of the Registrable
Securities held or acquired as of the date hereof by such Investor, provided,
however, that the Corporation is given written notice by the Holder at the time
of such transfer stating the name and address of the transferee and identifying
the securities with respect to which the rights under this Agreement are being
assigned. For such purpose, an "Affiliate" of any Investor (or any such
transferee) means any partner of such Investor (or transferee) if it is a
partnership, or any person or entity that, directly or indirectly, through one
or more intermediaries, controls or is controlled by, or is under common control
with, such Investor or transferee.

     15.  Mergers, Etc.  The Corporation shall not, directly or indirectly,
          ------------
enter into any merger, consolidation or reorganization in which the Corporation
shall not be the surviving corporation unless the proposed surviving corporation
shall, prior to such merger, consolidation or reorganization, agree in writing
to assume the obligations of the Corporation under this Agreement, and for that
purpose references hereunder to "Registrable Securities" shall be deemed to be
references to the securities which the Holders would be entitled to receive in
exchange for Registrable Securities under any such merger, consolidation or
reorganization; provided, however, that the provisions of this Agreement shall
not apply in the event of any merger, consolidation or reorganization in which
the Corporation is not the surviving corporation if the Holders of Registrable
Securities are entitled to receive in exchange therefor (i) cash, or (ii)
securities of the acquiring corporation which may be immediately sold to the
public without registration under the Act.

     16.  Accession.  Any Additional Investors as defined in the Purchase
          ---------
Agreement shall automatically become an Investor hereunder by delivering to the
Corporation a written instrument in the form of Exhibit A hereto, by which such
                                                ---------
Additional Investor agrees to be bound by the obligations imposed under this
Agreement, whereupon such Additional Investor shall automatically become a party
to this Agreement and shall thereupon be deemed an "Investor" for all purposes
of this Agreement.

     17.  Notices.  All notices, requests, consents and other communications
          -------
hereunder to any party shall be deemed to be sufficient if contained in a
written instrument delivered in person or duly sent by first class mail, postage
prepaid, or by any internationally recognized courier service, addressed to such
party at the address set forth below or such other address as may hereafter be
designated in writing by the addressee to the addressor listing all parties:

                                      -8-
<PAGE>

          (i)  if to the Corporation, to:

               Sequenom, Inc.
               c/o TVM Techno Venture Management
               101 Arch Street
               Suite 1950
               Boston, MA 02110
               Attention: President

               with a copy to:

               David R. Pierson, Esq.
               Foley, Hoag & Eliot
               One Post office Square
               Boston, Massachusetts 02109

          (ii) if to the Investors (or their transferees), to their respective
               last known address or their respective address, if any, appearing
               in the books of the Corporation.

     18.  Miscellaneous.
          -------------

     (a)  This Agreement states the entire agreement of the parties concerning
the subject matter hereof, and supersedes all prior agreements, written or oral,
between or among them concerning such subject matter.

     (b)  This Agreement may be amended, and compliance with any provision of
this Agreement may be omitted or waived, only by the written agreement of the
Corporation and the Holders of at least eighty-five percent (85%) in voting
power of the then outstanding Registrable Securities issued or issuable upon
conversion of the Series B Preferred Stock to be bound thereby.

     (c)  This Agreement shall be governed by, and construed and enforced in
accordance with, the substantive laws of The Commonwealth of Massachusetts,
without regard to its principles of conflicts of laws.

     (d)  This Agreement may be executed in any number of counterparts, each
such counterpart shall be deemed to be an original instrument, and all such
counterparts together shall constitute but one agreement. Any such counterpart
may contain one or more signature pages.

                                      -9-
<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement as a contract
under seal as of the date first written above.

                                   SEQUENOM, INC.

                                   By:  ________________________________________

                                     -10-
<PAGE>

                                SEQUENOM, INC.

                         Registration Rights Agreement

                            Investor Signature Page
                            -----------------------

     By executing this page in the space provided, the undersigned hereby agrees
(i) that it is an "Investor" as defined in the Registration Rights Agreement
dated as of __________ __, 1995, by and among Sequenom, Inc. and the parties
named therein, (ii) that it is a party to the Registration Rights Agreement for
all purposes and (iii) that it is bound by all terms and conditions of the
Registration Rights Agreement.

     EXECUTED this __ day of __________, 1995.

                                        ________________________________________
                                        (print name)

                                        By:    _________________________________

                                        Title: _________________________________

                                        Address: _______________________________
<PAGE>

                                 EXHIBIT 4.16B
                                 -------------

                           Form of Voting Agreement
                           ------------------------

<PAGE>

                                VOTING AGREEMENT

     Agreement made as of December 22, 1995 by and among Sequenom, Inc., a
Delaware corporation (the "Corporation"); Hubert Koster, Nola E. Masterson and
Robert E. Patterson (the "Founders"); TVM Techno Venture Enterprises No. II
Limited Partnership, TVM Intertech Limited Partnership TVM Zweite Beteiligung-
U.S. Limited Partnership, TVM Eurotech Limited Partnership, TVM Techno Venture
Investors No. 1 Limited Partnership and *** (the "Original Investors"); the
purchasers of shares of the Corporation's Series B Convertible Preferred Stock,
$.001 par value per share ("Series B Preferred Stock"), pursuant to the Series B
Convertible Preferred Stock Purchase Agreement dated as of the date hereof (the
"Purchase Agreement"), including Boston University Nominee Partnership ("BU")
and any Additional Investors as defined in the Purchase Agreement (all such
purchasers of Series B Preferred Stock under the Purchase Agreement being
referred to as the "Investors," and all such Founders, Original Investors and
Investors being referred to as the "Stockholders").

                                   AGREEMENT
                                   ---------

     In consideration of the mutual covenants herein contained, the parties
hereto agree as follows:

     1.   Board of Directors.  The Stockholders agree to vote all shares of the
          ------------------
Corporation's Common Stock, $.001 par value per share ("Common Stock"), Series A
Convertible Preferred Stock, $.001 par value per share ("Series A Preferred
Stock"), Series B Preferred Stock and any other class of voting security of the
Corporation (the "Shares") now or hereafter owned or controlled by them, and
otherwise to use their respective best efforts as stockholders of the
Corporation, to set the number of directors of the Corporation at seven and to
elect as directors, on the date of this Agreement and in any subsequent election
of directors of the Corporation: the Chief Executive Officer of the Corporation,
who shall initially be Randall R. Lunn; one person designated by the Founders,
who shall initially be Hubert Koster; one person designated by the Original
Investors, who shall initially be Helmut Schuhsler; one person designated by BU,
who shall initially be William Golden; one person designated by the Investors,
who shall be designated and elected after the date of this Agreement; and two
persons who are not employees of the Corporation, who have experience in the
Corporation's industry and who are reasonably acceptable to a majority of the
other directors, and who shall initially be Nola E. Masterson and Ernst Gunter
Afting.

     Any party or parties making director designations (a "Designating Party")
shall furnish written notice to the other parties at least 10 days prior to any
election of directors of their director-designee or director-designees.  In the
absence of such notice, the director-designee or director-designees of such
Designating Party then serving and previously designated shall be reelected if
still eligible to, serve as provided herein.  No party hereto shall vote to
remove any member of the Board of Directors designated in accordance with the
aforesaid procedure unless the Designating Party who designated such director so
votes, and if such Designating party so votes then the other parties shall
likewise so vote.

     Any vacancy on the Board of Directors created by the resignation, removal,
incapacity, or death of any person designated under this Section 1 shall be
filled by another person designated

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

<PAGE>

by the original Designating Party. The Stockholders shall vote their respective
Shares in accordance with such new designation, and any such vacancy shall not
be filled in the absence of a new designation by the original Designating Party.

     This Section 1 shall terminate and be of no further force and effect upon
the closing of a firm commitment underwritten public offering of Common Stock of
the Corporation pursuant to an effective registration statement under the
Securities Act of 1933, as amended, in which the aggregate gross proceeds to the
Corporation from such offering are not less than $10,000,000 and the offering
price per share is not less than $4.50, appropriately adjusted to take account
of any stock split, stock dividend, combination of shares or similar event.

     In the event that any Designating Party (or its or their respective
partners, stockholders and affiliates) owns, in the aggregate, fewer than
200,000 shares of the Corporation's Common Stock, subject to adjustment for
stock splits, stock dividends, combinations of shares and similar events, such
Designating Party's right to make designations under this Section 1 shall
terminate, and the obligation of the other parties under this Section 1 to vote
for any members of the Board of Directors designated by such Designating Party
shall terminate, but all other obligations of all parties hereunder shall
continue unless otherwise terminated.  For purposes of this paragraph, in
determining the number of shares of Common Stock owned by a Designating Party,
ownership by such Designating Party of shares of Series A Preferred Stock and
Series B Preferred Stock shall be deemed to be ownership by it of that number of
shares of Common Stock into which such shares of Series B Preferred Stock are
convertible.

     In the event that any group of Stockholders constituting a Designating
Party cannot agree upon a director-designee, the identity of the director-
designee of such Designating Party shall be determined by a plurality in voting
power of the outstanding capital stock of the Corporation held by such
Stockholders.

     In the event that BU shall fail to participate in any future equity
financing for the Corporation for its full pro rata share of the portion of such
financing purchased by the then-existing institutional investors in the
Corporation, (i) BU's right to make designations under this Section 1 shall-
terminate, and the obligation of the other parties under this Section 1 to vote
for any member of the Board of Directors designated by BU shall terminate, but
all other rights and obligations of all parties hereunder, including the right
of BU to participate as an Investor in the designation of any person to the
Board of Directors, shall continue unless otherwise terminated; and (ii)
thereafter the Investors shall have the right to designate two persons for
election to the Board of Directors.

     2.   Director Indemnification.  In the event that any director contemplated
          ------------------------
by this Agreement shall be made or threatened to be made a party to any action,
suit or proceeding with respect to which he may be entitled to indemnification
by the Corporation pursuant to its Certificate of Incorporation, By-Laws or
otherwise, he shall be entitled to be represented in such action, suit or
proceeding by counsel of his choice and the expenses of such representation
shall be reimbursed by the Corporation to the extent provided in or authorized
by said Certificate of Incorporation or other provision and permitted by
applicable law.

                                      -2-
<PAGE>

     The Corporation and the Stockholders agree not to take any action to amend
any provision of the Certificate of Incorporation or By-Laws of the Corporation
relating to indemnification of directors, as presently in effect, without the
prior written consent of a majority in voting power of the Investors.

     3.   Accession.  Any Additional Investors as defined in the Purchase
          ---------
Agreement shall automatically become an Investor hereunder by delivering to the
Corporation a written instrument in the form of Exhibit A hereto, by which such
                                                ---------
Additional Investor agrees to be bound by the obligations imposed under this
Agreement, whereupon such Additional Investor shall automatically become a party
to this Agreement and shall thereupon be deemed an "Investor" and a
"Stockholder" for all purposes of this Agreement.

          4.   Notices.  All notices, requests, consents and other
               -------
communications hereunder to any party shall be deemed to be sufficient if
contained in a written instrument delivered in person or duly sent by first
class mail, postage prepaid, or by any internationally recognized express
courier service, addressed to such party at the address set forth below or such
other address as may hereafter be designated in writing by the addressee to the
addressor listing all parties:

          (i)  if to the Corporation, to:

               Sequenom, Inc.
               c/o TVM Techno Venture Management
               101 Arch Street
               Suite 1950
               Boston, MA 02110
               Attention: President

               with a copy to:

               David R. Pierson, Esq.
               Foley, Hoag & Eliot
               One Post office Square
               Boston, Massachusetts 02109

          (ii) if to the Stockholders, to their respective last known address or
               their respective address, if any, appearing in the books of the
               Corporation.

     5.   Assignment; Binding Effect.  No Designating Party may assign its or
          --------------------------
their rights hereunder. Subject to termination or partial termination as
provided in Section 1, this Agreement shall be binding on the parties hereto and
their respective legal representatives, successors and permitted assigns and on
the transferees of any Shares now owned or hereafter acquired by them.

     6.   Entire Agreement; Amendment and Waiver.  This Agreement contains the
          --------------------------------------
sole and entire understanding of the parties with respect to its subject matter
and supersedes all prior negotiations, commitments, agreements and
understandings heretofore had among any of them with respect thereto. Without
limiting the generality of the foregoing, this Agreement supersedes

                                      -3-
<PAGE>

and replaces the Voting Agreement among the Founders and the Original Investors
dated May 26, 1994, which shall no longer have any force or effect. This
Agreement may not be changed or terminated or any performance or condition
waived, in whole or in part, except by the written agreement of the Corporation
and Stockholders or transferees of their rights hereunder holding two-thirds in
voting power of the Shares held by the Founders, two-thirds in voting power of
the Shares held by the Original Investors, eighty-five percent (85%) in voting
power of the Shares held by the Investors, and two-thirds in voting power of the
Shares held by the Stockholders or such transferees. A waiver on one occasion
shall not constitute a waiver on any further occasion.

     7.   Counterparts.  This Agreement may be executed in more than one
          ------------
counterpart, each of which shall be deemed to be an original and which,
together, shall constitute one and the same instrument. Any such counterpart may
contain one or more signature pages.

     8.   Applicable Law.  This Agreement shall be governed by, and construed
          --------------
and enforced in accordance with, the substantive laws of The Commonwealth of
Massachusetts, without regard to its principles of conflicts of laws.

     9.   Legend.  Each certificate for Shares shall bear a legend stating in
          ------
substance as follows, and each of the Stockholders shall cause its certificates
to be so legended promptly after the execution and delivery of this Agreement:

     The shares of stock represented by this certificate are subject to the
     terms and provisions of a Voting Agreement dated December 22, 1995 among
     the Corporation and certain stockholders of the Corporation.  The
     Corporation will furnish a copy of the Voting Agreement to the holder
     hereof upon written request and without charge.

                                    *  *  *

                                      -4-
<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Agreement as a
contract under seal as of the date-first written above.

                              SEQUENOM, INC.

                              By:___________________________________

                              FOUNDERS:

                              ______________________________________
                              Hubert Koster

                              ______________________________________
                              Nola E. Masterson

                              ______________________________________
                              Robert E. Patterson

                              ORIGINAL INVESTORS:

                              TVM Techno Venture Enterprises
                              No. II Limited Partnership

                              By:___________________________________

                              TVM Intertech Limited Partnership

                              By:___________________________________

                              TVM Zweite  Beteiligung-U.S.
                              Limited Partnership

                              By:___________________________________
<PAGE>

                              TVM Eurotech Limited Partnership

                              By:___________________________________

                              TVM Techno Venture Investors
                              No. 1 Limited Partnership

                              By:___________________________________

                              KBL Founder Ventures SCA

                              By:___________________________________
<PAGE>

                                 SEQUENOM, INC.

                          Stock Restriction Agreement

                            Investor Signature Page
                            -----------------------

     By executing this page in the space provided, the undersigned hereby agrees
(i) that it is an "Investor" as defined in the Stock Restriction Agreement dated
as of December 22, 1995, by and among Sequenom, Inc. and the parties named
therein, (ii) that it is a party to the Stock Restriction Agreement for all
purposes and (iii) that it is bound by all terms and conditions of the Stock
Restriction Agreement.

     EXECUTED this ___ day of ___________, 1995.

                              ______________________________________
                              (print name)

                              By:   ________________________________

                              Title:  ______________________________

                              Address:  ____________________________
<PAGE>

                                                                       Exhibit A
                                                                       ---------

                                 SEQUENOM, INC.

                                Voting Agreement

                       Additional Investor Signature Page
                       ----------------------------------

          By executing this page in the space provided, the undersigned hereby
agrees (i) that it is an "Additional Investor", as defined in the Series B
Convertible Preferred Stock Purchase Agreement dated as of ____________ ___,
1995, and an "Investor" and a "Stockholder" as defined in the Voting Agreement
dated as of ____________ ___, 1995, each by and among Sequenom, Inc. and the
parties named therein, (ii) that it is a party to the Voting Agreement for all
purposes and (iii) that it is bound by all terms and conditions of the Voting
Agreement.

          EXECUTED this _____ day of _____________, 1995.

                              ______________________________________
                              (print name)

                              By:___________________________________

                              Title:________________________________

                              Address:______________________________
<PAGE>

                                  EXHIBIT 4.19
                                  ------------

                              Related Transactions
                              --------------------

          Loan from the Corporation to Nola Masterson, a director, in the
outstanding principal amount of $8,800.
<PAGE>

                                  EXHIBIT 4.20
                                  ------------

                             Governmental Consents
                             ---------------------

None.
<PAGE>

                                 EXHIBIT 4.23
                                 ------------

                      Commitments from German Government
                      ----------------------------------

See attachment hereto.
<PAGE>

Sequenom, Inc. (the "Inc.") and Sequenom Instruments GmbH (the "GmbH")

Description of agreements with Technologie-Beteiligungs-Gesellschaft m.b.H. der
Deutschen Ausgleichsbank ("TBG")

1.   The May 1995 "BJTU" Agreement
     -----------------------------

The TBG has provided DM 1 million silent partnership financing to the GmbH,
which matches DM 1 million of capital invested in the GmbH by the Inc. The terms
of the silent partnership arrangement are as follows:

Interest rate of 6% on the principal amount of the silent partnership loan.

Interest payable beginning June 30, 1997.

Additional compensation as follows:
     9% of any annual profits, beginning with fiscal year 1997, if the profits
     exceed DM 100,000, up to a maximum compensation amount of 6% of the silent
     partnership loan.

Principal payment due on December 31, 2005

This agreement has no "downside protection" which is contained in the 1995
agreement.

2.   The December 1995 "BJTU" Agreement
     ----------------------------------

The TBG has committed to provide up to DM 3 million silent partnership financing
to the GmbH, which will match up to DM 3 million of capital invested in the GmbH
by the Inc.  To date the TBG has matched DM 250,000 of capital which has been
invested by the Inc.

The terms of the silent partnership arrangement are as follows:

Interest rate of 6% on the principal amount of the silent partnership loan.

Interest payable beginning June 30, 1997.

Additional compensation as follows:
     9% of any annual profits, beginning with fiscal year 1997 if the profits
     exceed DM 100,000, up to a maximum compensation amount of 6% of the silent
     partnership loan.

Principal payment due on December 31, 2005

This agreement also contains a "50% downside protection" for the investors in
the Inc. as follows: Under certain circumstances, if the Inc. exercises its "put
option" to the TBG of its equity interest in the GmbH, the TBG will pay to the
Inc. 50% of the amount of the silent partnership.
<PAGE>

Description of the grant programs for which Sequenom Instruments GmbH has
received approvals:

1.   Grant from the "Biotechnology 2000" grant scheme from the Ministry of
     Research and Technology ("BMBF"):

     The BMBF has approved a grant (which is a non-repayable contribution) in
     the amount of DM 2.2 million based on the application for the financing of
     a total research and development project of DM 4.4 million. The grant
     coverage is therefore 50% of total estimated project cost. The company will
     call the money quarterly in arrears based on actual cost attributable to
     the project. The project started on September 1, 1995 and has a duration of
     three years.

2.   Grant from Freie und Hansestadt Hamburg, (City of Hamburg):

     The City of Hamburg has approved a grant of DM 800,000 based on a list of
     equipment for Sequenom's laboratory to be purchased after September 1,
     1995. Total expected cash outflows for the equipment purchases is DM 1.6.
     million. Grant coverage is also 50% of estimated cost.

Both grants do not have to be repaid.
<PAGE>

                                  EXHIBIT 6.5
                                  -----------

                   Form of opinion of Counsel to Corporation
                   -----------------------------------------
<PAGE>

                      [LETTERHEAD OF FOLEY, HOAG & ELIOT]

                               December 22, 1995

To the Persons listed in the Schedule
of Investors to the Series B
Convertible Preferred Stock Purchase
Agreement dated as of December 22, 1995

Gentlemen:

     We are counsel to Sequenom, Inc., a Delaware corporation (the
"Corporation").  This opinion is rendered to you pursuant to Section 6.5 of the
Series B Convertible Preferred Stock Purchase Agreement (including the exhibits
thereto, the "Agreement") dated as of December 22, 1995, among the Corporation
and each of you relating to the issuance and sale by the Corporation to you of
2,333,333 shares (the "Initial Shares") of its Series B Convertible Preferred
Stock, par value $.001 per share (the "Transaction").  Capitalized terms used
herein and not otherwise defined herein shall have the meanings assigned to such
terms in the Agreement.

     In connection with our rendering this opinion, we have reviewed (i) the
Certificate of Incorporation and By-Laws of the Corporation, each as amended to
date; (ii) a certificate issued by the Secretary of State of the State of
Delaware on December 15, 1995, with respect to the due incorporation, legal
existence and good standing of the Corporation in the State of Delaware (the
"Legal Existence Certificate"); (iii) a certificate issued by the Secretary of
State of The Commonwealth of Massachusetts on December 15, 1995, with respect to
the qualification of the Corporation to do business in Massachusetts (the
"Foreign Qualification Certificate"); (iv) counterparts of the Agreement and the
related Registration Rights Agreement of even date herewith (the "Registration
Rights Agreement"); and (v) originals or copies, certified or otherwise,
identified to our satisfaction, of such other documents, certificates,
instruments and corporate records that we considered necessary for the purposes
of this opinion.

     In rendering the opinion expressed herein, we have also examined and have
relied completely as to matters of fact upon the representations and warranties
made by the Corporation and each of you in the Agreement, the Registration
Rights Agreement and the other agreements, instruments and documents delivered
in connection with the Initial Closing; and we have assumed the completeness and
accuracy of all factual matters described in such representations and
warranties.

     We have not, except as specifically noted above, made any independent
review or investigation of facts relating to the Corporation, including but
without limiting the generality of the foregoing, any investigation as to the
existence of any actions, suits or proceedings pending or threatened against the
Corporation or notes, indentures, mortgages, leases, contracts, instruments,
documents, agreements, judgments, injunctions, orders, writs or decrees to which

<PAGE>

To the Persons listed in the Schedule
of Investors to the Series B
Convertible Preferred Stock Purchase
Agreement dated as of December 22, 1995

the Corporation is a party, which are binding upon the Corporation or which
might result in the imposition of any lien or other encumbrance on any asset of
the Corporation.

     We have assumed the authenticity and completeness of all documents
furnished to us as originals, the genuineness of all signatures, the legal
capacity of natural persons, and the conformity to the originals of all
documents furnished to us as copies.

     In rendering the opinions expressed in paragraph 1 below with respect to
the due incorporation, legal existence and good standing of the Corporation in
Delaware and in paragraph 2 below with respect to the qualification of the
Corporation to do business in The Commonwealth of Massachusetts, we have relied
solely on the Legal Existence Certificate and the Foreign Qualification
Certificate, respectively.

     You have not asked us to pass upon your power and authority to enter into
the Agreement or the Registration Rights Agreement.  Accordingly, for the
purposes of this opinion, we have assumed that you have all requisite power and
authority to enter into the Agreement and the Registration Rights Agreement and
to effect the transactions contemplated thereby, and that each of the Agreement
and the Registration Rights Agreement constitutes the valid and legally binding
obligation of all parties thereto other than the Corporation.

     We have made such examination of Massachusetts and federal Law and of the
General Corporation Law of Delaware as we deem necessary for the purposes of
this opinion.  We do not purport to pass herein on the laws of any state or
jurisdiction other than the United States of America and The Commonwealth of
Massachusetts, and as to its General Corporation Law only, the State of
Delaware.

     The opinions herein expressed are qualified to the extent that (i) the
validity or enforceability of any provisions of any agreement or instrument or
of any rights granted thereunder may be subject to or affected by any
bankruptcy, reorganization, insolvency, moratorium or similar law from time to
time in effect and relating to or affecting the rights or remedies of creditors
generally, (ii) the remedy of specific performance or any other equitable remedy
may be unavailable in any jurisdiction or may be withheld as a matter of
judicial discretion; and (iii) a court may apply equitable principles in
construing or enforcing the provisions of any agreement or instrument.

     The phrase "of which we have knowledge" means the actual knowledge of the
lawyer signing this opinion letter and the other lawyers in our office who have
had active involvement in negotiating the Transaction and preparing the
Agreement and the Registration Rights Agreement.

     Based upon and subject to the foregoing, we are of the opinion that:

     1.   The Corporation is a corporation duly incorporated, validly existing
          and in good standing under the laws of the State of Delaware and has
          the requisite corporate power to carry on its business as it is
          currently being conducted.

                                       2

<PAGE>

To the Persons listed in the Schedule
of Investors to the Series B
Convertible Preferred Stock Purchase
Agreement dated as of December 22, 1995

     2.   The Corporation is qualified to do business in The Commonwealth of
          Massachusetts.

     3.   The execution and delivery of the Agreement and the Registration
          Rights Agreement and the performance by the Corporation of its
          obligations thereunder have been duly authorized by all necessary
          corporate action on the part of the Corporation and do not violate or
          cause any default under any provision of (i) the Corporation's
          Certificate of Incorporation or By-Laws, or (ii) except where any such
          violation or default would not have a material adverse effect on the
          Corporation, any note, indenture, mortgage, lease, contract or other
          instrument, document or agreement to which the Corporation is a party
          and of which we have knowledge, or any writ, injunction, order,
          judgment or decree of any court, administrative agency or other
          governmental body to which the Company is a party and of which we have
          knowledge.  Each of the Agreement and the Registration Rights
          Agreement constitutes a valid and legally binding obligation of the
          Corporation, enforceable against the Corporation in accordance with
          its terms; provided, however, that we express no opinion as to the
          enforceability of the indemnification provisions contained in Section
          10 of the Registration Rights Agreement.

     4.   The sale of Initial Shares to each of you is not required to be
          registered under the Securities Act of 1933 or the Massachusetts
          Uniform Securities Act.

     5.   Upon receipt by the Corporation of the purchase price therefor, the
          Initial Shares will be validly issued, fully-paid and non-assessable.

     6.   No authorization, consent, approval or other order of, declaration to,
          or filing with, any governmental agency or body is required to be made
          or obtained by the Corporation for or in connection with the valid and
          lawful authorization, execution and delivery by the Corporation of the
          Agreement and the Registration Rights Agreement, for or in connection
          with the valid and lawful authorization, issuance, sale and delivery
          of the Initial Shares or for or in connection with the valid and
          lawful authorization, reservation, issuance, sale and delivery of the
          Reserved Shares to be issued upon the conversion of the Initial
          Shares, except such exemptive filings, if any, as are required to be
          made under applicable securities laws.

                                        Very truly yours,

                                        FOLEY, HOAG & ELIOT

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]